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 ABSTRACT 
 
Impaired insulin action, termed insulin resistance, is characteristic of type 2 
diabetes, obesity and aging. Given the rising epidemic of diabetes, efforts to 
understand the mechanisms of insulin resistance and discover effective therapeutic 
interventions are urgent. Considerable evidence now implicates oxidative stress in the 
patho-physiology of insulin resistance, a condition prevalent in the elderly and obese. 
Oxidative stress is known to activate several signaling cascades. This includes 
pathways that activate the stress kinases c-Jun N-terminal kinase (JNK) and the 
inhibitor of kappa B kinase β (IKKβ), which interact with and inhibit the insulin 
signaling cascade. The heat shock proteins HSP72 and HSP25 have been recently 
identified as natural inhibitors of JNK and IKKβ, respectively, and therefore represent 
novel therapeutic targets against insulin resistance. Overexpression of HSPs has been 
shown to protect against obesity-induced insulin resistance as well as age-related 
muscle damage. Skeletal muscle, the largest glucose disposing tissue, also contains 
large amounts of inducible HSPs. We hypothesized that heat shock protein 
overexpression in skeletal muscle could protect against insulin resistance in obesity 
and aging. We tested this hypothesis using aged male Fischer 344 rats (24-month-old) 
as the aging model of insulin resistance and male Wistar rats given a high fat diet 
(60% calories from fat) as the model of diet induced-insulin resistance. We examined 
the role of HSPs in insulin resistance by inducing HSP expression with both in vitro 
and in vivo heat treatments and anti-oxidant administration. Our results showed that 
 v 
 
 reduced HSP expression in the aging muscles is associated with a higher degree of 
stress kinase activation and insulin resistance in fast-twitch muscles compared to 
slow-twitch muscles. Increasing HSP72 expression in the muscles of young and old 
animals via heat treatment inhibited JNK activation. Heat-mediated JNK inhibition 
was specific to HSP72 induction, as determined by HSP72-inhibition studies, and was 
mediated by a direct interaction between HSP72 and JNK. In contrast to the muscle, 
brain sections from aging rats showed a robust increase in HSP25 expression, 
suggesting a tissue-specific regulation of HSPs in aging. In the high fat diet model, 
alpha-lipoic acid (LA), a potent antioxidant, was administered to relieve oxidative 
stress associated with high fat feeding. LA treatment improved insulin signaling and 
glucose transport, reduced stress kinase activation and increased HSP expression. As 
another method of HSP-induction, heat treatment, given in parallel with a high fat 
diet, improved glucose tolerance, reduced hyperinsulinemia, and reduced epididymal 
fat storage. In skeletal muscles, heat treatment induced HSP72 expression, improved 
insulin sensitivity, and reduced stress kinase activities. Heat treatment also enhanced 
mitochondrial function in fast-twitch muscles, normalizing the compensatory changes 
in mitochondrial protein expression seen with high fat feeding. Studies in L6 
myotubes showed that heat treatment improved oxygen consumption and fatty acid 
oxidation. Mechanistically, our results indicate that heat shock proteins can 1). 
improve insulin sensitivity, 2). directly inhibit stress kinase activities, and 3). protect 
and enhance mitochondrial function. Our studies provide strong evidence that HSP 
 vi 
 
 induction in skeletal muscle could be a potential therapeutic treatment for age-related 
and obesity-induced insulin resistance. 
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INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 1
INTRODUCTION 
 
1.1. Diabetes and insulin resistance 
 
Diabetes mellitus is a metabolic disorder characterized by hyperglycemia, 
resulting from either impaired insulin action (insulin resistance) or impaired insulin 
secretion (insulin deficiency). It is this hyperglycemia that gives the disease its name: 
Diabetes meaning “passing through” and mellitus meaning “honey sweet”, in 
reference to the abundance of sugar detected in blood and urine.  
Diabetes mellitus is regarded as the 7th leading cause of deaths in the US 
(CDC, 2006). It is manifested in two types: type 1 diabetes (T1D) and type 2 diabetes 
(T2D). T1D constitutes 5-10% of the diabetic population and is characterized by 
insulin deficiency. T1D has an autoimmune pathology, in which a cell-mediated 
autoimmune response destroys the insulin-secreting beta cells in the pancreas (Knip 
and Siljander 2008). It is most commonly diagnosed in childhood. Type I diabetes has 
strong genetic factors, but also has some environmental factors that are yet to be 
completely defined. Insulin administration for life has been the most important 
treatment regime (Cohen and Shaw 2007), and thus it is often referred to as ‘Insulin-
dependent diabetes mellitus’.  
T2D, which is the most predominant form of diabetes (90-95% cases), is 
characterized by insulin resistance. It was previously referred to as ‘Non-insulin-
dependent diabetes’ or ‘adult onset diabetes’, but now these terms are seldom used. 
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Chronic insulin resistance results in a compensatory increase of insulin secretion by β 
cells in the pancreas in an effort to maintain euglycemia (Weir and Bonner-Weir 
2007). However, prolonged compensation by β cells can subsequently lead to β cell-
dysfunction and hyperglycemia ensues. Therefore, advanced T2D can also be 
characterized by insulin dependency (Prentki and Nolan 2006).  
T2D has emerged as one of the most serious health concerns across the globe. 
The Center for Disease Control and prevention (CDC) estimates that nearly 8% of the 
population of the US alone (23.6 million people) currently suffers from diabetes. 
Because of this prevalence, diabetes is often referred to as an ‘epidemic’. A very 
recent study by Novo Nordisk estimated the economic burden of diabetes in 2008 as 
$218 billion in the US (ADA, 2008). T2D has a close association with aging, and 
therefore, more than half the economic burden of diabetes is incurred by people 65 
years of age or older (Hogan et al. 2003). Diabetes is also tightly associated with the 
epidemic of obesity. More than 30% of American adults are obese (body mass index, 
BMI>30) and more than 65% are overweight (BMI>25). Furthermore, the average 
age of onset of T2D has now decreased due to an alarming rise in the incidence of 
childhood obesity (Klein et al. 2004). In the US 15.8% of children between the ages 
of 6 and 11 years and 16.1% of adolescents have a BMI in the range of overweight for 
their age (Hedley et al. 2004). 
Abdominal obesity and insulin resistance are 2 of the 5 factors defining the 
‘metabolic syndrome’. The ‘metabolic syndrome’ or ‘syndrome X’ was first described 
by Reaven in 1988 (Reaven 1988). Ever since, the definition of “metabolic 
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syndrome” has been evolving, but broadly encompasses a set of metabolic 
abnormalities. According to the National Cholesterol Education Program Adult 
Treatment Panel (NCEP), patients are considered to have the metabolic syndrome if 
they meet 3 of the 5 criteria: 1.) abdominal obesity, 2.) hypertriglyceridemia, 3.) low 
HDL cholesterol, 4.) high blood pressure or the use of antihypertensive medication, 
5.) insulin resistance or glucose intolerance (or the use of antidiabetic medication) 
(NCEP 2001). In general, the risk for cardiovascular events is doubled and the risk for 
type 2 diabetes is increased about 5 fold in patients with the metabolic syndrome 
compared to those without it (Grundy 2008).  
T2D is known to be one of the main causes of mortality and morbidity 
worldwide (Saltiel and Kahn 2001), although, mortality due to diabetes occurs mainly 
from the associated complications. Poorly-managed diabetes leads to complications 
such as cardiovascular diseases (CVD), nephropathy, neuropathy, neurodegenerative 
diseases, cerebrovascular diseases and retinopathy (Tripathi and Srivastava 2006). 
But recent evidence suggests that chronic whole body insulin resistance, even before 
the onset of full blown diabetes, could be the basic pathophysiological disturbance 
that underlies atherogenic risk factors (Park et al. 2005; Ferrannini and Iozzo 2006). 
Development of T2D begins with insulin resistance and glucose intolerance. 
Skeletal muscle is responsible for the majority (75%) of insulin-mediated glucose 
disposal in the body (Bjornholm and Zierath 2005), making this tissue vital in 
maintaining insulin action and glucose homeostasis. Consequently, insulin resistance 
in muscle quickly leads to global dysregulation of glucose metabolism in the body. 
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Thus, treatments that prevent muscle insulin resistance may improve whole-body 
insulin action and significantly minimize the associated risks of T2D and 
cardiovascular disease. 
 
1.2. Risk factors for insulin resistance 
 
1.2.1. Advancing age: 
Insulin sensitivity is known to decrease with advancing age. The decline 
begins in the third or fourth decade of life and progressively reduces throughout an 
individual’s lifespan (DeFronzo 1981). Although several factors have been proposed 
to be responsible for age-related insulin resistance, the exact mechanism remains to 
be elucidated.  
It is suggested that reactive oxygen species produced during metabolic 
processes such as cellular respiration accumulate over the life time of an individual 
(Frisard and Ravussin 2006). Systemic oxidative stress is prevalent in the elderly as 
indicated by increased levels of protein carbonyls with age (Berlett and Stadtman 
1997; Levine 2002), increased glycated proteins (Baynes 2001), increased formation 
of oxidizing species (Schoneich 1999) and reduced proteasomal activities required to 
selectively degrade the oxidized proteins (Petropoulos et al. 2000). In addition, there 
is a reduction in anti-oxidant levels with age, including vitamin E, glutathione and 
HSP70 (Hall et al. 2000; Hall et al. 2001). Collectively, increased oxidative stress and 
reduced anti-oxidant mechanisms are characteristic of aging and a potential cause of 
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insulin resistance (Asghar and Lokhandwala 2006). Aging is also associated with 
mitochondrial dysfunction (Short et al. 2005), as a result of increased reactive oxygen 
species (ROS) (Sohal and Orr 1992), decreased mtDNA abundance (Barazzoni et al. 
2000; Welle et al. 2003) and cumulative mtDNA damage (Melov et al. 1995) in the 
skeletal muscle. Reductions in mitochondrial activity, which contribute to 
dysregulated intracellular lipid metabolism, have been implicated in the increased 
incidence of insulin resistance and subsequent T2D that occurs with aging (Petersen 
et al. 2003).  
The underlying insulin resistance poses increased risks for several diseases in 
the elderly, including diabetes, CVD, hypertension, neurodegenerative diseases, etc. 
As baby boomers grow older, the number of people over the age of 65 years is 
expected to double in the next 25 years (CDC), making the rise of diabetes within this 
population an increasingly critical health issue. As seen by the rise in the percentage 
of nursing facility residents with type 2 diabetes, it is thought that an age trend and an 
epidemic are converging (Adler 2008; Marquess 2008).  
1.2.2. Obesity:  
- Adiposity: Adiposity plays a central role in causing insulin resistance. 
Likewise, weight loss and bariatric surgery have shown significant reversal of 
metabolic derangements and insulin resistance associated with obesity (Leichman et 
al. 2008). Although obesity is a serious health concern, a significant proportion of 
obese individuals can achieve longevity without developing any morbidity such as 
T2D and CVD. One hypothesis to explain this observation is that total body fat is not 
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the sole source of the adverse health complications of obesity; rather the fat 
distribution or the relative proportion of lipids in various lipid deposition 
compartments is what determines the metabolic risk of the individual. It is now 
recognized that abdominal (visceral) obesity is a greater risk factor for insulin 
resistance than subcutaneous adiposity (Hamdy et al. 2006). Adipose tissue 
distribution is significantly altered in T2D patients. Compared to subcutaneous 
adiposity, visceral fat and intramuscular adipose depots are more closely associated 
with exacerbated insulin resistance in persons with T2D (Gallagher et al. 2009). A 
proposed mechanism by which visceral fat may cause its adverse effects is related to 
secretion of inflammatory cytokines. When examined in vitro, visceral fat has been 
shown to secrete increased amounts of inflammatory mediators, including C-reactive 
protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), retinoic acid 
binding protein-4 (RBP-4) and plasminogen activating factor-1 (PAI-1), compared to 
subcutaneous fat (Fain et al. 2004). Similarly, obese individuals with increased 
visceral adiposity have increased markers of systemic inflammation compared to 
equally obese subjects with increased subcutaneous fat (Tsigos et al. 1999).  
- Free fatty acids (FFA) and adipokines: Adipocytes decrease insulin action 
in peripheral tissues by releasing fatty acids and adipokines. In humans, even short 
term infusion of fatty acids is shown to induce insulin resistance and reduce insulin 
stimulated muscle glucose uptake (Dresner et al. 1999). It has been suggested that 
fatty acids and the associated oxidative stress activate several inflammatory stress 
kinases including JNK, IKKβ, PKCθ, mTOR and GSK3β (reviewed in detail in 
 7
section 1.4.1). Adipose tissue, previously considered only a storage tissue, is now 
recognized as an endocrine tissue, secreting several adipokines which regulate insulin 
sensitivity and global metabolism (Kershaw and Flier 2004). While adipokines such 
as leptin (Friedman and Halaas 1998), adiponectin (Berg et al. 2002) and visfatin 
positively regulate insulin action, inflammatory cytokines secreted by adipocytes such 
as TNF-α (Hotamisligil et al. 1993), IL-6, IL-1β, PAI-1 (Shimomura et al. 1996), 
resistin (Steppan et al. 2001) and RBP4 (Yang et al. 2005) inhibit insulin action.  
- Intramyocellular lipid accumulation: Skeletal muscle triglyceride levels are 
increased in obese individuals and are inversely related to insulin action (Pan et al. 
1997). Muscles from obese individuals exhibit increased rates of fatty acid uptake 
(Luiken et al. 2001) and extremely obese individuals have reduced capacity for lipid 
oxidation through lowered activity of key mitochondrial enzymes (Thyfault et al. 
2004). Thus, the imbalance between fatty acid uptake and fatty acid oxidation is 
thought to cause accumulation of lipids in the insulin resistant muscle.  
The relationship between intramuscular lipid content and reduced insulin 
action is not always consistent since elite athletes, who are very insulin sensitive, also 
have very high levels of intramuscular lipid content (Goodpaster et al. 2001). Further, 
improvements in muscle insulin sensitivity can happen with little or no change in 
muscle lipid levels (Phillips et al. 1996). The nature of this metabolic paradox, also 
called the ‘athlete’s paradox’, seems to indicate that it is not the size of the 
intramyocellular pool, but rather the balance between fatty acid availability, cellular 
uptake, oxidation (lipid turnover) and cellular energy demand.  
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- Intrahepatic lipid accumulation: Non-alcoholic fatty liver disease 
(NAFLD) is caused by fatty infiltration of the liver without excessive alcohol 
consumption (Adams and Angulo 2006). Factors that contribute to the hepatic fatty 
acid pool include circulating FFAs, de novo lipogenesis within the liver and dietary 
factors, including intake of both fatty acids and carbohydrates that serve as precursors 
for lipogenesis (Diraison et al. 2003). The balance between lipogenesis and lipolysis 
in the liver is mainly affected by the ratio of insulin to glucagon. In the case of insulin 
resistance, fatty acid flux to the liver is increased due to increased lipolysis in adipose 
tissue, which further leads to increased fatty acid uptake. This, in turn, increases 
hepatic glucose output and triggers increased insulin secretion, in order to maintain 
euglycemia. Finally, increased concentrations of insulin in the liver induce de novo 
lipogenesis, thus creating a vicious cycle (Diraison et al. 2003).  
1.2.3. Genetic susceptibility:  
 Although determining the genetic basis of a polygenic, multifactorial disease 
such as T2D has been very challenging, some putative genetic links have been made. 
Genes such as CAPN10, TCF7L2, PPARG, KCNJ11, TCF2/HNF1B and WFS1 have 
been implicated in T2D (Ridderstrale and Groop 2008). Since not all obese 
individuals develop diabetes, and not all diabetic individuals are obese, genetic 
susceptibility is a prerequisite, but determining susceptibility to T2D with genetic 
testing is still premature. Maturity Onset Diabetes in the Young (MODY) is a 
monogenic disease which has a phenotypic expression similar to the symptoms of 
T2D. Future studies will indicate the role of genetic susceptibility in diabetes.  
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1.2.4. Sedentary lifestyle 
 Exercise has been long recognized as the best known treatment against insulin 
resistance. The imbalance between increased caloric intake and reduced physical 
activity causes storage of the unutilized calories as fat, which is the underlying cause 
of insulin resistance. Studies have shown that clinical measures of physical fitness, or 
the lack thereof, can be used to predict insulin resistance in people at risk for diabetes 
(Chen et al. 2008), and even short term physical inactivity can have adverse 
metabolic effects (Hamburg et al. 2007).  In contrast, even a single session of exercise 
increases glucose uptake into the muscles during exercise, and increases glycogen 
accumulation and the ability of insulin to promote glucose uptake in the muscles after 
the exercise; all of which are important for glucose metabolism (Turcotte and Fisher 
2008). The pathways mediating glucose uptake with exercise include activation of 
AMPK, p38 MAPK and CAMK and will be discussed in detail in section (1.3.6.) 
below. Exercise also induces expression of GLUT4 (Ren et al. 1994), increases fatty 
acid oxidation (Thyfault et al. 2007) and increases mitochondrial biogenesis (Wright 
et al. 2007). Muscle from insulin-resistant individuals exhibit decreased fatty acid 
oxidation rates and it is thought that aerobic exercise may alleviate insulin resistance 
by correcting the mismatch between fatty acid uptake and fatty acid oxidation (Koves 
et al. 2005; Koves et al. 2008).   
1.2.5. Psychological stress:  
Recent evidence suggests that psychosocial stress also exerts a profound 
impact on glucose metabolism (van Dijk and Buwalda 2008). Stress can also alter 
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eating habits and thereby affect insulin metabolism indirectly. A study examining a 
cohort of 425 middle aged women showed that women who exhibited high levels of 
psychological stress including depression, tension and anger had elevated risk for 
developing the metabolic syndrome as seen in the follow up screening (Raikkonen et 
al. 2002). Thus, reduction of psychological stress may prevent the development of 
metabolic abnormalities.  
Clearly, there are multiple factors that can predispose individuals to develop 
insulin resistance and T2D. The multifactorial nature of this disease makes it a 
complex disease in need of future studies designed to investigate basic molecular 
mechanisms and identify molecular targets for treatment.  
 
1.3. Physiological functions of insulin 
 
1.3.1. Structure, synthesis and release of insulin: 
Insulin is a small protein secreted by the β-cells of the pancreas in response to 
increasing blood glucose concentrations. The insulin gene is highly conserved 
(Philippe 1991) and has two polypeptide chains A and B (21 and 30 amino acids, 
respectively), linked together by a pair of disulphide bonds. During synthesis of 
insulin, pre-proinsulin is first converted to proinsulin by proteolytic action, followed 
by folding of the protein into its stable configuration with the addition of three 
disulphide bonds. Proinsulin is then cleaved into C-peptide and mature insulin in the 
golgi. Insulin, C-peptide, Zn++ and amino acids are packaged into vesicles within the 
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golgi (Halban 1994). Release of the insulin vesicles requires increased uptake of 
glucose by pancreatic β-cells, which, leads to a concomitant increase in metabolism. 
Increased metabolism leads to an elevation in the ATP/ADP ratio, and ATP is 
responsible for the inhibition of an ATP-sensitive K+ channel. The net result is a 
depolarization of the cell, leading to Ca2+ influx, and fusion of vesicles with the 
membrane in a Ca-calmodulin-dependent process. Insulin is secreted from the beta 
cells into the portal vein in a pulsatile fashion, and impairment of the pulsatility of 
insulin secretion is observed in type 2 diabetes (Porksen 2002). 
1.3.2. Glucose metabolism: 
 The levels of circulating glucose are maintained within a narrow range of 4 
mM to 7 mM (80-100 mg/dL) by insulin in normal individuals (Saltiel and Kahn 
2001). Insulin maintains blood glucose levels by increasing glucose uptake in adipose 
tissue and striated muscle and by inhibiting hepatic glucose release. Once secreted 
into the blood stream, insulin binds several insulin responsive tissues that express the 
insulin receptor. Insulin signaling mediates several other functions beside glucose 
uptake in most tissues in the body, but the primary glucose disposing tissue is the 
skeletal muscle, responsible for almost 75% of glucose disposal in the body 
(Bjornholm and Zierath 2005). The adipose tissue accounts for less than 10% of 
glucose disposal (Klip et al. 1990). Insulin signaling in the liver controls 
gluconeogenesis by the inhibition of the chief gluconeogenic enzyme 
phosphoenolpyruvate carboxykinase (PEPCK) (Barthel and Schmoll 2003). 
Increasing evidence suggests that insulin also impacts glucose metabolism in several 
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other tissues, including the brain. Impaired insulin signaling in the brain has been 
recently implicated in diabetes (Reagan 2005).  
1.3.3. Other metabolic roles of insulin: 
 The role of insulin in metabolism is not limited to glucose homeostasis. 
Insulin is a very potent hormone, with functions in almost all areas of metabolism in 
the body. Insulin regulates vital processes such as lipogenesis, protein expression, 
protein synthesis, cell survival, cell differentiation and proliferation. It also acts to 
inhibit lipolysis, glycogenolysis and protein breakdown. For example, in adipose 
tissue, insulin inhibits the hormone sensitive lipase (HSL) by activating 
phosphodiesterase enzyme (PDE-3). This in turn decreases cAMP levels required to 
activate HSL-activating-PKA (protein kinase A), which inhibits lipolysis and 
stimulates lipogenesis (Large and Arner 1998).  
 Two main branches of the insulin signaling mitogenic cascade have been 
characterized, one controlled by phosphatidylinositol 3 kinase (PI3K) and another 
controlled by the small GTP-binding protein p21ras (Ras) (Tsakiridis et al. 1996). The 
downstream effectors of PI3K activation are mTOR and p70S6K (ribosomal S6 
kinase), which initiate protein synthesis by activating translation machinery including 
eukaryotic initiation factors (eIFs) and eukaryotic elongation factors (eEFs) (Chung et 
al. 1994). Insulin-activated Akt inhibits glycogen synthase kinase 3 (GSK3β) and thus 
inhibits GSK3β-mediated eIF2B inactivation. Akt also phosphorylates the TSC1 
(tuberous sclerosis complex 1)–TSC2 complex to relieve its inhibitory action on 
mTOR. mTOR controls translation initiation and elongation via p70S6K and eEF2K 
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(Proud 2006). Activation of small GTP binding proteins by insulin also turns on the 
proliferative signal through the sequential activation of Raf, MEK1/2, ERK1/2 and 
p70S6K (Iijima et al. 2002). Insulin also activates the stress activated mitogen 
activated protein kinases (MAPKs) such as c-Jun N-terminal kinase (JNK) acutely 
(Lee et al. 2003).  
1.3.4. Insulin signal transduction: 
Insulin signaling is mediated by a highly complex and intricate integrated 
network which is also highly regulated (reviewed in (Taniguchi et al. 2006)). The 
binding of insulin to its dimeric receptor (insulin receptor, IR) on the cell surface 
activates the receptor tyrosine kinase activity of the IR. The receptor phosphorylates 
itself and also results in recruitment and phosphorylation of insulin receptor 
substrates. There are at least 11 intracellular substrates of the IR, and 6 of these 
belong to the IRS family (IRS-1 to 6) (Cai et al. 2003). Other substrates include Gab-
1 (Lehr et al. 2000), Cbl (Baumann et al. 2000) and isoforms of Shc (Gustafson et al. 
1995). The IRS proteins have both pleckstrin homology (PH) domains and 
phosphotyrosine binding (PTB) domains which account for the high affinity of these 
substrates for the insulin receptor. The center and C terminus of IRS contain up to 20 
potential tyrosine phosphorylation sites (Gual et al. 2005), which upon 
phosphorylation are capable of binding to molecules containing Src-homology-2 
(SH2) domains, such as the phosphatidylinositol 3 kinase (PI3K). IRS-1 is the 
predominant isoform in skeletal muscle and IRS-1 deficiency results in impaired 
insulin action primarily in the muscle (Araki et al. 1994). Along with tyrosine 
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phosphoryation sites, the IRS-1 has several potential serine phosphorylation sites. 
Serine phosphorylation of IRSs seems to negatively regulate IRS signaling and has 
been implicated in the pathogenesis of insulin resistance (Gual et al. 2005; Zick 
2005).  
Tyrosine phosphorylated IRS recruits and activates PI3K, which consists of a 
regulatory and a catalytic subunit, each occurring in several isoforms (Myers et al. 
1992). PI3K catalyzes the formation of the lipid second messenger 
phosphatidylinositol tri phosphate (PIP3). PIP3 binds to proteins containing the PH 
domains, and allows such proteins to localize to the membrane and be activated. 
Activation of PH domain-containing 3-phosphoinositide-dependent protein kinase-1 
(PDK1) causes phosphorylation of Akt/PKB on Thr308 (Alessi et al. 1997) and PKCζ 
on Thr410 (Le Good et al. 1998), thereby activating these kinases. For complete 
activation, Akt requires phosphorylation on Ser473 as well, which is proposed to be 
mediated by mTOR (Sarbassov et al. 2005). Downstream targets of Akt include 
GSK3 (which leads to glycogen synthesis), tuberin (TSC2, inhibition of which by Akt 
activates mTOR), FOXO (regulates expression of gluconeogenic and lipogenic genes) 
and the Rab-GTPase-activating protein, AS160. Phosphorylation of AS160 triggers 
the activation of Rab small GTPases that are involved in the cytoskeletal 
reorganization required for the translocation of the glucose transporter GLUT4 to the 
plasma membrane (Sano et al. 2003). PKCζ, one of the atypical PKCs, is also 
activated in the PI3K axis and has been shown to have a role in insulin stimulated 
glucose uptake (Farese 2002).  
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1.3.5. Redistribution of glucose carriers by insulin: 
 The lipid bilayer of cells is impermeable to hydrophilic molecules such as 
glucose. Thus, glucose has to be transported across the plasma membrane by means 
of membrane associated carrier proteins, glucose transporters. The two types of 
glucose transporters are: the sodium dependent glucose transporters (SGLT) and the 
facilitative glucose transporters (GLUT) (Bell et al. 1990). SGLT co-transporters, or 
symporters, are essentially Na+K+ ATPase pumps that mediate the energetically 
favored movement of a sodium ion across the plasma membrane into the cell, driven 
by a concentration gradient and a membrane potential; and this is coupled to the 
movement of the glucose molecule (Scheepers et al. 2004).  
The facilitative glucose transporter, or GLUT family, comprises of 13 
members and all catalyze hexose transport across membranes in an ATP-independent 
manner (reviewed in (Joost and Thorens 2001)). All members have a striking tissue 
specific expression and variable hexose affinities. The facilitative glucose transporters 
are predicted to have 12 membrane spanning regions with intracellular amino- and 
carboxy-termini (Scheepers et al. 2004). GLUT1 is ubiquitously expressed and its 
highest expression is seen in erythrocytes and endothelial cells of brain. GLUT2 is 
primarily expressed in pancreatic β cells, liver, kidney and intestine. GLUT3 is 
expressed in neurons (Joost and Thorens 2001).  
GLUT4 is primarily present in insulin responsive tissues such as skeletal 
muscle, adipose tissue, brain, and heart and is the insulin responsive glucose 
transporter. Insulin acts by stimulating the translocation of specific GLUT4 
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containing vesicles (GLUT4 storage vesicles, GSV) from intracellular pools to the 
plasma membrane resulting in glucose transport (Bryant et al. 2002). Impaired 
mobilization of GLUT4 via insulin signaling and decreased expression of GLUT4 in 
adipose tissue has been implicated in insulin resistance and diabetes (Shepherd and 
Kahn 1999). 
 Under basal conditions, GLUT4 vesicles reside in the intracellular storage 
vesicles and a small fraction (4-5%) are present at the plasma membrane (Klip et al. 
1990). GLUT4 vesicles travel to the plasma membrane at a very slow rate even in the 
absence of insulin, but the rate of endocytosis is greater than that of exocytosis (Li et 
al. 2001). Insulin reverses this rate profile. Insulin signaling changes the cellular 
dynamics of GLUT4 vesicles via the actin cytoskeleton (Guilherme et al. 2000) and 
increases the plasma membrane distribution of GLUT4. The organization of the actin 
cytoskeleton aids the movement of GLUT4 vesicles to the plasma membrane and 
their subsequent fusion (Guilherme et al. 2000).  
 GLUT4 storage vesicles have a perinuclear location in 3T3L1 adipocytes and 
L6 myocytes and co-localize with v-SNARE (soluble N-ethylmaleimide-sensitive 
factor attachment protein receptors) vesicle-associated membrane protein (VAMP)2 
(Malide et al. 1997). VAMP2 is a selective marker of GSVs and is required for 
insulin-stimulated fusion of GSVs to the plasma membrane, but not in the basal state. 
Despite several studies, the characterization of GLUT4 vesicles and the regulation of 
their translocation in response to insulin still remain controversial. The fusion process 
is mediated by interaction of v-SNARE (VAMP2) on the vesicles with cognate 
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receptors t-SNARE (soluble NSF-attachment protein, SNAP23) on the target 
membrane, orchestrated by several accessory proteins such as Munc18c, Synip and 
Tomosyn (Watson and Pessin 2006).  
1.3.6. Insulin independent GLUT4 translocation: 
 Although insulin-stimulated GLUT4 translocation to the plasma membrane 
constitutes the major pathway of increasing glucose transport, several other 
mechanisms have been described. These insulin-independent mechanisms are 
receiving great attention with the prospect of improving glucose uptake in insulin 
resistant patients. Muscle contraction and exercise (Lund et al. 1995; Kennedy et al. 
1999), osmotic pressure (Chen et al. 1997), hypoxia (Mu et al. 2001; Wright et al. 
2005) and acute oxidative stress (Kim et al. 2006; Dokken et al. 2008) each stimulate 
glucose transport in muscle. The PI3K-independent signaling pathways mediating 
glucose uptake are not clearly defined, although Ca2+/calmodulin dependent protein 
kinase (CAMKII) (Wright et al. 2004), AMP dependent protein kinase (AMPK) (Mu 
et al. 2001; Fujii et al. 2007), conventional protein kinase C isoforms (α,β,γ,ζ) (Perrini 
et al. 2004)  and p38 MAPK (Geiger et al. 2005) have been implicated. Contraction-
associated changes in intramyocellular calcium concentrations activate CAMKII, 
which, by yet unclear mechanisms, induces glucose uptake. Inhibition of CAMKII 
with its inhibitor KN62 decreases contraction-induced glucose transport by about 
50% (Wright et al. 2004). p38 MAPK is activated by muscle contraction (Wretman et 
al. 2001) but its role in glucose uptake is under debate (Fujishiro et al. 2001). While 
some studies show inhibitory effects of p38 MAPK (Ho et al. 2004), others support 
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its role in glucose uptake. Recent studies indicate a role for p38 MAPK in GLUT4 
activation rather than GLUT4 translocation (Somwar et al. 2001).   
AMPK, a sensor of cellular energy status, has been implicated in exercise and 
contraction mediated glucose transport (Kurth-Kraczek et al. 1999; Mu et al. 2001). 
AMPK is a heterotrimeric protein consisting of a catalytic α subunit and two 
regulatory subunits (β and γ). AMP activates AMPK allosterically and induces 
phosphorylation of a threonine residue (Thr172) within the activation domain of the α 
subunit by upstream kinases such as LKB-1 and CAMKK β (Hurley et al. 2005; Kahn 
et al. 2005). AMPK can also be activated by an adenosine analog (AMP mimetic) 5-
aminoimidazole-4-carboxamide-riboside (AICAR) in resting muscle to stimulate 
glucose uptake (Merrill et al. 1997). The downstream signaling from AMPK leading 
to glucose uptake is not clearly understood, but AS160 is thought to be one of its 
substrates. Likewise, in human skeletal muscle, insulin (Karlsson et al. 2005) and 
exercise (Deshmukh et al. 2006) stimulate phosphorylation of AS160. Thus, the two 
pathways (insulin-PI3K-Akt and AMPK signaling) are thought to converge at the 
point of AS160 leading to glucose uptake (Thong et al. 2007).   
The AMPK pathway also has profound effects on the regulation of fatty acid 
metabolism. Fatty acid oxidation in the muscle involves a rate-controlling step that is 
regulated by carnitine palmitoyltransferase 1 (CPT1). CPT1 transfers long chain acyl-
CoA into the mitochondria and this process is inhibited allosterically by malonyl-
CoA (Ruderman et al. 1999), synthesized by acetyl CoA carboxylase (ACC) 
(Trumble et al. 1995). The activity of ACC is inhibited by AMPK via reversible 
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phosphorylation (Winder et al. 1997). During exercise or in presence of AICAR, 
AMPK inhibits ACC to reduce malonyl CoA concentrations, thereby driving long 
chain acyl-CoA into the mitochondria for beta oxidation to restore energy balance 
(Merrill et al. 1997). Thus the ability of AMPK to induce lipid oxidation and thus 
lower muscle lipid deposition is considered an important feature for the insulin 
sensitizing effects of AMPK.  
 
1.4. Mechanisms of insulin resistance 
 
1.4.1. Oxidative stress: 
Increasing evidence points at chronic tissue oxidative stress as the underlying 
factor in the etiology of insulin resistance (Houstis et al. 2006). In high fat feeding, 
increased oxidative stress has been shown to precede the onset of insulin resistance 
(Matsuzawa-Nagata et al. 2008).  Furukawa and colleagues have shown that fat 
accumulation in obesity correlates with systemic oxidative stress in humans and mice 
(Furukawa et al. 2004). Oxidative stress can result from endoplasmic reticulum stress, 
mitochondrial dysfunction, nutrient excess, hyperinsulinemia and inflammatory 
cytokines such as TNF-α. Aging is also associated with oxidative stress and 
accumulation of reactive oxygen species over the years is believed to in fact 
contribute to the aging process itself (Beckman and Ames 1998). Insulin resistance 
appears to be a manifestation of metabolic overload in obesity, and obesity/high fat 
 20
feeding is associated with high levels of reactive oxygen species formed during 
incomplete oxidation of fatty acids (Muoio and Newgard 2008).  
The connecting link between oxidative stress and insulin resistance are the 
stress activated kinases which can phosphorylate the IRSs on serine residues (Figure 
1). The pivotal point in the switch to insulin resistance is believed to be at the level of 
the IRSs, where serine phosphorylation of IRS causes a conformational change in the 
IRS, preventing insulin induced tyrosine phosphorylation (Liu et al. 2004; Draznin 
2006). Specifically, phosphorylation on the Serine 307 (Ser307 in mouse, rat; Ser312 
in humans) residue of IRS-1 is thought be the crucial inhibitory signal leading to 
insulin resistance (Aguirre et al. 2000; Jiang et al. 2003). Transgenic mice with a 
muscle-specific serine to alanine substitution in IRS-1 are protected from fat-induced 
insulin resistance, as seen by improved glucose tolerance, increased insulin stimulated 
glucose uptake and increased IRS-1-PI3K association (Morino et al. 2008). IRS-1 
serine phosphorylation occurs in response to insulin stimulation as well, primarily as 
a feedback mechanism to contain insulin action (Hers and Tavare 2005). But it has 
been shown that insulin/Insulin like growth factor-1 (IGF-1) and TNF-α associated 
phosphorylation of IRS-1 Ser307 occur by distinct pathways, indicating that normal 
regulatory negative feedback mechanisms and mechanisms of insulin resistance are 
distinct (Rui et al. 2001). Chronic serine phosphorylation of IRS-1 can lead to 
proteasomal degradation of the protein, and low protein levels of IRS-1 are observed 
in patients with diabetes (Carvalho et al. 1999; Zhande et al. 2002). On the other 
hand, some evidence also argues against the sole involvement of IRS-1 in causing 
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insulin resistance (Potashnik et al. 2003). Using a heterologous system involving a 
platelet derived growth factor pathway that recapitulates many aspects of insulin 
action independent of IRS-1, Hoehn et al. showed that the major nodes of insulin 
resistance are independent of IRS-1 (Hoehn et al. 2008).  
The kinases implicated in serine phosphorylation of IRS-1 include c-Jun N-
terminal kinase (JNK) (Aguirre et al. 2000), inhibitor of kappa B kinase (IKKβ) 
(Yuan et al. 2001; de Alvaro et al. 2004; Sriwijitkamol et al. 2006), mammalian target 
of rapamycin (mTOR) (Carlson et al. 2004), protein kinase C theta  (PKCθ) (Griffin 
et al. 1999; Haasch et al. 2006) and glycogen synthase kinase-3 (GSK3) (Dokken et 
al. 2005; Henriksen et al. 2008). Of these kinases, the roles of JNK, IKKβ and PKCθ 
have been the most extensively characterized in causing insulin resistance and an 
orchestrated effect of all these kinases is suggested (Gao et al. 2004). The activation 
stimuli for JNK and IKKβ include cellular stresses such as oxidative stress, UV 
radiation, heat, proinflammatory cytokines like TNF-α, IL-1β (Ip and Davis 1998; 
Hacker and Karin 2006), while PKCθ is primarily activated by the breakdown 
products of fatty acids, namely diacylglycerols and ceramide (Griffin et al. 1999; Idris 
et al. 2002).   
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FIGURE 1.  
Figure 1. Mechanisms of insulin resistace: role of oxidative stress, IRS-1 
inhibition by JNK and IKKβ, and mitochondrial stress.  High fat diet and aging 
(1.) are associated with accumulation of reactive oxygen species and free fatty acids, 
mitochondrial dysfunction and endoplasmic reticulum stress. Cumulatively, these 
factors cause chronic oxidative stress (2.) in the skeletal muscle. Oxidative stress 
activates stress kinases JNK (3.) and IKKβ (4.), which, in turn, phosphorylate the 
insulin receptor substrate IRS-1 on Ser307. (p)-Ser307-IRS-1 inhibits the insulin 
stimulated tyrosine phosphorylation of IRS-1 (5.), and thereby reduces the action of 
insulin to mediate glucose transport (6.). Lipid excess or overnutrition seen in obesity 
(7.) leads to incomplete beta oxidation, and thereby results in accumulation of 
intermediate products of oxidation, increased reactive oxygen species (ROS) and 
mitochondrial stress (8.). In aging, mtDNA damage and reduced enzyme activities 
cause mitochondrial dysfunction. Mitochondrial stress and the associated oxidative 
stress are believed to contribute in causing insulin resistance. 
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1.4.2. Role of JNK in insulin resistance:  
JNK activity levels are elevated in liver, muscle, and adipose tissues of diet 
induced- and genetic models of obesity, and its involvement in causing insulin 
resistance has been confirmed by showing that JNK-/- mice are resistant to insulin 
resistance (Hirosumi et al. 2002). Overexpression of a dominant negative JNK mutant 
in the liver of obese mice resulted in dramatic improvements in insulin sensitivity and 
reduced IRS-1 serine phosphorylation (Nakatani et al. 2004). Further, a recent study 
proposed the use of a cell permeable JNK inhibitory peptide as an effective treatment 
to reverse diabetes by reducing (p)-Ser307-IRS-1 (Kaneto et al. 2004). Also, silencing 
of the upstream MAP4K4 in human skeletal muscle prevented  TNF-α-JNK-mediated 
insulin resistance (Bouzakri and Zierath 2007). Inversely, activation of JNK with free 
fatty acids/TNF-α/western diet (Nguyen et al. 2005; Prada et al. 2005) or with obesity 
in human skeletal muscle (Bandyopadhyay et al. 2005) increased (p)-Ser307-IRS-1 
and reduced insulin signaling. Taken together, the JNK pathway is implicated in the 
development of insulin resistance, and JNK-mediated (p)-Ser307-IRS-1 is implicated 
as the molecular mechanism (Figure1).  
1.4.3. Role of IKKβ in insulin resistance:  
Oxidative stress also activates the inhibitor of kappa B kinase β (IKKβ), the 
kinase that activates the NFκB pathway (Ogihara et al. 2004; Arkan et al. 2005). 
Activity of IKKβ has been reported to be increased in insulin resistant muscles of 
obese animal models, and inhibition of IKKβ with salicylates has reversed this insulin 
resistance (Shoelson et al. 2003). Targeted disruption of IKKβ reversed obesity and 
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diet induced-insulin resistance (Yuan et al. 2001). IkBα/β are the downstream targets 
of IKKβ and get phosphorylated and degraded upon activation of IKKβ, further 
activating the NFkB pathway (Mercurio et al. 1997). Protein levels of IkBβ are 
reduced in the skeletal muscle of diabetic patients, indicating increased activity levels 
of the inflammatory kinase IKKβ (Sriwijitkamol et al. 2006). The insulin resistance-
inducing inflammatory cytokine TNF-α induces activation of IKKβ in obesity, but 
sodium salicylate has been shown to inhibit this activation (Schwenger et al. 1998; de 
Alvaro et al. 2004) (Figure1). 
The involvement of IRS-1 serine phosphorylation in insulin resistance, and 
the role of JNK and IKKβ in mediating (p)-Ser307-IRS-1, has been extensively 
characterized in obesity models of insulin resistance. However, the mechanisms of 
insulin resistance in the aging muscle are poorly understood. Studies addressing the 
involvement of stress kinases and IRS-1 phosphorylation status are needed to get a 
better understanding of age-related impairment of insulin signaling.  
1.4.4. Mitochondria and insulin resistance: 
Mitochondrial dysfunction is characteristic of aging and has been proposed to 
be a cellular malfunction that contributes to insulin resistance and diabetes even in the 
obese (Figure 1). Reduced mitochondrial numbers are seen in patients with diabetes 
and insulin resistant individuals with glucose intolerance (30% less than the insulin 
sensitive control subjects) (Lowell and Shulman 2005; Morino et al. 2006). Along 
with reduced numbers, diabetic patients, insulin resistant individuals, and insulin 
resistant offsprings of patients with T2D have impaired mitochondrial function, 
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downregulation of OXPHOS metabolism, and impaired mitochondrial enzyme 
activities (Kelley et al. 2002; Patti et al. 2003; Petersen et al. 2004; Sparks et al. 2005; 
Asmann et al. 2006). The master regulator of mitochondrial biogenesis PGC-1α 
(Peroxisome proliferator-activated receptor-  Coactivator-1α), and the corresponding 
PGC-1 responsive genes are downregulated in diabetes and obesity (Mootha et al. 
2003; Crunkhorn et al. 2007). Mitochondrial dysfunction appears to result from 
chronic oxidative stress (Bonnard et al. 2008). Therefore, interventions that protect 
mitochondrial function in insulin resistance could have potential benefits in protecting 
against insulin resistance. Studies exploring such interventions are important and 
could lead to novel approaches for the prevention of diabetes.  
Although mitochondrial depletion and dysfunction have been believed to be 
intrinsic to the pathology of insulin resistance, recent evidence argues against it. 
Hancock et al. show that a high fat diet is associated with insulin resistance despite 
increased mitochondrial number and activity (Hancock et al. 2008). Another study by 
Turner et al. showed that increased mitochondrial number, increased enzyme 
activities, increased fatty acid oxidation, and increased PGC-1α are seen in rodents 
given a high fat diet (Turner et al. 2007). An increase in the expression of citrate 
synthase protein has been reported in epitrochlearis muscles from rats with high 
plasma fatty acid levels, along with cytochrome c, COX1, COX4 and others (Garcia-
Roves et al. 2007). Thus, further studies are warranted to resolve the controversy of 
mitochondrial function in insulin resistance.  
 
 26
1.4.5. Muscle type differences in insulin action: 
The mammalian skeletal muscle comprises the following four different fiber 
types characterized by specific myosin heavy chain (MHC) isoforms (Delp and Duan 
1996):  
1. slow-twitch fiber type (type I, oxidative, MHC1β),  
2. fast-twitch fiber types (type II) 
- type IIA, oxidative/glycolytic, MHCIIa  
- type IIB, non-oxidative/glycolytic, MHCIIb 
- type IID/X, MHCIId/x, which is in between type IIA and IIB fibers 
Humans do not typically express MHCIIb in locomotor skeletal muscles 
(Spangenburg and Booth 2003). Types IIA, IIX, and IIB fibers are found in skeletal 
muscle of other mammals (e.g., rodents and cats). The rat has muscles with highly 
specific fiber types and therefore provides a good model for studying their specific 
responses. For example, the soleus muscles in the hind limb consist predominantly of 
slow-twitch red fibers (84% type I, 16% type II) (Ariano et al. 1973), while the 
Epitrochlearis muscle in the fore limb is comprised of primarily fast-twitch white 
fibers (15% type I, 20% type IIA, 65% type IIB) (Nesher et al. 1980). 
 Type I fibers seem to be more responsive to insulin, exhibiting greater insulin 
binding capacity and increased activation of insulin signaling intermediates compared 
with type II fibers (Song et al. 1999). Aging-associated muscle atrophy and loss of 
muscle mass, termed as ‘sarcopenia’, and is thought to occur almost exclusively in 
the type II myofibers. Sarcopenia develops focally along the length of the fiber in 
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regions that are characterized by compromised respiratory function, mitochondrial 
DNA deletions and oxidative damage (Lopez et al. 2000; Wanagat et al. 2001; Bua et 
al. 2002). Anderson et al. found that mitochondrial free radical leak (H2O2 
produced/O2 consumed) is two- to three-fold higher in type II fibers than in type I 
fibers during basal respiration. Further, when normalized for mitochondrial content, 
the H2O2 scavenging capacity is lower in the type II fibers compared with type I 
soleus muscle fibers, indicating that there are muscle fiber type-specific differences in 
the capacity of handling oxidative stress (Anderson and Neufer 2006).  In contrast, 
obese subjects tend to exhibit fewer type I fibers and increased percentage of type II 
fibers than do lean subjects (Hickey et al. 1995). In light of these observations, it 
would be important to determine whether the susceptibility of the two fiber types to 
insulin resistance with age or high fat feeding is different.  
The mitochondria in the skeletal muscle are morphologically and functionally 
heterogenous because of the metabolic demands and substrate preferences associated 
with each specific muscle fiber type (Kushmerick et al. 1992; Jackman and Willis 
1996). Thus it would also be important to determine how the mitochondria in the 
different muscle fiber types respond to a change in diet (example, a high fat diet) and 
an intervention such as heat treatment.  
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1.5. Heat shock proteins 
 
1.5.1. Chaperone function of HSPs:  
Heat shock proteins have been extensively characterized in their role of being 
chaperones. As chaperones, HSPs maintain proteins in correctly folded conformation 
by: 1.) prevention of aggregation, 2.) promotion of folding to native state, 3.) 
solubilization of aggregates and refolding of proteins, and 4.) targeting severely 
damaged proteins for degradation (reviewed in (Mayer and Bukau 2005)). The best 
characterized heat shock protein is HSP72, the inducible member of the HSP70 
family. HSP72 contains 3 major functional domains:  
1.) N-terminal ATPase domain, which functions to bind ATP and hydrolyzes it. 
Unfolded proteins are bound in the ATP-bound state.  
2.) Substrate binding domain that contains a binding site for about 7 hydrophobic 
amino acid residues. Hydrolysis of ATP locks the substrate in the cavity.  
3.) C-terminal domain, which serves as a ‘lid’ for the substrate binding domain. 
Release of ADP and inorganic phosphate, iP at the end of the ATP cycle allows the 
release of substrate and subsequent binding of ATP.  
The exact mechanism by which protein refolding occurs is still not clearly 
understood, but it is thought that binding and release cycles allow local refolding of 
the substrate, and help overcome the kinetic barriers for proper folding (reviewed in 
(Slepenkov and Witt 2002; Mayer and Bukau 2005)). Although the chaperone 
function of HSPs may be one of the factors involved in protection from insulin 
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resistance, evidence suggests that there may be other poorly understood roles of the 
HSPs in the cells (Yaglom et al. 1999) as discussed below.   
1.5.2. Evidence of involvement of HSPs in insulin resistance:  
The first direct evidence of the association of HSPs with insulin resistance, to 
our knowledge, came from a study by Kurucz et al. (Kurucz et al. 2002). They 
showed that HSP72 expression was decreased in skeletal muscle of type 2 diabetic 
patients and the reduction in HSP72 expression correlated with the degree of insulin 
resistance. The study also showed that HSP expression correlates with the rate of 
glucose uptake and other measures of insulin-stimulated carbohydrate and lipid 
metabolism. Shortly after, another study by Bruce et al. (Bruce et al. 2003), also 
showed that intramuscular HSP72 mRNA expression was reduced in patients with 
type 2 diabetes. Furthermore, in a study comparing 5600 genes of nondiabetic 
subjects with diabetic subjects, HSP701A was one of only 12 genes that were 
significantly lower (by 42%) in individuals with diabetes and whose expression 
correlated inversely with fasting glucose levels (Patti et al. 2003). These studies 
therefore brought up the idea that loss of HSPs may be involved in the pathogenesis 
of insulin resistance.  
Experimental diabetes induced with streptozotocin, an alkylating agent that 
selectively destroys pancreatic beta cells (Wang and Gleichmann 1998), also shows 
altered heat stress response, seen as reduced HSP expression in response to heat 
(Najemnikova et al. 2007). Along with other anti-oxidant mechanisms, HSP 
expression is reduced in the serum from subjects with metabolic syndrome (Armutcu 
 30
et al. 2008). Taken together, it is clear that reduction of HSP expression is somehow 
related to insulin resistance. Consequently, increasing HSP expression could be 
considered a therapeutic strategy to protect from insulin resistance and diabetes.   
In light of HSP induction as a therapeutic strategy, a pilot study in patients 
with type 2 diabetes found that hot tub therapy can improve glycemia control in these 
patients (Hooper 1999). Kokura et al. showed similar findings in obese db/db mice 
subjected to heat therapy (Kokura et al. 2007). HSP induction as been proven 
beneficial in several other conditions, including protection from ischemia reperfusion 
injury (Ooie et al. 2001; Chen et al. 2005), reducing transplantation rejects (Ghavami 
et al. 2002), attenuation of skeletal muscle damage by cryolesioning (Miyabara et al. 
2006), and in protection from age-related muscle damage during contractile activity 
(Broome et al. 2006). In their anti-oxidant function, HSPs are known to protect 
against oxidative stress (Escobedo et al. 2004; Selsby and Dodd 2005; Broome et al. 
2006).  
The strongest evidence of HSP induction as a protective mechanism came 
from the study by Chung et al., who showed that HSP72 overexpressing mice were 
protected from insulin resistance (Chung et al. 2008). A combination of a mild 
electric stimulation and heat shock was shown to improve insulin signaling and 
reduce lipid accumulation in the liver (Morino et al. 2008).  
Clearly, it is now being recognized that HSPs might play a major role in 
glucose homeostasis. The mechanisms of action and therapeutic interventions to reap 
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the benefits of HSP-overexpression are yet to be identified. Further, the role of HSPs 
in muscle-specific glucose uptake has not been established.  
1.5.3. Mechanisms of HSP benefits: 
  The mechanisms underlying the beneficial effects of HSPs are poorly 
understood, but several hypotheses have been proposed:  
1.5.3.1. Inhibition of stress activated kinases: 
Studies in the apoptosis area of research have shown that HSP72 induction is 
associated with reduction in JNK-associated apoptosis (Mosser et al. 1997). Cell 
culture studies have shown that HSP72 can specifically interact with JNK and inhibit 
activation of JNK (Park et al. 2001). Using siRNA silencing techniques, this study 
confirmed the role of HSP72 in JNK inhibition and HSP72-associated apoptosis 
inhibition. Interestingly, this novel role of HSP72 in JNK inhibition is independent of 
HSP72’s role in prevention of protein damage (Yaglom et al. 1999). Further evidence 
suggests that HSP25 can bind and inhibit activation of IKKβ (Park et al. 2003) and 
HSP25 overexpression is protective against apoptosis (Lee et al. 2004). Thus, HSP72 
and HSP25 have been suggested to function as natural inhibitors of the stress kinases 
JNK and IKKβ respectively. But the effects of HSP-mediated stress kinase inhibition 
on insulin action are not known. Novel information regarding this novel role of HSPs 
may lead to discovering novel therapeutic targets and interventions.  
Some evidence suggests that HSP72 interaction with JNK directly inhibits 
activation of JNK by upstream kinases (Park et al. 2001). HSP72 interacts with and 
inhibits the Dual Leucine zipper bearing kinase-1 (DLK-1), known as a kinase 
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responsible for activating JNK (Daviau et al. 2006). Other studies suggest that 
HSP72-JNK interaction activates a phosphatase such as the MAPK phosphatase-1 
(MKP-1), which dephosphorylates and inactivates JNK (Meriin et al. 1999; Lee et al. 
2005). Indeed, overexpression of MKP-1 can increase insulin sensitivity (Emanuelli 
et al. 2008). Nevertheless, either mechanism results in reduced JNK activity despite 
the presence of a JNK-activating stimulus (oxidative stress, anisomycin etc). The 
characterization of the interaction of HSPs with other kinases such as IKKβ has been 
very limited and warrants further study.  
1.5.3.2. Removal of oxidative stress:  
Exercise is a potent inducer of HSPs and is associated with modest amounts of 
oxidative stress. It is believed that HSP overexpression in exercise could be a 
mechanism of protection against oxidative stress (Smolka et al. 2000). In support of 
this possibility, heat stress and HSP induction are known to reduce oxidant damage in 
the muscle as seen by reduced 4-hydroxy-2-nonenol levels and reduced nitrosylated 
tyrosine residues (Selsby and Dodd 2005).  
1.5.3.3. Prevention of stress-induced apoptosis: 
 JNK is involved in both intrinsic as well as extrinsic pathways of apoptosis 
and functions to suppress several inhibitors of apoptosis including p53, Bcl-2, Bax 
and Bak, while HSPs can prevent this suppression (reviewed in (Beere 2005)). HSP70 
can prevent the activation of stress activated JNK (Gabai et al. 1997) and prevent 
TNF-induced Bid-dependent apoptosis pathways (Gabai et al. 2002). Inversely, 
reduced  thermotolerance in aged rats is thought to result from a loss of HSP72-
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mediated control of JNK pathway (Volloch et al. 1998). The relationship between 
reduced apoptosis and insulin sensitivity is not clear but HSPs would play a role in 
maintaining healthy cell structures that would be crucial in facilitating efficient 
signaling.  
1.5.3.4. Mitochondrial protection:  
Heat shock proteins have been shown to protect mitochondrial function from 
hypoxia/reoxgenation injury (Williamson et al. 2008), from oxidative stress (Downs 
et al. 1999) and from ischemic injury (Voloboueva et al. 2008; Xu et al. 2008). In 
fact, mitochondria have been suggested to be the selective targets for the protective 
effects of heat shock treatment against oxidative stress (Polla et al. 1996). Heat shock 
proteins have been implicated in maintaining mitochondrial function by reducing 
oxidative stress (Ouyang et al. 2006), mediating protein folding in stress conditions 
(Kregel 2002), increasing mitochondrial enzyme activities (Sammut et al. 2001) and 
improving protein import (Young et al. 2003). HSPs are known to aid transport of 
nuclear encoded proteins into the mitochondria via  interaction with the mitochondrial 
protein import receptor protein Tom70 (Young et al. 2003). Sammut et al. showed 
that heat stress enhances the activity of the mitochondrial complex, affording 
prolonged preservation of the cardiac cells for transplantation (Sammut et al. 2001). It 
is thought that the protection by heat stress is primarily due to enhancement of 
mitochondrial energetics in conditions of stress. Further, the target of one HSP72 
inducing drug, geranylgeranylacetone (GGA), is cardio-protection in the 
mitochondria. GGA preserves mitochondrial function and reduces apoptosis in 
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response to hypoxia-reoxygenation (Shinohara et al. 2007). HSP72 can directly 
enhance the activity of superoxide dismutase during myocardial ischemia-reperfusion 
and thereby protect the mitochondria from injury (Suzuki et al. 2002).  
Taken together, mitochondria have been repeatedly implicated in insulin 
resistance and HSPs are thought to protect mitochondrial function. Thus, it would be 
crucial to determine whether HSPs modulate mitochondrial function in an insulin-
resistant animal model and whether such modulations have benefits on reversing 
insulin resistance.   
Mitochondrial function is also regulated by the uncoupling protein-3 (UCP-3), 
which is expressed almost exclusively in the skeletal muscle (Gong et al. 1997).  
UCP-3 has been implicated in increasing fatty acid oxidation capacity (Wang et al. 
2003; Bezaire et al. 2005), and mitigating ROS production by providing a negative 
feedback loop to reduce transmembrane proton motive force (Echtay et al. 2002). But 
unlike UCP-1, UCP-3 may not play a significant role in non shivering thermogenesis, 
unless there is supraphysiological adrenergic stimulation (Mills et al. 2003). Acute 
exercise (Schrauwen et al. 2002) and high fat feeding (Matsuda et al. 1997) have both 
demonstrated increased UCP-3 expression in rodents and humans. The effect of heat 
treatment on mitochondrial UCP-3 expression is not known and whether the 
beneficial effects of heat of mitochondrial function are associated with UCP-3 
expression needs to be investigated.  
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1.5.4. Tissue-specific regulation of HSPs:  
The skeletal muscle is a suitable tissue for studying HSP regulation and 
glucose metabolism, since it exhibits high levels of inducible HSPs and is a major site 
for glucose metabolism. But other tissues involved in glucose homeostasis, such as 
the brain, adipose tissue, liver and the pancreas also show HSP expression, although 
the HSP expression levels are highly variable from tissue to tissue in conditions of 
stress. For example, in diabetic monkeys, Kavanagh et al. (Kavanagh et al. 2008) 
found that HSP72 expression was reduced by 32% and 50% in serum and liver, 
respectively, although HSP72 expression was increased in the pancreas. The latter has 
been speculated as a compensatory response to protect the vulnerable beta cells from 
the stress of insulin hypersecretion. It is not well understood if HSP upregulation in 
tissues such as the brain, can be beneficial and even less is known about the 
regulation of HSP in these tissues in response to aging, high fat diet and oxidative 
stress.  
1.5.5. HSP induction: 
1.5.5.1. The heat shock response: 
HSP induction is part of the cellular stress response and is controlled at the 
transcriptional level by the transient activation of the heat shock transcription factor 
HSF-1 (reviewed in (Wu 1995)). Under normal conditions, HSF-1 is maintained as 
latent non-DNA binding monomers, which upon receiving a stress stimulus, assemble 
into active homotrimers capable of interacting with heat shock elements upstream of 
HSP genes. In the unstressed cells, HSP90 serves as the principal cellular repressor of 
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HSF-1, maintaining HSF-1 in the inactive monomeric form. Upon stress, HSP90 is 
sequestered into protein aggregates and HSF-1 is free for activation and trimerization 
(Zou et al. 1998). Complete activation is a multistep process involving 
hyperphosphorylation and de-phosphorylation of certain residues. Upon removal of 
the stress stimulus, or after achieving critical levels of HSP expression, the trimers of 
HSF-1 are disassembled back to inactive monomers in a process called attenuation 
(Chu et al. 1996; Winegarden et al. 1996; Kline and Morimoto 1997; Xia and 
Voellmy 1997).  
Previous studies have demonstrated that serine residues 303, 307 and 363 in 
the regulatory domain of human HSF-1 are constitutively phosphorylated by GSK3, 
ERK1/2, and JNK/PKC respectively, and in vivo mutational analyses have shown that 
these phosphorylations function to repress the DNA-binding and transcriptional 
activity of HSF-1 (Chu et al. 1996; Knauf et al. 1996; Kline and Morimoto 1997; Chu 
et al. 1998; Dai et al. 2000; Xavier et al. 2000). On the other hand, phosphorylation 
on Serine 230, 326 and 419 has been shown to promote transcriptional activity 
(Holmberg et al. 2001; Westerheide and Morimoto 2005). Aging is associated with a 
decrease in HSF-1 transcriptional activity as seen in cell free systems and isolated 
hepatocytes (Heydari et al. 2000).  
 1.5.5.2. Manipulating heat shock protein expression: 
Most of the pioneering work describing the protective role of HSPs has been 
done in cell culture, but to study the physiological effects of HSP upregulation and its 
potential in therapy, various methods of HSP induction are being actively pursued in 
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laboratory animals (reviewed by (Tolson and Roberts 2005)). Physical methods 
include water immersion, where anaesthetized animals are immersed in a water bath 
set at 41.5°C and core body temperature is maintained between 41°C and 41.5°C for 
20 min. Upregulation of HSPs is seen as early as 6 hours, peaking around 48 hr, and 
persists till 96 hours. A similar treatment can be given using a heating pad (Demirel et 
al. 2003). When HSP upregulation is needed in a specific region of the body, local 
heating is used by using small heating steel cylinders (Oishi et al. 2002), diathermy 
(Touchberry et al. 2008), photoirradiation with an 815 nm diode lazer (Souil et al. 
2001), ultrasound (Madio et al. 1998) or microwave radiation of 2.06 GHz (Walters et 
al. 1998). Genetic alteration approaches have produced several HSP overexpression 
mouse models (Marber et al. 1995), some of which are now commercially available. 
Exercise increases HSP expression in several tissues including the skeletal muscle, 
myocardial tissue, adrenal gland, brain and liver (Skidmore et al. 1995; Powers et al. 
1998; Campisi et al. 2003; Gonzalez and Manso 2004). Cold treatment and 
psychological stress has shown HSP induction in a few tissues (Matz et al. 1996; 
Hoekstra et al. 1998), but results from these applications have been limited. Lastly, 
pharmacological methods inducing HSPs include amphetamine (Salminen et al. 
1997), aspirin (Ghavami et al. 2002), bimoclomol/arimoclomol/BRX-220 (Kurthy et 
al. 2002; Lubbers et al. 2002), geranylgeranylacetone (Ikeyama et al. 2001; Ooie et al. 
2001; Fujiki et al. 2003; Yasuda et al. 2005), stannous chloride (House et al. 2001), β-
estradiol (Papaconstantinou et al. 2003), resveratrol (Putics et al. 2008), curcumin 
(Kanitkar and Bhonde 2008), glutamine (Wischmeyer et al. 2001), HSP90-inhibitors 
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such as geldanamycin (Kiang et al. 2004) and many more. Modified derivatives of 
several of the above drugs are being actively investigated for lower toxicity and better 
efficacy. 
1.5.5.3. Drug trials: 
Several HSP-inducing drugs are being actively pursued in bench research as 
well as clinical trials for treatment of a variety of diseases from neurodegenerative 
diseases to cancer and autoimmune diseases. The non-toxic hydroxylamine derivative 
Bimoclomol or its related conjugates BRX-220 and BGP15 have been explored in 
treatment against insulin resistance, diabetes and diabetic neuropathy in animal 
models (Vigh et al. 1997; Kurthy et al. 2002; Sebokova et al. 2002). Substances in 
this class of therapeutics are thought to function as co-activators of the heat shock 
protein response (Torok et al. 2003). N-Gene Research Laboratories, Inc. has reported 
positive Phase II results with BGP-15 functioning as an insulin sensitizer. In 42 
nondiabetic individuals with insulin resistance given the agent for 28 days, whole-
body glucose utilization and mitochondrial function was significantly improved 
(Kolonics et al. 2006).  
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1.6. Antioxidant treatments to alleviate oxidative stress and reverse insulin 
resistance 
 
Oxidative stress has been implicated as one of the important mechanisms of 
insulin resistance (Houstis et al. 2006). Consequently, antioxidant treatments to 
alleviate oxidative stress are expected to improve insulin sensitivity. Several anti-
oxidants have been shown to successfully improve insulin sensitivity in insulin 
resistance and diabetes, including alpha-lipoic acid (LA) (Jacob et al. 1995; Bitar et 
al. 2004), vitamin E (Laight et al. 1999), Tempol, a compound that mimics the action 
of superoxide dismutase (Blendea et al. 2005), or a combination of vitamin E, vitamin 
C and lipoic acid (Vinayagamoorthi et al. 2008). Of these antioxidants, LA presents a 
very potent effect and has unique properties that other anti-oxidants lack. Apart from 
its anti-oxidant properties that reduce oxidative stress, LA also possesses certain pro-
oxidant properties (Konrad 2005) that enable it to directly induce the insulin signaling 
cascade and stimulate glucose uptake (Estrada et al. 1996; Konrad et al. 2001). LA 
can also induce glucose uptake through insulin independent pathways via the 
activation of AMPK (Khanna et al. 1999; Lee et al. 2005). Besides increasing the 
GSH/oxidized glutathione GSSG ratio, LA also enhances GSH biosynthesis (Packer 
et al. 2001). 
LA is a short chain fatty acid that functions as a cofactor in the pyruvate 
dehydrogenase complex (Konrad et al. 1999). Natural synthesis of LA occurs in the 
liver. Two enantiomers of LA are seen: R(+) is the naturally occurring stereoisoform, 
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more potent that the S(+) for insulin sensitivity actions. In fact, S(+) LA could be 
inhibitory to insulin action (Klip et al. 1994). Synthetic LA occurs as a racemic 
mixture.  
LA has both hydrophilic as well as hydrophobic properties, another unique 
characteristic among anti-oxidants. Thus LA can elicit its action in both the cytosol as 
well as the plasma membrane; in serum as well as in lipoproteins (Kagan et al. 1992). 
Three activities of LA and its reduced form, dihydrolipoic acid have been observed: 
1.) direct ROS scavenging, 2.) capacity to regenerate endogenous anti-oxidants such 
as glutathione and Vitamin C and E due to its redox potential, and 3.) metal chelating 
activity resulting in reduced ROS production through a metal-catalyzed chemical 
reaction (Konrad 2005).  
Lipoic acid protects against oxidative stress induced impairment in insulin 
stimulation of protein kinase B and glucose transport in 3T3-L1 adipocytes (Rudich et 
al. 1999). In L6 muscle cells, LA protects against oxidative stress-induced insulin 
resistance when used in micromolar concentrations (Maddux et al. 2001). At higher 
concentrations (millimolar), LA can directly engage the insulin pathway to stimulate 
glucose transport (Yaworsky et al. 2000). In vivo anti-diabetic effects of LA have 
been reported in several animal models, including Goto-Kakizaki rats (Bitar et al. 
2004), streptozotocin injected rats (Khamaisi et al. 1997), obese zucker fatty rats 
(Saengsirisuwan et al. 2004), high fructose fed rats (Thirunavukkarasu et al. 2004), 
diabetes prone OLETF rats (Song et al. 2005) and high fat diet-fed rats (Yang et al. 
2008). In humans, LA has been used in Germany for more than 30 years to treat 
 41
diabetic neuropathy and liver cirrhosis (Ziegler et al. 1999). Oral administration of 
alpha-lipoic acid improves glucose effectiveness in lean and obese patients with type 
2 diabetes (Jacob et al. 1999; Konrad et al. 1999; Strokov et al. 2000; Kamenova 
2006). Other reports suggest that oral administration of LA has shown only marginal 
effects, while intravenous infusion has the best effects on insulin mediated glucose 
transport in T2D patients (Evans and Goldfine 2000).  
 Despite the beneficial effects of LA repeatedly seen in humans and animal 
models, the exact mechanism of action of LA remains unclear. Further studies are 
needed to understand if the benefits of LA are from a combination of its anti-oxidant 
and pro-oxidant properties.  
 
1.7. Research questions 
  
With the background of the above literature, our studies attempted to fill the 
knowledge gaps in the understanding of insulin resistance and identify potential 
therapeutic targets against insulin resistance. Our primary goals were to determine the 
roles of heat shock proteins and their association with insulin action in two different 
models of insulin resistance- aging and diet induced-insulin resistance. We examined 
the mechanisms of insulin resistance and their alleviation with HSPs using 
interventions such as anti-oxidant treatment and heat treatment. HSPs were examined 
in fast- and slow-twitch muscle types and in various regions of the brain.  
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2.1. Abstract 
 
Aging is associated with an increase in insulin resistance in skeletal muscle, 
yet the underlying mechanism is not well established. We hypothesize that with 
aging, a chronic increase in stress kinase activation, coupled with a decrease in 
oxidative capacity, leads to insulin resistance in skeletal muscle. In aged (24 month-
old) and young (3 month-old) Fischer 344 rats, 2-deoxy glucose uptake and insulin 
signaling (as measured by phosphorylation of IRS-1, Akt and AS160) decreased 
significantly with age. Activation of c-Jun NH2-terminal kinase (JNK), glycogen 
serine kinase-3β (GSK-3β), and degradation of IkBα by the upstream inhibitor of 
kappa B kinase (IKKβ), as measured by Western blot analysis, were increased with 
age in both soleus and Epi muscles. However, much higher activation of these kinases 
in Epi muscles from young rats compared to soleus results in a greater effect of these 
kinases on insulin signaling in fast-twitch muscle with age. Heat shock protein 72 
(HSP72) expression and phosphorylation of HSP25 were higher in soleus compared 
to Epi muscles and both parameters decreased with age. Age and fiber type 
differences in cytochrome oxidase activity are consistent with observed changes in 
HSP expression and activation. Our results demonstrate a significant difference in the 
ability of slow-twitch and fast-twitch muscles to respond to insulin and regulate 
glucose with age. A greater constitutive HSP expression and lower stress kinase 
activation may account for the ability of slow-twitch muscles to preserve the capacity 
to respond to insulin and maintain glucose homeostasis with age.  
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2.2. Introduction 
 
Aging is associated with a decrease in the body’s ability to respond to the 
hormone insulin, a condition referred to as insulin resistance. Insulin resistance 
represents an independent risk factor in age-related diseases and insulin resistance of 
skeletal muscle glucose transport represents a key defect in the development of type 2 
diabetes. The underlying mechanism for age-related insulin resistance remains poorly 
defined, yet increased oxidative stress, inflammation and impaired defense against 
stress are likely involved.   
The initial step in the insulin-signaling pathway is binding of insulin to its 
receptor at the cell surface of tissue such as muscle, fat or liver. Insulin binding 
stimulates the intrinsic tyrosine kinase activity of the insulin receptor resulting in the 
tyrosine phosphorylation of its cytosolic substrate, insulin receptor substrate-1 and -2 
(IRS-1 and IRS-2) (White 1998). After tyrosine phosphorylation, IRS-1 and IRS-2 
bind and activate the enzyme phosphatidylinositol 3-kinase (PI3K). PI3K activation 
results in serine phosphorylation of Akt/protein kinase B (Akt), and ultimately, 
stimulation of glucose transport in skeletal muscle and adipose tissue. Previous 
studies indicate the development of insulin resistance with age occurs downstream of 
the insulin receptor (Arias et al. 2001). 
IRS-1 is the primary IRS expressed in skeletal muscle and acts as a metabolic 
switch for the insulin signaling pathway (Tamemoto et al. 1994). Serine/threonine 
phosphorylation of IRS-1 can result in suppression of the insulin signaling pathway 
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and increased serine phosphorylation of IRS-1 has been reported in animal models of 
insulin resistance (Werner et al. 2004) and in muscles of patients with insulin 
resistance (Bandyopadhyay et al. 2005). Previous studies have shown a decrease in 
tyrosine IRS-1 phosphorylation (Carvalho et al. 1996) and a decrease in total IRS-1 
protein (Arias et al. 2001) in aged rats. To our knowledge, only one other study has 
assessed chronic serine phosphorylation of IRS-1 with age and they showed an 
increase in serine IRS-1 phosphorylation in 30 month-old Brown Norway/Fischer 344 
rats compared to 6 month-old rats (Haddad and Adams 2006). These investigators 
examined the mixed fiber type medial gastrocnemius muscle and therefore could not 
make any correlations between muscle fiber type specific insulin signaling and age. 
Skeletal muscle displays a fiber type specific response in the activation of key insulin 
signaling intermediates (Song et al. 1999), and given the preferential atrophy of fast-
twitch fibers that occurs with age (Lexell 1995), we might expect insulin signaling to 
be compromised to a greater extent in fast-twitch muscles compared to slow. The 
current study examined the effect of age on IRS-1 function in fast-twitch and slow-
twitch rat skeletal muscles with age. 
Obesity-induced insulin resistance is characterized by increased oxidative 
stress, inflammation and impaired defense against stress (Wellen and Hotamisligil 
2005; Chung et al. 2008). Obesity is linked to a state of chronic inflammation 
resulting in TNF-α mediated activation of serine threonine kinases, primarily c-Jun 
NH2-terminal kinase (JNK), inhibitor of kappa B kinase (IKKβ) and PKCθ (Wellen 
and Hotamisligil 2005). These serine/threonine kinases phosphorylate IRS-1 on serine 
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residues and suppress the insulin signaling pathway. The important role of JNK and 
IKKβ in obesity models of insulin resistance is well established and genetic models 
that alter JNK and IKKβ expression offer protection against obesity induced insulin 
resistance (Hirosumi et al. 2002; Arkan et al. 2005). Aging is also characterized by 
chronic inflammation and oxidative stress (Broome et al. 2006), yet the extent to 
which inflammatory mediators affect insulin signaling in aged skeletal muscle is not 
known.  
A decline in the body’s best known endogenous defense system, the heat 
stress response, could play an important role in the development of insulin resistance. 
Aging, hyperlipidemia, and type 2 diabetes are all associated with a diminished heat 
stress response, as measured by decreased expression of heat shock protein 72 
(HSP72) (Hooper and Hooper 2005; Selsby et al. 2005; Najemnikova et al. 2007) and 
recent studies of individuals with type 2 diabetes demonstrate that reduced skeletal 
muscle HSP72 mRNA  correlates with the degree of insulin resistance (Kurucz et al. 
2002; Bruce et al. 2003). Although expression levels of heat shock protein 25 
(HSP25) were not reduced in streptozotocin-induced diabetic rats, the ability to 
increase HSP25 with heat stress in these animals was attenuated (Najemnikova et al. 
2007). In addition to their chaperonin functions, HSPs have been shown to confer 
resistance to oxidative stress and inhibit stress kinase activation (Gabai et al. 1997; 
Park et al. 2001). Consequently, HSP72 expression levels and HSP25 activation may 
play a significant role in the development of age-related insulin resistance in skeletal 
muscle. HSPs have also been shown to have a protective effect on mitochondrial 
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function (Polla et al. 1996) and therefore could have a significant role in preserving 
muscle oxidative capacity with age. In order to examine potential mediators of insulin 
resistance of glucose uptake with age, we measured insulin signaling intermediates, 
stress kinases, and HSPs in fast-twitch and slow-twitch skeletal muscles from young 
and aged rats.  We hypothesize that with aging, a chronic increase in stress kinase 
activation, coupled with a decrease in oxidative capacity, leads to insulin resistance in 
skeletal muscle. Comparing the oxidative soleus muscle and the more glycolytic Epi 
muscle will allow us to determine the extent to which the muscle’s oxidative capacity 
impacts the development of age-related insulin resistance.  
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2.3. Materials and methods  
 
Materials 
 [14C] Mannitol was obtained from ICN Radiochemicals (Irvine, CA). 2-
Deoxy [1,2-3H] glucose was purchased from American Radiolabeled Chemicals (St. 
Louis, MO).  Antibodies against phospho-SAPK/JNK(T183/Y185), total SAPK/JNK, 
phospho-Akt (S473), total Akt, IkBα , phospho-GSK-3 α/β (Ser21/9), and phospho-
PKCθ (T538) were purchased from Cell Signaling (Beverly, MA). Anti-HSP72, anti-
phospho-HSP25 (S82) and anti-HSP25 were obtained from Stressgen (Victoria, BC, 
Canada), and anti-tubulin was obtained from Sigma (St.Louis, MO). Anti-PKCθ and 
goat-anti-rabbit HRP-conjugated secondary antibodies were obtained from Santa 
Cruz Biotechnology (Santa Cruz, CA), while goat anti-mouse HRP-conjugated 
secondary antibodies were obtained from Bio-Rad (Hercules, CA). Anti-phospho-
Ser307-IRS-1, phospho-AS160 (Thr 642) and total AS160 antibodies were purchased 
from Upstate (Lake Placid, NY), anti-phospho-Tyr612-IRS-1 from Biosource 
(Camarillo, CA) and anti-IRS-1 was from BD Biosciences (Franklin lakes, NJ). 
Enhanced chemiluminescence reagents were purchased from Amersham (Little 
Chalfont, Buckinghamshire, UK). All other reagents were obtained from Sigma 
(St.Louis, MO).  
Experimental animals and muscle dissection  
The Fischer 344 rat strain provides a suitable aging model due to its relatively 
short life span (senescence is reached at 24 months) (Yu et al. 1985). In addition, 
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considerable background data exists for this particular strain, including the extensive 
characterization of age-associated changes under many environmental and genetic 
conditions. Finally, barrier-reared aging colonies of Fischer 344 rats, maintained 
under the supervision of the NIA, are readily available for purchase from reputable 
commercial breeders. Male Fischer 344 rats were purchased at 3 (n=6, body mass 
238.50 ± 5.11 g) and 24 (n=6, body mass 393.0 ± 17.72 g) months of age via the 
National Institutes of Health. Rats were housed in pairs in large cages in a 
temperature controlled facility (24+1 oC) with a 12 h light/dark cycle. All animals 
were given free access to Purina Rat Chow and water ad libitum. A total of 5 rats per 
age group were used in the current study. The rats were fasted for 12 h overnight 
prior to the following morning’s experiment to remove effects of endogenous insulin 
on the experiments. During this time, the normal 12 h dark cycle was maintained. The 
rats were anesthetized with an intraperitoneal injection of pentobarbital sodium (5 
mg/100 g body weight) followed by the removal of the soleus and epitrochlearis (Epi) 
muscles.  Soleus muscles consist predominantly of slow-twitch red fibers (84% type 
I, 16% type II) (Ariano et al. 1973), while the Epi is comprised of primarily fast-
twitch white fibers (15% type I, 20% type IIa, 65% type IIb) (Nesher et al. 1980). 
Soleus muscles were split prior to incubation to allow adequate diffusion of oxygen 
and substrates. In spite of the sarcopenia associated with age, due to the greater body 
weight of the aged rats compared to the young rats, the soleus muscles of the aged 
rats remained larger than those from the young rats.  The slightly larger soleus 
muscles of aged rats were carefully trimmed to remain comparable in size with those 
 50
of the young soleus. Muscle wet weight was used to determine equivalent size. The 
thin Epi muscles are well suited for glucose transport and the Epi does not 
significantly increase in thickness with age (Cartee et al. 1993), so the intact Epi is 
used for all experiments. All protocols were approved by the Animal Care and Use 
Committee of the University of Kansas Medical Center. 
Muscle incubations 
Following dissection, muscles recovered for 60 min in flasks containing 2 ml 
of Krebs-Henseleit bicarbonate buffer (KHB) with 8 mM glucose, 32 mM mannitol 
(recovery medium), and a gas phase of 95% O2/5% CO2.  The flasks were placed in a 
shaking incubator maintained at 35°C. Following recovery, muscles were either 
treated with 1 mU/ml insulin or left untreated for 30 min and then clamp frozen in 
liquid nitrogen. For measurement of basal MAP and stress kinase phosphorylation, 
soleus and Epi muscles from young and aged F344 rats were removed and rapidly 
frozen for Western blot analysis.   
Measurement of glucose transport activity 
The muscles were rinsed for 30 min at 29°C in 2 ml of oxygenated KHB 
containing 40 mM mannitol, with or without insulin. After the rinse step, muscles 
were incubated for 20 min at 29°C in flasks containing 2 ml KHB with 4 mM 2[1,2-
3H] deoxyglucose (2-DG) (1.5 µCi/ml) and 36 mM [14C] mannitol (0.2 µCi/ml), with 
or without insulin, with a gas phase of 95% O2/5% CO2, in a shaking incubator. The 
muscles were then blotted, clamp-frozen, and processed for determination of 
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intracellular 2-DG accumulation and extracellular space as described previously 
(Young et al. 1986; Geiger et al. 2006).  
Measurement of cytochrome oxidase activity 
Mitochondria were isolated from soleus and epitroclearis muscles as described 
previously (Ghosh et al. 2007). Briefly, muscles were dissected out and homogenized 
in a mitochondria isolation medium (0.32 M sucrose, 2 mM K+EDTA, 10 mM Tris 
Base, 0.3% BSA, 1 mM ATP, pH 7.4). After 3 low speed centrifugations (two at 
3200 rpm and one at 11,000 rpm), the final supernatant was layered on a Ficoll 
gradient (10-7.5%) and subjected to ultracentrifugation at 27,500 rpm for 45 min.  
The mitochondrial pellet was resuspended in BSA-free isolation buffer. Protein 
concentrations were determined with a Bradford assay. For the cytochrome oxidase 
assay, a cuvette containing 50 µg of protein, potassium phosphate buffer (20 mM, pH 
7.0), and dodecyl maltoside (20 µl of 10 mg/ml stock solution) was warmed to 30°C 
for three min. The reaction was initiated by addition of 25 µM reduced cytochrome c, 
which brought the total cuvette volume to 1 ml. The oxidation of the reduced 
cytochrome c was followed for 2 min at 550 nm on a DU series spectrophotometer 
(Beckman Coulter, Fullerton, CA). To facilitate calculation of enzyme activity, the 
maximally oxidized cytochrome c absorbance was determined by adding a few grains 
of potassium ferricyanide. The activity was calculated and normalized to the amount 
of protein (seconds–1 per milligram of protein). 
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Western Blotting 
Clamp frozen soleus and Epi muscles were homogenized in a 12:1 (volume to 
weight) ratio of ice cold buffer from Biosource containing: 10 mM Tris-HCL (pH 
7.4), 100 mM NaCl, 1 mM each of EDTA, EGTA, NaF, PMSF and 2 mM Na3VO4, 
20 mM Na4P2O7, 1% Triton X-100, 10% glycerol, 0.1 % SDS, 0.5% deoxycholate, 
250 μl/5ml protease inhibitor cocktail. Homogenized samples were rotated for 30 
minutes and then centrifuged for 20 minutes at 13,000 rpm at 4°C. The protein 
concentration of the supernatant was determined by Bradford method (Bio-Rad, 
Hercules, CA).  Samples were prepared in 2X Laemmli buffer containing 100 mM 
dithiothreitol and heated in a boiling water bath for 5 minutes.  
30-100 μg of protein was subjected to SDS-PAGE (6.25-10% gel) followed 
by a wet transfer to a nitrocellulose membrane for 90 min (200 mA/tank). Membranes 
were blocked for 1 hour at room temperature in TBST 5 % non-fat dry milk followed 
by an overnight incubation with the appropriate primary antibodies at a concentration 
of 1:1000. Antibodies were diluted in Tris-buffered saline, 0.1% Tween-20 (TBST), 
5% BSA. Following 3 brief rinses in TBST, blots were incubated in TBST 1% non-
fat dry milk supplemented with an HRP-conjugated goat anti-rabbit secondary 
antibody at a concentration of 1:10,000 for 1 hour at room temperature. Bands were 
visualized by ECL and quantified using densitometry. To allow direct comparisons 
between age groups and muscle types, young and aged, soleus and Epi samples were 
run on the same gel and identical conditions (including transfer time, washing 
conditions, antibody dilutions and chemiluminescence detection) were maintained 
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across gels. Equal amounts of protein were loaded onto each gel lane and to ensure 
accuracy, protein concentration was determined in triplicate prior to gel loading. To 
verify transfer of proteins and equal loading of lanes, the membranes were stained 
with ponceau S (Figure 2). From the ponceau stain, a protein band was selected at 
random (~60kDa) and quantified in each lane via densitometry. This band was 
directly proportional to the amount of protein loaded and there was no significant 
difference in band intensity across soleus and Epi muscles. Blots were stripped and 
probed for tubulin to further assess equal protein loading and transfer. Tubulin 
expression does not change with age in soleus and Epi muscles, making this an 
accurate loading control for age comparisons within each muscle. However, tubulin 
expression did differ between soleus and Epi muscles and therefore could not be used 
as a loading control for soleus and Epi muscle protein comparisons.  
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FIGURE 2. 
 
 
 
 
 
Statistical Analysis 
Two-way analysis of variance (ANOVA) was used when both age and muscle 
fiber type differences were studied. This was followed by a post hoc comparison 
using the Student-Newman-Keuls test when necessary. Statistical significance was set 
at P<0.05.   
Tubulin -- -- 55 KDa 
Ponceau stain -- -- 60 KDa 
Soleus EPI 
Young Aged Young Aged 
Figure 2. Western blot loading controls. Samples from both young and aged soleus 
and Epi muscles were run together on gels to allow comparison across groups. 
Following the ponceau S stain, a protein band was selected at random (~60kDa) and 
quantified in each lane via densitometry. This band was directly proportional to the 
amount of protein loaded and there was no significant difference in band intensity 
across soleus and Epi muscles. Blots were stripped and probed for tubulin to further 
assess equal protein loading and transfer. Tubulin expression does not change with age 
in soleus and Epi muscles, making this an accurate loading control for age 
comparisons and further verifying equal loading. 
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2.4. Results  
 
Insulin-stimulated glucose uptake  
Glucose uptake in isolated soleus and Epi muscles was measured using 2-DG 
uptake analysis. Figure 3 shows the basal (non-insulin stimulated) and insulin-
stimulated 2-DG response in soleus and Epi muscles from young and aged rats. Basal 
2-DG uptake was higher in soleus muscles compared to Epi from both young and 
aged rats. Basal 2-DG uptake was maintained with age in the soleus muscle, while a 
significant decrease in basal glucose uptake was observed in Epi muscles with age 
(32% decrease from young). To determine the muscle glucose uptake in response to 
insulin, soleus and Epi muscles were incubated in the presence of 1 mU/ml insulin. 
As shown in Figure 3, insulin-stimulated glucose uptake was higher in young soleus 
compared to young Epi muscles. In aged rats, insulin-stimulated glucose uptake was 
significantly decreased in both the soleus and Epi muscles. Although the decrease in 
insulin-stimulated 2-DG uptake with age was slightly greater in the soleus muscles 
(35% decrease from young) compared to Epi muscles (26% decrease from young), 
the insulin-stimulated 2-DG uptake remained greater in soleus muscles compared to 
Epi.   
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Figure 3.  Insulin stimulated glucose transport in muscles from young and aged 
rats. Young (3 mo) and aged (24 mo) F344 rats were fasted overnight and the soleus 
and Epi muscles were dissected out. Muscles recovered in KHB for 1 hr and were then 
incubated without (open bars) or with (filled bars) insulin (1 mU/ml) in flasks 
containing KHB with 2[1,2-3H]-deoxy glucose (1.5 µCi/ml) and [14C] mannitol. 
Insulin stimulation resulted in a significant increase from basal glucose uptake for all 
muscles shown (P<0.005). Intracellular 2-DG and extracellular space were quantified 
in a scintillation counter. Values are means of + SE for muscles from 10-14 muscles 
per group. Symbols for basal 2-DG values, open bars: Significance between young Epi 
and soleus basal glucose uptake #P<0.05. Significance between young and aged Epi 
basal glucose uptake +P<0.05. Symbols for insulin-stimulated glucose uptake, filled 
bars: *P<0.05, **P<0.001. 
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Insulin-stimulated  phosphorylation of Akt 
Akt is a serine kinase located downstream of IRS-1/PI3K in the insulin 
signaling pathway. Akt phosphorylation in the absence and presence of 1 mU/ml 
insulin was measured by Western blot analysis with a phosphospecific antibody that 
recognizes Akt when phosphorylated on Ser 473. Basal, non-insulin stimulated, Akt 
phosphorylation levels were similar between soleus and Epi muscles from both young 
and aged rats (Figure 4A). The pattern of Akt phosphorylation in response to insulin 
displayed a similar pattern to the 2-DG transport in soleus and Epi muscles. As shown 
in Figure 4A, Akt phosphorylation on Ser 473 was increased with insulin to a greater 
extent in the soleus muscle compared to the Epi in both young and aged muscles. 
Insulin-stimulated Akt phosphorylation was significantly decreased with age in both 
soleus and Epi muscles. The relative decrease in Akt phosphorylation with age is 
greatest in Epi muscles (35% decrease from young) compared with soleus muscles 
(22% decrease from young). Basal and insulin-stimulated total Akt protein expression 
was measured and as shown in Figure 4B, there were no differences in total Akt 
expression in response to insulin. However, muscle fiber type differences in total Akt 
expression were observed with soleus muscle Akt expression greater than Epi in 
young rats. Somewhat surprisingly, there was no decrease in total Akt expression 
with age in either the soleus or Epi muscles.   
Insulin-stimulated  phosphorylation of AS160 
 Akt substrate of 160 kDa (AS160) is a Rab GTPase-activating protein 
previously shown to be activated by insulin and muscle contraction, the latter most 
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likely via AMPK (Bruss et al. 2005; Kramer et al. 2006).  We measured AS160 
phosphorylation in the absence and presence of 1 mU/ml insulin by Western blot 
analysis with a phosphospecific antibody that recognizes AS160 when 
phosphorylated on Thr642. Basal, non-insulin stimulated, phosphorylation of AS160 
did not differ between soleus and Epi muscles (Figure 4C). Although basal 
phosphorylation of AS160 increased slightly with age in the soleus muscle, no 
significant age differences in basal AS160 phosphorylation were observed in either 
muscle fiber type (P<0.08 between young and aged basal AS160 phosphorylation). In 
response to insulin, phosphorylation of AS160 was increased to the same extent in 
soleus and Epi muscles. An age-related decrease in insulin-stimulated AS160 
phosphorylation was observed in both soleus and Epi muscle (37% and 37.5% in 
soleus and Epi, respectively). Figure 4D demonstrates basal and insulin-stimulated 
total AS160 protein expression and similar to Akt, there were no effects of insulin on 
total protein expression of AS160 in soleus and Epi muscles. Total AS160 protein 
expression did not differ between soleus and Epi muscles, however there was a 
significant effect of age in both muscles. Total AS160 protein expression decreased 
by 22% and 33% in soleus and Epi muscles, respectively. 
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FIGURE 4. 
 
 A.  
pAkt -- 
Insulin - +
  
- +
  
- +
  
- +
Young Aged Young Aged
-- 60 KDa 
Soleus EPI
Young Aged Young Aged
p-
A
kt
0.0
0.1
0.2
0.3
0.4
0.5
0.6 *
**
*
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
 
 
 
  
-- 
Insulin - +
  
- +
  
- +
  
- +
Young Aged Young Aged
60  Akt -- KDa 
Young Aged Young Aged
To
ta
l A
kt
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
Soleus EPI
*
  
 60
 C. 
 
p-AS160 -- 
Insulin  -     +     -     +      -    +     -     + 
Young Aged Young Aged
-- 160 KDa 
Soleus EPI
Young Aged Young Aged
p-
AS
16
0
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7 * *
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D. 
 
 
AS160 -- 
Insulin  -     +     -     +      -    +     -     + 
Young Aged Young Aged
-- 160 KDa 
Soleus EPI
Young Aged Young Aged
To
ta
l A
S1
60
0.0
0.2
0.4
0.6
0.8
1.0 **
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 61
Figure 4. Effect of insulin on phosphorylation of Akt and AS160 in young and 
aged muscles. Soleus and Epi muscles were incubated in the absence (open bars) or 
presence (filled bars) of insulin (1 mU/ml) for exactly 10 min. Homogenates of clamp 
frozen muscles were used for measurements of phosphorylation of Akt on serine 437 
(A), total Akt (B), phosphorylation of AS160 (C), and total AS160 (D), with Western 
blot analysis. Insulin stimulation resulted in a significant increase from basal 
phosphorylation of Akt and AS160 in all muscles shown (P<0.05). The effect of 
insulin on total Akt and AS160 values was not significant. Values are means of + SE 
for 4-9 muscles per group. *P<0.05 and **P<0.001.  
 
 
 
 
 
 
 62
 Insulin-stimulated tyrosine and basal serine phosphorylation of IRS-1  
Our observations of a decrease in glucose uptake and phosphorylation of Akt 
and AS160 with age suggest a defect in insulin signaling. IRS-1 functions as a 
metabolic switch in skeletal muscle, with tyrosine phosphorylation resulting in 
downstream activation of PI3K and serine phosphorylation of Akt. To determine 
whether differences in insulin-stimulated IRS-1 tyrosine phosphorylation exist 
between young and aged soleus and Epi muscles, muscles were exposed to 1 mU/ml 
insulin for 30 min. Western blots were performed on muscle homogenates with an 
antibody that recognizes IRS-1 tyrosine 612 phosphorylation. Basal, non-insulin 
stimulated, tyrosine phosphorylation of IRS-1 is negligible in skeletal muscle and 
therefore this data is not shown. Figure 5A demonstrates that insulin-stimulated 
phosphorylation of IRS-1 at tyrosine 612 was significantly greater in soleus muscles 
compared to Epi for both young and aged muscles. Insulin-stimulated tyrosine 
phosphorylation of IRS-1 was decreased with age in both soleus and Epi muscles 
(57% and 60% decrease from young, respectively). Serine phosphorylation of IRS-1 
inhibits tyrosine IRS-1 phosphorylation and chronic increased serine phosphorylation 
could prevent activation of the normal insulin signaling cascade. For this reason, we 
measured basal, non-insulin stimulated, serine phosphorylation of IRS-1 to determine 
the extent to which serine phosphorylation of IRS-1 could impact insulin action. 
Basal IRS-1 serine phosphorylation was measured with an antibody that recognizes 
IRS-1 when serine 307 is phosphorylated (Figure 5B). Serine phosphorylation of IRS-
1 was significantly increased with age in both the soleus and Epi muscles. The 
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increase in serine 307 phosphorylation in soleus muscles with age was significantly 
greater than that observed in the Epi muscles (160% and 56% increase above young, 
respectively). Our findings also reveal a significant decrease in total IRS-1 levels in 
both muscles with age (Figure 5C). Although total IRS-1 expression is greater in 
soleus compared to Epi in young rats, the relative decrease in IRS-1 expression with 
age is similar in both muscles (65% and 64% decrease from young, respectively).  
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Figure 5. Insulin-stimulated tyrosine and basal serine phosphorylation of IRS-1 
in young and aged muscles. Soleus and Epi muscles were dissected from overnight 
fasted rats and incubated with insulin (1 mU/ml) for 30 min and muscle homogenates 
were then used to determine the insulin-stimulated tyrosine phosphorylation of IRS-1 
(A). Alternatively, muscles were incubated in KHB without insulin to assess basal 
serine phosphorylation of IRS-1 (B), and total IRS-1 (C). Filled bars represent young 
muscle values and open bars represent aged muscles values. Values are means of + SE 
for 4-12 muscles per group. *P<0.05 ** P<0.001. 
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Modulation of serine/threonine kinases  
A number of serine/threonine kinases have been identified with the potential 
to serine phosphorylate IRS-1, with JNK and IKKβ being the most commonly 
associated with insulin resistance. We measured basal phosphorylation levels of JNK 
with Western blot analysis in soleus and Epi muscles from young and aged rats 
(Figure 6A). JNK phosphorylation was significantly lower in soleus muscles 
compared to Epi muscles in young and aged rats. In both soleus and Epi muscles, 
JNK phosphorylation increased with age, but to a much greater extent in the soleus 
compared to the Epi (184% and 70%, respectively). Total JNK protein expression 
was measured and no significant differences exist between soleus and Epi muscle 
total JNK expression (Figure 6B). Total JNK decreased significantly with age only in 
the Epi muscles. These data demonstrate that, regardless of age, JNK phosphorylation 
is greater in the fast Epi muscles compared to the soleus.  
IKKβ activation results in degradation of the downstream target IkBα and 
IkBα degradation is considered a marker of increased IKKβ activity. Figure 6C 
demonstrates that IkBα expression levels were higher in soleus muscles compared to 
Epi muscles from both young and aged rats, indicating a lower level of activation of 
IKKβ in soleus. With age, a decrease in IkBα protein levels occurred in both soleus 
and Epi muscles, with a greater degradation in the Epi (27% and 40% decrease, 
respectively).   
We measured phosphorylation of GSK-3β on serine 9, a measure inversely 
related to GSK-3 activity (Dokken et al. 2005). As previously shown with JNK and 
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IKKβ activation, GSK-3β activation is lower in the slow soleus muscle, indicated by 
increased GSK-3β phosphorylation in young and aged soleus compared with young 
and aged Epi muscle (Figure 6D).  Phosphorylation of GSK-3β on serine 9 is 
decreased with age in both soleus and Epi muscles to a similar extent (34% and 31% 
decrease, respectively). Total GSK-3β protein expression is dramatically higher in 
soleus muscle compared to Epi in both young and aged rats (Figure 6E).  GSK-3β 
protein expression did not change with age in either muscle type. Phospho-PKCθ 
levels were similar across soleus and Epi muscles from both young and aged rats 
(data not shown). There was no change in PKCθexpression with age in either muscle 
type.  
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Figure 6. Modulation of serine/threonine kinases in young and aged muscles. 
Soleus and Epi muscles from young and aged rats were dissected, clamp frozen and 
homogenized. Lysates were analyzed by Western blot for JNK phosphorylation (A), 
and total JNK (B), inhibitor I kappa B alpha (IkBα, C), and phosphorylation of GSK-
3β (D) and total GSK-3β (E). Filled bars represent young muscle values and open bars 
represent aged muscles values. Values are means of + SE for 4-6 muscles per group. 
*P<0.05 ** P<0.001.  
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Modulation of HSPs  
In the present study, HSP72 expression was significantly greater in soleus 
muscles compared to Epi muscles from both young and aged rats (Figure 7A). This is 
consistent with other results indicating HSP72 expression correlates with muscle 
oxidative capacity (Locke et al. 1991). HSP72 expression was significantly reduced 
in both soleus and Epi muscles with age, although to a greater degree in the Epi (10% 
and 41% decrease, respectively). The phosphorylation state of HSP25 is thought to 
play an important role in modifying its function (Huey 2006). HSP25 is 
phosphorylated by MAPKAPK2, a kinase downstream of p38 MAPK (Stokoe et al. 
1992). Similar to our findings for HSP72 expression, phosphorylation of HSP25 was 
greater in soleus muscle compared with Epi from both young and aged rats (Figure 
7B). Phosphorylation of HSP25 decreased with age in both soleus and Epi muscles to 
the same extent (32% and 29% in soleus and Epi, respectively). Total HSP25 
expression was greater in the soleus muscle compared to Epi from young rats and 
aged rats (Figure 7C) but there was no significant change with age in either muscle. 
This supports previous findings of greater HSP25 expression in oxidative compared 
with glycolytic muscle (Huey 2006). 
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Figure 7. Heat shock protein expression in young and aged muscles. Soleus and 
Epi muscles from young and aged rats were dissected, clamp frozen and 
homogenized. Lysates were analyzed by Western blot for HSP72 (A), 
phosphorylation of HSP25 (B), and total HSP25 (C). Filled bars represent young 
muscle values and open bars represent aged muscles values. Values are means of + 
SE for 8-15 muscles per group. *P<0.05 ** P<0.001.  
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Cytochrome oxidase activity  
Cytochrome oxidase activity was measured in soleus and Epi muscle 
homogenates (Figure 8). Enzyme activities in soleus muscle were 48% higher than 
Epi muscle from both young and aged rats. Cytochrome oxidase activity decreased 
with age in both soleus and Epi muscles by approximately 15%.  A decrease in 
cytochrome oxidase activity is indicative of a reduced mitochondrial content per 
milligram of muscle. 
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Figure 8. Cytochrome oxidase enzyme activity in young and aged muscles. 
Mitochondria were isolated from soleus and Epi muscles from young and aged rats. 
Cytochrome oxidase activity was determined spectrophotometrically. Filled bars 
represent young muscle values and open bars represent aged muscles values. *P<0.05 
** P<0.001.  
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2.5. Discussion 
 
The purpose of this study was to determine the role of stress kinases and HSPs 
in mediating age-related insulin resistance. By comparing the slow-twitch oxidative 
soleus muscle and the fast-twitch glycolytic Epi muscle, we assessed the impact of 
muscle insulin and oxidative capacity on the development of insulin resistance with 
age. Our results demonstrate that decreased insulin-stimulated glucose uptake in 
soleus and Epi muscles occurs primarily due to decreased total protein expression and 
increased serine phosphorylation of IRS-1. However, the combination of higher stress 
kinase activation and lower HSP expression in the Epi muscle compared to the soleus 
muscle, results in fast-twitch muscle being more susceptible to a decline in insulin 
action with age. Examination of the mechanisms through which slow-twitch muscles 
preserve the capacity to respond to insulin and maintain glucose homeostasis with age 
could have implications for future treatment of insulin resistance and diabetes.  
Insulin-stimulated glucose uptake was greater in young soleus compared to 
young Epi muscles, consistent with previous studies indicating insulin-stimulated 
glucose transport activity is positively correlated with the percentage of oxidative 
muscle fibers (Henriksen et al. 1990; Zierath et al. 1996). Similarly, insulin signaling 
intermediates are present and activated to a greater extent in oxidative muscle fibers 
(Song et al. 1999). Our present findings demonstrating greater phospho-Akt, 
phospho-tyrosine IRS-1 and total IRS-1 in the oxidative soleus muscle compared with 
the Epi muscle agree with these previous studies. Oxidative muscles appear to have a 
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greater reserve for insulin signaling and glucose uptake that is not utilized under 
normal conditions. However, the aging condition may be one in which the reserve 
capacity for insulin signaling in slow muscles serves a valuable purpose. In the 
current study, although insulin-stimulated glucose transport decreased significantly 
with age in both soleus and Epi muscles, glucose transport in aged soleus muscles 
was still greater than that seen in young Epi muscles. This occurred in spite of a 
similar decrease in tyrosine IRS-1 phosphorylation in both soleus and Epi muscles 
with age, and an even greater increase in serine IRS-1 phosphorylation in soleus 
muscles with age compared to Epi muscles.  
The decrease in basal glucose uptake observed in Epi muscles with age further 
demonstrates the decline in glucose homeostasis that occurs in fast-twitch muscle. In 
a previous study by Cartee et al. (Cartee et al. 1993), Epi muscles from 25 month-old 
male Fischer 344/Brown Norway hybrid rats demonstrated a pattern of lower basal 3-
methyl glucose uptake values compared to 3.5 month-old rats, although the 
differences were not statistically significant. We did not measure the levels of glucose 
transporters in the current study, however, a decrease in basal glucose uptake with 
age could result from decreased GLUT1 protein expression (Buse et al. 2002). 
Similarly, a decrease in GLUT4 protein expression with age as previously reported 
(Cartee et al. 1993), could also contribute to the observed decrease in insulin-
stimulated glucose uptake with age in this study. Interestingly, fiber type differences 
in insulin-stimulated phosphorylation of AS160 were not observed in the present 
study. Although AS160 phosphorylation decreased with age in both muscles in a 
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manner similar to that seen with Akt, muscle fiber type differences in insulin 
signaling are not maintained downstream of Akt. The lack of a fiber type difference 
in total AS160 between soleus and Epi muscles, potentially allows for a greater 
insulin-stimulated phosphorylation of AS160 in Epi muscles. These findings indicate 
fiber type differences in insulin-stimulated glucose uptake occur upstream of AS160.  
Results from the present study reveal a significant decrease in total IRS-1 
levels in soleus muscle from aged rats compared with young rats (Figure 5C). While 
serine phosphorylation of IRS-1 is often thought of as a short-term inhibitory 
mechanism, degradation of IRS-1 protein could result from long-term insulin 
resistance. Cellular and oxidative stress and proinflammatory cytokines can induce 
the degradation of IRS-1 through proteasome-dependent or -independent processes 
(Gual et al. 2003). Serine phosphorylation of IRS proteins is considered the primary 
means of suppressing IRS-1 activity and contributing to insulin resistance (White 
1998; Werner et al. 2004; Wellen and Hotamisligil 2005). Previous studies have 
shown a decrease in tyrosine IRS-1 phosphorylation (Carvalho et al. 1996), a 
decrease in total IRS-1 protein (Arias et al. 2001) and no change in Akt in aged rats, 
findings consistent with our results. Although not measured in the present study, 
Arias et al. (Arias et al. 2001) previously demonstrated that muscle levels of insulin 
receptor (IR) and PI3K were increased in aged rats, a finding that would suggest these 
proteins are not involved in age-related insulin resistance. These studies measured a 
mixture of hindlimb muscles (Carvalho et al. 1996) and exclusively plantaris (Arias et 
al. 2001) or Epi muscle (Cartee et al. 1993) and thus could not assess muscle fiber 
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type differences in insulin signaling with age. Haddad et al.(Haddad and Adams 
2006) showed an increase in serine IRS-1 phosphorylation with age in the medial 
gastrocnemius muscle from 30 month-old Fischer/Brown Norway rats. Our findings 
are the first to show an increase in serine IRS-1 phosphorylation in both slow-twitch 
and fast-twitch skeletal muscle with age.  
There are a number of serine/threonine kinases capable of inducing serine 
IRS-1 phosphorylation and we demonstrated several that are increased with age in the 
current study. Recent investigations of oxidative stress and inflammatory pathways 
on insulin signaling have focused on obesity and genetic models of insulin resistance. 
This has resulted in a gap in the literature concerning the primary inflammatory 
mediators of age-related insulin resistance. Our findings suggest that JNK, IKKβ and 
GSK-3β could play a role in the development of insulin resistance in aged skeletal 
muscle. Although increased activation of PKCθ and extracellular regulated kinase 
(ERK) have been implicated in other animal models of insulin resistance, findings 
from our laboratory indicate these serine/threonine kinases are not increased in 
skeletal muscles from aged rats (data not shown). As PKCθ has been primarily 
associated with insulin resistance in the presence of increased lipid availability 
(Wellen and Hotamisligil 2005), the lack of an increase in PKCθ in aged, insulin-
resistant skeletal muscle potentially differentiates the development of insulin 
resistance in aging and obesity models of insulin resistance. Future studies designed 
to inhibit inflammatory-mediated pathways in aging skeletal muscle could profoundly 
impact the prevalence of insulin resistance and diabetes in this population.  
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Results from this study are the first to characterize these potential mediators of 
insulin resistance in fast-twitch and slow-twitch skeletal muscles with age. A previous 
study demonstrated an increase in basal JNK phosphorylation in soleus and the fast-
twitch extensor digitorum longus (EDL) muscles from 30 month-old and 36 month-
old compared with 6 month-old Fischer 344/Borwn Norway rats (Mylabathula et al. 
2006). However these investigators did not compare JNK activation or expression 
levels between the two muscle types. In the current study, we show dramatically 
greater phosphorylation levels of JNK in Epi muscles compared to soleus (Figure 
6A), suggesting JNK may play an important inhibitory role in Epi muscle insulin 
action. In our findings, IKKβ (as measured by increased degradation of IkBα) and 
GSK-3 follow this same pattern of increased activation in fast-twitch compared to 
slow-twitch muscle, further emphasizing the role these inhibitory stress kinases may 
play in regulating insulin signaling in fast-twitch muscle. Atherton et al. (Atherton et 
al. 2004) support our findings of greater GSK-3β expression in soleus muscles 
compared to the fast-twitch EDL, although these investigators did not measure serine 
9 phosphorylation as an estimate of GSK-3 activation in these muscles. Dokken et al. 
(Dokken et al. 2005) measured GSK-3β serine 9 phosphorylation in soleus and Epi 
muscles from lean and obese Zucker rats. The results of this study showed a greater 
GSK-3 activity in obese soleus compared to obese Epi muscles from Zucker rats. 
These findings along with a study of the spontaneous nonobese model of GK rats 
suggest insulin resistance is more pronounced in skeletal muscle composed 
predominantly of oxidative fibers (Song et al. 1999; Dokken et al. 2005).  
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Our findings in an aging model suggest a different fiber type effect with a 
greater impact of insulin resistance on fast-twitch glycolytic muscle. One possible 
explanation for divergent fiber type specific effects of insulin resistance with aging 
and obesity models could be due to age- and obesity-specific metabolic changes that 
occur in skeletal muscle. A greater impact on insulin signaling in fast-twitch muscle 
in the aging model could be due to the greater sarcopenia, muscle atrophy (Lexell 
1995) and decrease in expression of insulin signaling intermediates that occurs with 
age in fast-twitch muscle (Carvalho et al. 1996; Arias et al. 2001). In contrast, a 
theory of obesity-induced insulin resistance suggests the metabolic overload and 
influx of fatty acids that occurs in skeletal muscle with overnutrition results in an 
increase in β-oxidation without a subsequent increase in tricarboxylic acid cycle flux 
(Muoio and Newgard 2008). This dysregulation results in accumulation of metabolic 
by-products of incomplete fat oxidation (acylcarnitines, ROS) in the mitochondria. 
Given the greater mitochondrial content of oxidative muscle fibers, this lipid stress 
could have a greater impact on oxidative fibers compared to glycolytic fibers.   
Our findings regarding fiber type differences in HSP72 and HSP25 expression 
support what has been previously shown in the literature, with more oxidative fiber 
types expressing higher levels of HSPs (Locke et al. 1991; Huey 2006). Previous 
studies demonstrate that skeletal muscle HSP72 expression correlates with the degree 
of insulin resistance (Kurucz et al. 2002; Bruce et al. 2003) and this is also supported 
by our data demonstrating a decrease in HSP expression in aged, insulin resistant 
muscle. The HSP72 content in skeletal muscle has previously been shown to decrease 
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with age in soleus muscle from male Fischer 344 rats (Selsby et al. 2005) and to 
remain unchanged in the soleus and plantaris muscles of aged female Fischer 344 rats 
(Naito et al. 2001).The lack of a decrease in HSP72 with age in the study by Naito et 
al. (Naito et al. 2001) could be due to the ability of estrogen to upregulate HSP72 as 
previously shown in female rat skeletal muscle (Voss et al. 2003). While few studies 
have examined fiber type specific changes in HSP25 with age, HSP25 expression 
increased with age in rat mixed gastrocnemius muscle (Chung and Ng 2006) and 
decreased with age in rat cardiac muscle (Colotti et al. 2005). The downregulation of 
HSP25 that occurs with unloading suggests activity plays a role in regulation of 
HSP25 expression in skeletal muscle (Lawler et al. 2006), a theory that is consistent 
with an age-related decrease in HSP25 phosphorylation shown here.  
Previous studies have demonstrated a role for HSPs in protecting 
mitochondria from oxidative stress (Polla et al. 1996) and a correlation between 
HSP72 mRNA expression and mitochondrial enzyme activity (Bruce et al. 2003). Our 
findings of age and fiber type differences in cytochrome oxidase activity are 
consistent with observed changes in HSP expression and activation. Muscle fiber type 
differences in cytochrome oxidase activity demonstrated in the present study are 
consistent with previous findings. Chabi et al. (Chabi et al. 2008) recently reported 
that soleus muscle cytochrome oxidase activity was approximately 40% higher than 
the fast-twitch plantaris muscle. In addition, they reported a 30% decrease in 
cytochrome oxidase activity in 36-month-old male Fischer 344 Brown Norway 
hybrids as compared to 6-month-old rats. Different muscle and animal strain account 
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for the slight difference in age effect, however the pattern of cytochrome oxidase 
changes is evident. Future studies are needed to determine the exact mechanism by 
which HSPs could protect mitochondria from oxidative damage. 
Although the reason for a decrease in HSP expression with age and insulin 
resistance is not known, it appears that stress kinase activation may play a role. For 
example, GSK-3, and the MAP kinases, ERK and JNK, are known to negatively 
regulate the primary HSP transcription factor, HSF-1. Phosphorylation of HSF-1 by 
GSK-3, ERK and JNK on serine residues 303, 307, and 363, respectively (He et al. 
1998; Dai et al. 2000) holds HSF-1 in an inactive state under normal physiological 
growth conditions. Consequently, overactivity of stress kinases capable of 
phosphorylating HSF-1 on serine residues may repress HSF-1 activation, and 
subsequent HSP72 transcription and HSP25 activation, in insulin resistant tissue.  
Induction of HSPs may serve as a powerful tool for preventing insulin 
resistance with age. A recent publication demonstrated, for the first time, that 
increased HSP72 expression protects against obesity-induced insulin resistance 
(Chung et al. 2008). In the study by Chung et al. (Chung et al. 2008) heat shock 
therapy, as well as transgenic and pharmacologic means of overexpressing HSP72, all 
resulted in improved glucose tolerance and insulin action in skeletal muscle. In all 
cases, this corresponded with a decrease in JNK phosphorylation. It has been 
proposed that HSP72 binds to JNK, preventing activation of JNK by upstream 
kinases SEK1 and MKK7 (Park et al. 2001). Similar studies revealed that HSP72 
inhibits IKKβ, either by direct binding or through an, as yet, uncharacterized 
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signaling intermediate (Park et al. 2003). This natural inhibitory effect of HSP72 on 
JNK, and of HSP25 on IKKβ could serve as a powerful tool for targeting stress 
kinase inhibition in the treatment of skeletal muscle insulin resistance. The ability of 
HSPs to protect against age-related insulin resistance has not yet been tested. In 
conclusion, our results demonstrate a significant difference in the ability of slow-
twitch and fast-twitch muscles to respond to insulin and regulate glucose with age. 
While a decrease in insulin signaling and glucose uptake occurs in both slow-twitch 
soleus muscles and fast-twitch Epi muscles with age, the greater reserve capacity of 
the slow-twitch soleus muscle results in a far smaller decrement in insulin capacity in 
this muscle with age. Our findings suggest the proportionately lower activation of 
JNK, GSK-3β degradation of IkBα by IKKβ and greater expression and 
phosphorylation of HSP72 and HSP25, play a role in protecting slow-twitch muscle 
from further insulin resistance with age. Future studies are needed to examine the 
relationship between HSP expression and stress kinase activation and the impact of 
these pathways on insulin signaling in skeletal muscle.  
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3.1. Abstract  
 
Aging is associated with impaired insulin action and reduced expression of 
heat shock proteins. Recently, induction of heat shock proteins has been implicated in 
protection from obesity-related insulin resistance, however, the ability of heat shock 
proteins to protect against age-related insulin resistance is not known. Heat treatment 
to 24-month-old Fischer 344 rats showed improved insulin-stimulated glucose uptake 
in soleus muscles. Induction of HSP72 with an in vitro heat treatment to muscles 
from young and old rats was associated with reduced anisomycin-induced JNK 
activation. But heat treatment had no effect on p38 MAPK, which is a related kinase 
that is also activated with anisomycin. The heat-mediated JNK inhibition was 
specifically associated with HSP72 upregulation since inhibition of HSP72 with 
KNK437 reversed the heat-induced inactivation of JNK. In the heat treated muscles, 
HSP72 co-immunoprecipitated with JNK, indicating a direct protein-protein 
interaction. In conclusion, an acute bout of heat treatment can alleviate age-related 
insulin resistance with HSP72-mediated JNK inhibition as the potential mechanism.  
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3.2. Introduction  
  
 Type 2 diabetes is known to be one of the main causes of mortality and 
morbidity worldwide (Saltiel and Kahn 2001). Currently, diabetes, affects 7% of the 
U.S. population and 20% of the elderly population suffers from diabetes (CDC). The 
estimated economic burden of diabetes in United States is $132 billion per year, of 
which 51.8% is incurred by people 65 years of age or older (Hogan et al. 2003). As 
the baby boomers grow older, the number of people over the age of 65 years is 
expected to double in the next 25 years, increasing the demands for better treatments 
for diabetes. 
 Insulin resistance, an early defect in the development of type 2 diabetes, is 
strongly associated with the aging process itself (DeFronzo 1981). Exercise training is 
known to improve insulin sensitivity, but even endurance-trained individuals exhibit a 
decline in insulin action with age, indicating that the aging process itself limits insulin 
sensitivity (Clevenger et al. 2002). Aging is associated with chronic accumulation of 
the reactive oxygen species and several age-related pathologies, including diabetes, 
are thought to occur due to oxidative stress (Houstis et al. 2006). Oxidative stress can 
increase activation of inflammatory mediators such as c-jun terminal kinase (JNK) 
and inhibitor of kappa B kinase β (IKKβ) (Shoelson et al. 2003; Kaneto et al. 2007). 
Activation of these kinases results in serine phosphorylation of the insulin receptor 
substrate 1 (IRS-1), ultimately leading to impaired insulin signaling and insulin 
resistance. Insulin resistance in skeletal muscle, the tissue responsible for 75% of 
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glucose utilization in the body, is an important risk factor for the development of type 
2 diabetes (Bjornholm and Zierath 2005). 
 One of the body’s major endogenous defense systems against the increased 
production of reactive oxygen species in skeletal muscle is the highly conserved 
family of proteins known as heat shock proteins (HSPs) (McArdle et al. 2001). The 
role of HSPs in tissue protection and repair against a number of pathological 
conditions has been well documented (Welsh et al. 1995; Powers et al. 2001). 
Expression of HSPs and their upregulation in response to stress are significantly 
reduced with aging and diabetes (Kregel et al. 1995; Vasilaki et al. 2002; Atalay et al. 
2004). We have previously shown that HSP expression is reduced in aging rat muscle 
and is associated with increased stress kinase activities and reduced insulin sensitivity 
(Gupte et al. 2008). But the mechanism of HSP-mediated stress kinase inhibition is 
not clear.  
Enhanced heat shock protein 72 (HSP72) expression can protect cells and 
tissue from injury, modulate inflammatory signaling by directly inhibiting JNK, and 
decrease injurious oxidative stress associated with normal aging in skeletal muscle 
(Broome et al. 2006). Studies show decreased expression of HSPs in patients with 
type 2 diabetes correlates with reduced insulin sensitivity (Kurucz et al. 2002). 
Conversely, increased HSP72 expression with heat therapy has been shown to 
improve clinical parameters in patients with type 2 diabetes (Hooper 1999). Lifelong 
overexpression of HSP72 in skeletal muscle protected mice from the age-associated 
accumulation of oxidative damage and preserved muscle function (Smolka et al. 
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2000; Broome et al. 2006). We and others have shown previously that induction of 
HSPs with heat treatment can protect against obesity-related insulin resistance 
(Kokura et al. 2007; Chung et al. 2008; Gupte 2008; Morino et al. 2008), but the 
effects of HSPs on aging muscle are not known. 
The purpose of the current study was to examine the specific involvement of 
HSP72 in the benefits of heat treatment in aging, insulin resistant muscle. Earlier 
studies from our lab have shown that weekly repeated heat treatments given in 
parallel with a high fat diet protects skeletal muscle from insulin resistance (Chapter 
6, (Gupte 2008)). We were interested in knowing whether a single bout of heat 
treatment can improve insulin sensitivity in an insulin resistant animal. We examined 
the benefits of in vivo heat treatment in soleus muscles from insulin resistant F344 
rats and then examined the importance of HSP72 upregulation in young and aged 
soleus muscle with in vitro muscle incubation.  
 
 
 
 
 
 
 
 
 
 88
3.3. Materials and methods  
 
Materials 
 [14C] Mannitol was obtained from ICN Radiochemicals (Irvine, CA). 2-
Deoxy [1,2-3H] glucose was purchased from American Radiolabeled Chemicals (St. 
Louis, MO).  Antibodies against phospho-SAPK/JNK(T183/Y185), total SAPK/JNK, 
phospho-p38 MAPK (T180/Y182) , total p38 MAPK, were purchased from Cell 
Signaling (Beverly, MA). Anti-HSP72 antibody was obtained from Stressgen 
(Victoria, BC, Canada), and anti-tubulin was obtained from Sigma (St.Louis, MO). 
Goat-anti-rabbit HRP-conjugated secondary antibodies and Protein A/G PLUS 
agarose beads were obtained from Santa Cruz Biotechnology (Santa Cruz, CA), while 
goat anti-mouse HRP-conjugated secondary antibodies were obtained from Bio-Rad 
(Hercules, CA). KNK437 and Anisomycin were obtained from Calbiochem (San 
Diego, CA). Insulin was purchased from Humalog (Elli Lilly, Indianapolis, IN). 
Enhanced chemiluminescence reagents were purchased from Amersham (Little 
Chalfont, Buckinghamshire, UK). All other reagents were obtained from Sigma 
(St.Louis, MO).  
Experimental animals and muscle dissection  
The Fischer 344 rat strain provides a suitable aging model due to its relatively 
short life span (Yu et al. 1985), extensive characterization of age-associated changes 
and the availability of barrier-reared aging colonies of Fischer 344 rats, maintained 
under the supervision of the NIA. Male Fischer 344 rats were purchased at 3 (body 
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weight 238.50 ± 5.11 g) and 24 (body weight 393.0 ± 17.72 g) months of age via the 
National Institutes of Health. Rats were housed in pairs in large cages in a 
temperature controlled facility (24+1 oC) with a 12 h light/dark cycle. All animals 
were given free access to Purina Rat Chow and water ad libitum. The rats were 
anesthetized with an intraperitoneal injection of pentobarbital sodium (5 mg/100 g 
body weight) followed by the removal of the soleus which consists predominantly of 
slow-twitch red fibers (84% type I, 16% type II) (Delp and Duan 1996). Soleus 
muscles were split longitudinally prior to incubation to allow adequate diffusion of 
oxygen and substrates.  The slightly larger soleus muscles of aged rats were carefully 
trimmed to remain comparable in size with those of the young soleus. Muscle wet 
weight was used to determine equivalent size. All protocols were approved by the 
Animal Care and Use Committee of the University of Kansas Medical Center. 
In vivo heat treatment 
 Animals were lightly anesthetized with an intraperitoneal injection of 
pentobarbital sodium (5 mg/100 g body weight). While in supine position, a thermal 
blanket (Chattanooga group, Hixson, TN) was wrapped around the lower body such 
that only the hind legs are completely covered with the blanket. As previously 
described (Tolson and Roberts 2005), the blanket temperature was set to 112°F and 
core body temperature was monitored using a rectal probe from ThermoWorks 
(Braintree scientific, Braintree, MA). The rats took between 40-55 min to get to 41°C, 
after which the core temperature was maintained between 41oC and 41.5oC for 20 min 
by opening and closing the blanket. For the sham treatment, rats were anesthetized 
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and their core temperature was maintained at 35°C. After the heat or sham treatments, 
the rats were administered 5 ml of 0.9 % saline, I.P. to prevent dehydration. Rats were 
fasted overnight (12 h) and anaesthetized once again 24 h post heat treatment for 
assessment of glucose transport.  
Measurement of glucose transport activity 
Twenty four following heat treatment, isolated soleus muscle strips were 
recovered for 60 min in Krebs-Henseleit bicarbonate buffer (KHB) with 8 mM 
glucose, 32 mM mannitol (recovery medium), and a gas phase of 95% O2/5% CO2. 
The muscles were rinsed for 30 min at 29°C in 2 ml of oxygenated KHB containing 
40 mM mannitol, with (1 mU/ml) or without insulin. After the rinse step, muscles 
were incubated for 20 min at 29°C in flasks containing 2 ml KHB with 4 mM 2[1,2-
3H] deoxyglucose (2-DG) (1.5 µCi/ml) and 36 mM [14C] mannitol (0.2 µCi/ml), with 
(1 mU/ml) or without insulin, with a gas phase of 95% O2/5% CO2, in a shaking 
incubator. The muscles were then blotted, clamp-frozen, and processed for 
determination of intracellular 2-DG accumulation and extracellular space as described 
previously (Young et al. 1986; Geiger et al. 2006).  
In vitro heat treatment and muscle incubations 
Following dissection, isolated soleus muscles were incubated in flasks 
containing 2 ml MEM (Invitrogen, Carlsbad, CA) supplemented with 0.01% BSA, 
2.2 g/L NaHCO3, 5 mM mannitol, 2.54 mM CaCl2, 10% FBS, 1 ml/L Pen/Strep (all 
from Sigma) and 50 µU/ml of insulin (Elli Lilly) and supplied with a gas phase of 
95% O2/5% CO2 at 35°C (Henriksen et al. 1990; Geiger et al. 2005). The flasks were 
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incubated in a temperature-controlled shaking water bath. For the in vitro heat shock 
treatment, muscles were incubated at 42°C for 30 minutes while non-heat shock 
treated muscles remained in recovery buffer at 35°C. Following 30 min at 42°C or 
35°C, muscles were allowed to recover for 12 h in the MEM recovery medium at 
35°C. For subsequent treatments, the muscles were transferred to fresh flasks 
containing anisomycin (10 μg/ml) for 30 min in Krebs-Henseleit bicarbonate buffer 
(KHB). When KNK437 (100 μM) was used, muscles were pre-incubated with 
KNK437 for 3 h, followed by heat treatment in presence of KNK437 and then 
incubated in fresh media containing KNK437 for 8 h. Finally the muscles were 
rapidly frozen in liquid nitrogen and processed for Western blot analysis.  
Immunoprecipitation assay: 
Anti-JNK antibody (BD Biosciences, San Jose, CA) was coupled to 50 μl of 
Protein A/G PLUS agarose beads in 200 ul of 1X PBS with constant rotation at 4°C. 
Coupled beads were spun down briefly, washed a couple of times with 1X cold PBS 
and mixed with 1 mg of protein lysate which was diluted to a final volume of 1 ml. 
After an overnight incubation on a rotator at 4°C, pellets were separated with a brief 
centrifugation and washed thoroughly 3 times with ice cold PBS. Pellets were 
resuspended in 40 μl 1X Laemmli buffer and analyzed for HSP72 with Western blot 
analysis. Pellets were also analyzed for total JNK pulled down in the assay.  
Western Blotting 
Clamp frozen soleus muscles were homogenized in a 12:1 (volume to weight) 
ratio of ice cold buffer while L6 myotubes were scraped in 100 μl per well of 
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homogenization buffer from Biosource (Invitrogen). The buffer contains: 10 mM 
Tris-HCL (pH 7.4), 100 mM NaCl, 1 mM each of EDTA, EGTA, NaF, PMSF and 2 
mM Na3VO4, 20 mM Na4P2O7, 1% Triton X-100, 10% glycerol, 0.1% SDS, 0.5% 
deoxycholate, 250 μl/5ml protease inhibitor cocktail. Homogenized samples were 
rotated for 30 minutes and then centrifuged for 20 minutes at 3,000 rpm at 4°C. The 
protein concentration of the supernatant was determined by Bradford method (Bio-
Rad, Hercules, CA).  Samples were prepared in 1X Laemmli buffer (final) containing 
100 mM dithiothreitol and heated in a boiling water bath for 5 minutes.  
Protein samples (30-100 μg) were subjected to SDS-PAGE (6.25-10% gel) 
followed by a wet transfer to a nitrocellulose membrane for 90 min (200 mA/tank). 
Membranes were blocked for 1 hour at room temperature in TBST 5% non-fat dry 
milk followed by an overnight incubation with the appropriate primary antibodies at a 
concentration of 1:1000. Antibodies were diluted in Tris-buffered saline, 0.1% 
Tween-20 (TBST), 5% BSA. Following 3 brief rinses in TBST, blots were incubated 
in TBST 1% non-fat dry milk supplemented with an HRP-conjugated goat anti-rabbit 
secondary antibody at a concentration of 1:10,000 for 1 hour at room temperature. 
Bands were visualized by ECL and quantified using densitometry (Image J, NIH). 
Blots were stripped and normalized for the total protein or tubulin as loading controls.  
Citrate synthase assay 
Citrate synthase activity was assessed in muscle lysates, using a modified 
protocol (Smirnova et al. 2006) by Srere et al. (Srere 1969). The absorbance was 
recorded at 405 nm every 20 sec for 3 min at 30°C, using a MRXII microplate reader 
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and kinetic software package (Dynex Technologies, Chantilly, VA). The linear 
portion of the reaction curve was used to calculate activity levels of citrate synthase, 
in µmol/g/min.  
Statistical Analysis 
 Two-way analysis of variance (ANOVA) was used when both age and 
treatment differences were studied. This was followed by a post hoc comparison 
using the Student-Newman-Keuls test when necessary. Values are expressed as 
means of ± SE. Differences between young and aged muscles are stated in the figure 
legends. Statistical significance was set at P<0.05.   
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3.4. Results  
 
Reversal of insulin resistance with heat treatment in aged rats 
 Heat treatment given in parallel with an insulin resistance-inducing diet, has 
been shown to protect against insulin resistance (Chapter 6, (Chung et al. 2008; Gupte 
2008)). Whether heat treatment can improve insulin sensitivity in already insulin 
resistant animals is not known. Previous studies from our lab have shown that 24 
month old F344 rats are insulin resistant as reflected by decreased glucose uptake into 
soleus and epitrochlearis muscles (Chapter 2, (Gupte et al. 2008)). We administered 
lower body heat treatment to the aged rats with a thermal blanket (41 oC for 20 min), 
while the controls were given a sham treatment (35 oC for 20 min). Twenty four hours 
post heat treatment, soleus muscles were dissected and 2-deoxyglucose uptake was 
measured. Insulin stimulated glucose uptake was significantly improved in the heat 
treated rats compared with the sham treated rats (Figure 9). Thus, a single dose of 
mild heat treatment can effectively improve insulin sensitivity in the insulin resistant 
aged muscles.  
In vitro heat shock treatment induces HSP72 expression in soleus muscles from young 
and aged rats.  
To dissect the mechanisms and the specificity of HSP72 involvement in the 
heat induced benefits of insulin sensitivity, we developed an in vitro model of heat 
treatment. The in vitro model allows us to manipulate temperature, add/remove 
activators/inhibitors in a time dependent manner. This system allows us to study  
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FIGURE 9. 
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Figure 9. In vivo heat treatment improves glucose uptake in insulin resistant 
soleus muscles from aged rats. 24 mos old F344 were given a either a sham 
treatment (Control, 35 oC for 20 min) or a heat treatment (41 oC for 20 min) using a 
thermal blanket. Soleus muscles were removed 24 hours after the treatments and 
analyzed for basal (- insulin, open bars) and + Insulin (1 mU/ml, dark bars) glucose 
transport. (*P<0.001 Insulin vs. Basal and #P<0.001 Heat treatment vs. control for 
+Insulin). Values are means of ± SE for 4-7 muscles per group. 
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effects of heat treatment in the muscle independent of the whole body physiological 
changes that an in vivo heat treatment will have. Previous studies examining the in 
vivo heat shock response in muscle have found that maximal HSP72 expression 
occurs 4-48 h post heat treatment, depending on the muscle type (Oishi et al. 2002). 
We found that the maximal response to in vitro heat treatment to soleus muscles is 
seen 12 h post heat shock (data not shown). Both young and aged soleus muscles 
showed a robust induction of HSP72 protein expression (120% increase in young 
soleus, 90% increase in aged soleus, compared to the respective basals) (Figure 10A). 
The aged soleus muscles have slightly less HSP72 expression and the heat shock 
response is considerably dampened in the aged muscle compared to the young soleus. 
In vitro heat shock treatment prevents JNK activation with Anisomycin. 
Basal (35oC for 30 min) or heat treated (42oC for 30 min) muscles were 
allowed to recover for 12 hr and then treated with anisomycin (10 µg/ml) for 30 min. 
Anisomycin is a potent activator of stress activated protein kinases JNK and p38 
MAPK and previous studies have shown that incubation at low concentrations and for 
a short period as used in this study do not have any adverse effects on protein stability 
(Geiger et al. 2005). In basal muscles, anisomycin induced a robust activation of JNK 
as seen by increased phosphorylation levels (Figure 10B). Activation of JNK was 
much greater in the aged muscles than the young soleus muscles, given that aged 
muscles have greater basal phospho-JNK levels due to oxidative stress (Mylabathula 
et al. 2006). But in heat treated muscles, the same concentrations of anisomycin could 
not fully activate JNK in both young and aged muscles (gray bars).  
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FIGURE 10.  
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Figure 10. In vitro heat treatment induces HSP72 expression and inhibits 
Anisomycin induced JNK activation. Soleus muscles from young (3 mos) and aged 
(24 mos) old F344 rats were heat treated at 42 oC for 30 min (HS) or sham (basal) at 
35 oC for 30 min. Muscles recovered for 12 hours, were then frozen and analyzed for 
HSP72 expression (A) with Western blots. Blots were stripped and probed for tubulin 
as a loading control. (*P<0.01 Heat shock vs. Basal and #P<0.001 aged vs. young for 
Heat shock treatment; n=8-17 muscles/group). A subset of the muscles was stimulated 
with anisomycin (10 μg/ml) for 30 min after the 12 h recovery and then snap-frozen. 
Muscle lysates were analyzed for (p)-JNK/JNK (B). (*P<0.001 Anisomycin vs. Basal, 
#P<0.001 HT+Anisomycin vs. Basal+Anisomycin, P<0.01 for all aged vs. all young 
groups; n=7-20 muscles/group). Lysates were also analyzed for (p)-p38 MAPK/p38 
MAPK (C) (*P<0.05 Anisomycin vs. Basal, #P<0.01 young vs. aged basal; n=8-14 
muscles/group) and for citrate synthase activity (D) (*P<0.001 aged vs. young; n=3 
muscles/group). 
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This indicates that heat shock treatment prevents JNK activation even in the presence 
of a strong activator like anisomycin. Anisomycin also activates p38 MAPK, a MAP 
kinase with properties similar to JNK. Therefore we examined whether heat treatment 
affects p38 MAPK activation as well. Anisomycin induced activation of p38 MAPK 
as seen by increased phosphorylation levels in the young soleus muscles (Figure 
10C). Basal phospho-p38 MAPK was much greater in the aged soleus and therefore 
did not increase further with anisomycin treatment. Heat treatment had no effect on 
the activation of p-38 MAPK in either the young or aged soleus muscles.  
To further verify that heat shock mediated JNK inhibition was not an artifact 
of the heat treatment itself, we examined citrate synthase activity, routinely measured 
to assess muscle viability. Citrate synthase activity levels were greater in the young 
soleus muscles than the aged soleus muscles as has been reported before (Figueiredo 
et al. 2008), but no reduction in activity levels were seen with the heat treatment 
(Figure 10D).  
KNK437 inhibits heat induced HSP72 expression 
KNK437 is a specific inhibitor of inducible heat shock proteins (Yokota et al. 
2000; Koishi et al. 2001). Its mechanism of action is believed to be inhibition at the 
transcriptional level (Yokota et al. 2000). Muscles were pre-incubated with KNK437 
(100 µM) for 3 h, followed by an in vitro heat or sham treatment as described above. 
Since KNK437 is a reversible inhibitor, it was included during most of the recovery 
period as well (8h). HSP72 induction with heat treatment was significantly dampened 
in muscles from both young and aged rats in the presence of KNK437 (Figure 11A).  
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FIGURE 11.  
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 Figure 11. Pharmacological inhibition of HSP72 induction eliminates heat 
stress-mediated inhibition of JNK. Isolated soleus muscles from young and old 
F344 rats were exposed to sham or heat shock (HS) at described above. A reversible 
pharmacological inhibitor of HSP, KNK437 (100 µM), was included in the 
incubation buffer 2 h prior to, during and 8 h post HT for a subgroup of muscles. 
Following recovery for a total of 12 h at 35°C, muscles were assessed for HSP72 
(A). JNK activation in response to anisomycin (Aniso, 10 µg/µl, 30 min), was tested 
at the end of the recovery period (B). (*P<0.001 HS vs. Basal and Basal+Aniso vs. 
Basal, #P<0.001 HS+KNK vs. HS and HS+Aniso vs. Basal+Aniso, +P <0.001 
HS+KNK+Aniso vs. HS+Aniso, P<0.001 for all aged vs. all young groups). Values 
are means of ± SE for 4-7 for the aged muscles and 7-20 for young muscles per 
group. 
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KNK437 had no significant effect on the muscles without heat treatment (data not 
shown).  
Inhibition of HSP72 with KNK437 reverses heat shock mediated JNK inhibition:  
Heat treatment induces several molecular and physiological changes in cells, 
including membrane fluidization (Nagy et al. 2007), upregulation of chaperone 
proteins, reducing oxidative stress etc. To verify that HSP72 has a specific role in the 
observed JNK inactivation, we examined JNK activity levels in the presence of the 
HSP72 inhibitor KNK437. Anisomycin induced JNK activation was reduced with 
heat shock, but in the muscles incubated with KNK437, heat shock did not decrease 
JNK activation with anisomycin (Figure 11B). Thus, pharmacological inhibition of 
the HSP72 response to heat shock reversed the heat-mediated inhibition of JNK. This 
data indicates that JNK inactivation was specifically mediated by HSP72.  
Heat induced HSP72 interacts with JNK  
Homogenates from basal and heat treated muscles were subjected to an 
immunoprecipitation assay using anti-JNK antibody. HSP72 co-immunoprecipitated 
with JNK only in the heat treated muscles, from both young and aged rats (Figure 
12). This indicates that HSP72 interacts with JNK in the muscles receiving heat 
treatment. This could indicate a potential mechanism by which HSP72 could inhibit 
JNK activation.  
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FIGURE 12. 
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Figure 12. HSP72 and JNK co-immunoprecipitate in heat shock treated muscles. 
Lysates of heat shock treated (42oC 30 min, 12 h recovery) and basal (35oC 30 min, 12 
h recovery) soleus muscles were subjected to an immunoprecipitation assay using an 
anti-JNK antibody coupled to Protein A/G PLUS agarose beads. Pellets were analyzed 
for HSP72 and total JNK with Western blot analysis. Blots are representative of 3 
independent experiments, 4-5 muscles per condition. 
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3.5. Discussion 
 
Age related-insulin resistance is a serious health concern since it represents an 
underlying risk factor for several age-related diseases including diabetes, Alzheimer’s 
disease and cardiovascular disease. The role of HSPs in protecting insulin sensitivity 
in muscle is under recognized. Although previous studies, including ours, have shown 
that HSP induction can protect against insulin resistance (Chung et al. 2008; Gupte 
2008), we now show that HSP induction can also reverse pre-existing insulin 
resistance in the aged rats. We also report that HSP72 induction is associated with 
JNK inactivation, that JNK inactivation is specific to HSP72 induction and is 
mediated by a direct protein-protein interaction. Our results suggest that HSP72 
inducing treatments may have potential therapeutic benefits for insulin resistance in 
the elderly.  
Aging and insulin resistance are associated with an inter-dependent cycle of 
reduced heat shock proteins, chronic inflammation and reduced insulin sensitivity. 
Therapeutic upregulation of HSPs is thought to forestall this cycle (Hooper and 
Hooper 2008), but the precise mechanisms are not clear. Overexpression of HSPs 
could potentially protect skeletal muscle from oxidative stress-induced insulin 
resistance by decreasing muscle susceptibility to stress (chaperone role of HSPs). 
Alternatively, increased HSP expression could more directly improve insulin 
resistance and mediate insulin action by inhibiting stress kinase activation. In 
NIH3T3 cells, HSP72 has been shown to bind to JNK and prevent its activation by 
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the upstream kinases SEK1 and MKK7 (Park et al. 2001). While other investigators 
suggest HSP72 prevents stress-mediated inactivation of a phosphatase that targets 
JNK, both proposed mechanisms effectively inhibit JNK activation (Meriin et al. 
1999; Gabai et al. 2000). This role of HSP72 as a natural inhibitor of JNK has been 
shown to be independent of its chaperone function since removal of the ATPase 
domain of HSP72 still maintains JNK inactivation (Yaglom et al. 1999). In agreement 
with previous studies in NIH3T3 cells (Park et al. 2001), we report here that HSP72 
interacts with JNK in heat treated muscles.  Future studies are required to understand 
whether binding of HSP72 to JNK prevents phosphorylation of JNK by upstream 
kinases or facilitates its de-phosphorylation by MAPK-phosphatases. Other 
mechanisms proposed recently are mitochondrial protection (Polla et al. 1996; 
Williamson et al. 2008), reduction of oxidative stress (Selsby and Dodd 2005), and 
inhibition of DLK-1, a kinase upstream of JNK (Daviau et al. 2006). 
Heat shock protein expression is vastly different between fast- and slow-
twitch muscles, with slow-twitch muscles expressing several fold more HSP72 
(Locke et al. 1991). The degenerative loss of muscle mass and energy with aging, 
known as sarcopenia, occurs primarily in type II glycolytic fibers (Grimby 1995). 
Thus type I muscle fibers such as those in the soleus muscles are more abundant and 
relatively healthier in aged animals, and treatments designed for improving age-
related insulin resistance should factor in this fiber type difference. It is for this 
reason that we chose the soleus muscles for our experiments. Inhibition of JNK with 
HSP72 overexpression could not only protect the aging muscle from insulin 
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resistance but also from age-related muscle loss and oxidative stress (Broome et al. 
2006). Thus HSP inducing treatments in the aging muscle could have several 
beneficial effects.  
Aging is associated with a reduced heat shock response(Kregel et al. 1995) 
and in our hands, we also find that HSP72 induction with heat was dampened in the 
soleus muscles from aged rats compared with young rats. We also found that the in 
vivo heat treatment was stressful on the old rats, particularly if the temperature was 
raised to 41°C very quickly (ie <30 min). If the temperature was raised slowly over a 
period of 45 min or more by opening and closing the blanket, the stress was reduced. 
To remove the effects of whole body stress and hone into the mechanisms of HSP 
function, we used the in vitro muscle heat treatment. A solution to reducing the stress 
of heat and other potential complications in the elderly would be to use milder heat 
stress along with co-inducers such as bimoclomol and its derivatives. Nevertheless, 
our studies show that HSP72 upregulation can improve insulin action in aged muscle, 
indicating that HSP72 is a very promising therapeutic target in reversing advanced 
insulin resistance. Several HSP72-inducing compounds have been explored for 
treating diabetic neuropathy (Kurthy et al. 2002), myocardial infarction (Lubbers et 
al. 2002) etc. and now could be potentially investigated in treatment of advanced 
insulin resistance.  
In conclusion, our studies show that HSP72 can specifically inhibit JNK in the 
aging muscle and protect against insulin resistance. HSP-inducing treatments like 
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exercise, heat treatments and BGP-15 could be explored as interventions to alleviate 
insulin resistance in the elderly.  
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4.1. Abstract  
 
The aging process of the brain is associated with chronic oxidative stress. 
However, neuronal cells are thought to actively utilize compensatory defense 
mechanisms such as the heat shock proteins (HSPs) to protect themselves from 
persisting stress over time. Pharmacologically induced HSP expression has been 
shown to protect against age-related mitochondrial stress and oxidative stress. Despite 
the protective role of HSPs, little is known about the HSP response in the aging brain 
and the time point of its activation. The purpose of this study was to examine HSP 
expression in 3 different age-points: 6-months, 18-months and 30-months in the 
striatum, substantia nigra, globus pallidus and cortex regions from Male Fischer 
344/Brown Norway hybrid rats. Phosphorylated HSP25 and total HSP25 expression 
showed robust increases with age in the 30-month-old animals. But p38 MAPK, a 
protein previously implicated in activating HSP25 did not change with age. Although 
HSC70 and HSP60 expression did not change with age in any brain sections, HSP72 
was reduced with age only in the striatum. In conclusion, our results suggest that 
HSP25 is the main HSP responding to age-related pathology in the brain. 
Understanding the patterns of endogenous HSP protection in the aging brain may 
have potential implications in designing therapeutic interventions to prevent age-
related neurodegenerative disorders. 
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4.2. Introduction  
 
In the brain, normal aging is associated with oxidative stress, reduced 
antioxidant levels (including vitamin E and glutathione) (Hall et al. 2000; Hall et al. 
2001), and mitochondrial dysfunction (Hiona and Leeuwenburgh 2008). These 
changes are thought to contribute to motor and cognitive impairment (Weissman et al. 
2007; Sekler et al. 2008), as well as to age-related diseases such as Parkinson’s 
disease (PD) and Alzheimer’s disease (AD) (Heneka et al. 2003; Mosconi et al. 
2008). One mechanism used by neurons to counteract pathogenic conditions is to 
induce the expression of heat shock proteins (HSPs) (Calabrese et al. 2004). These 
proteins serve as biomarkers for stress conditions that accompany neurodegenerative 
diseases (Goldbaum and Richter-Landsberg 2001). HSC70, the constitutively 
expressed member of the HSP70 family and HSP72, the inducible HSP70 have been 
shown to increase with age in the brain (Unno et al. 2000; Calabrese et al. 2004).  
Small HSPs such as the HSP25 have been shown to increase in the reactive 
astrocytes of brains undergoing neurodegeneration (Brzyska et al. 1998), although 
HSP25 expression and phosphorylation of HSP25 in various regions of the aging 
brain has not been characterized. A positive correlation has been reported between the 
decrease in reduced glutathione levels (indicating increased oxidative stress) and 
increase in HSP72 expression levels (Calabrese et al. 2004). HSP25 has been shown 
to protect mitochondrial function, specifically complex I activity in murine PC12 
cells (Downs et al. 1999). HSP25 inhibits actin polymerization, (Wieske et al. 2001) 
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and also functions as a chaperone, preferentially interacting with unfolded actin and 
preventing formation of aggregates (Panasenko et al. 2003). Phosphorylation and 
supramolecular organization of HSP25 reduces its inhibition of actin polymerization 
(Benndorf et al. 1994). 
Despite their importance as intracellular protectors in aging, the time point at 
which changes in the activation and expression of HSPs occur is not known. For 
example, it is not known whether these changes occur progressively with age or 
whether they are an indicator of senescence. The purpose of this study was to 
determine if the changes in HSP expression occur progressively over age and whether 
they differ in the different regions of the brain.  
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4.3. Materials and methods  
 
Animals and dissection  
Male Fischer 344/Brown Norway hybrid rats were purchased at 6 (n=3, body 
weight 466.67 ± 5.77 g), 18 (n=3, body weight 518.67 ± 32.02 g) and 30 (n=3, body 
weight 625 ± 43.00 g) months of age from NIA colonies. Rats were housed in pairs in 
large cages in a temperature controlled facility with a 12 h light/dark cycle, with ad 
libitum access to food and water. The rats were fasted for 12 h overnight prior to 
sacrificing. Rats were deeply anesthetized with sodium pentobarbital and decapitated 
for brains removal. The following sections were collected in tubes and frozen on dry 
ice: striatum (Str), substantia nigra (SN), globus pallidus (GP) and cortex (Ctx). All 
protocols were approved by the KUMC Institutional Animal Care and Use 
Committee and procedures adhered to the Guide for the Care and Use of Laboratory 
Animals. 
Western blotting 
 Antibodies against HSP72 (SPA-810), phospho-HSP25 (S82), total HSP25, 
HSC70 (SPA-815) and HSP60 were obtained from Stressgen (Victoria, BC, Canada), 
and antibodies against Actin were obtained from Abcam (Cambridge, MA). 
Antibodies against phospho-p38 MAPK and total p38 MAPK were purchased from 
Cell Signaling (Beverly, MA). Goat-anti-rabbit HRP-conjugated secondary antibodies 
were obtained from Santa Cruz Biotechnology (Santa Cruz, CA), while goat anti-
mouse HRP-conjugated secondary antibodies were obtained from Bio-Rad (Hercules, 
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CA). Enhanced chemiluminescence reagents were purchased from Amersham (Little 
Chalfont, Buckinghamshire, UK). All other reagents were obtained from Sigma 
(St.Louis, MO).  
Frozen brain sections were homogenized using a hand held homogenizer in a 
12:1 (volume to weight) ratio of ice cold buffer from Biosource (Invitrogen, Carlsbad, 
CA) as described before (Morris et al. 2008). Homogenized samples were rotated for 
30 minutes and then centrifuged for 30 minutes at 3,000 rpm at 4°C. The protein 
concentration of the supernatant was determined by Bradford method (Bio-Rad, 
Hercules, CA).  Samples were prepared in 1X Laemmli buffer (final) containing 100 
mM dithiothreitol and denatured in a boiling water bath for 5 minutes.  
Protein samples (30-100 μg) were subjected to SDS-PAGE (6.25-10% gel) 
followed by a wet transfer to a nitrocellulose membrane for 90 min (200 mA/tank). 
Membranes were blocked for 1 hour at room temperature in TBST 5 % non-fat dry 
milk followed by an overnight incubation with the appropriate primary antibodies at a 
concentration of 1:1000. Antibodies were diluted in Tris-buffered saline, 0.1% 
Tween-20 (TBST), 1% milk. Following 3 brief rinses in TBST, blots were incubated 
in TBST 1% non-fat dry milk supplemented with the respective HRP-conjugated anti-
rabbit or anti-mouse secondary antibody at a concentration of 1:10,000 for 1 hour at 
room temperature. Bands were visualized by ECL and quantified using Image J 
densitometry. Blots were then stripped and probed for actin as a loading control.  
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 Statistical analysis 
One-way analysis of variance (ANOVA) was used to evaluate differences 
between age groups within each brain section. This was followed by a post hoc 
comparison using the Student-Newman-Keuls test when appropriate. Statistical 
significance was set at P<0.05.   
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4.4. Results  
 
HSP25 phosphorylation and expression 
Robust increases in phosphorylated HSP25 (pHSP25) occurred with age in 
Ctx, SN, GP and striatum sections (Figure 13A-D). The greatest increase in pHSP25 
was in the GP, with a 1356% increase in the 30-month-old animals compared to the 
6-month-olds. While pHSP25 peaked at 30 months in each brain section examined, 
significant pHSP25 increase in 18-month-old animals was seen only in the SN. Total 
HSP25 expression also increased markedly in all 4 brain sections in the 30-month-old 
old compared to the 6-month-old animals. Like pHSP25, the increase in total HSP25 
in the 30-month-old animals was greatest in the GP and least in the striatum. When 
pHSP25 is normalized to total HSP25, changes in pHSP25 were no longer seen, 
indicating that most of the total HSP25 protein present is in the phosphorylated state 
(data not shown). 
p38 MAPK phosphorylation and activation 
Activation of p38 MAPK, as indicated by its phosphorylation, did not differ 
significantly with age in any of the brain sections examined (Table 1). Neither the 
total p38 MAPK protein expression, nor phosphorylated to total protein ratio, differed 
significantly with age.  
HSP72 expression 
HSP72, the inducible member of the HSP70 family, was examined using an 
antibody (SPA-810) that specifically recognizes the inducible HSP72 and does not 
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cross-react with HSC70. Although HSP72 expression was very low compared to 
HSC70 in the brain sections under investigation, the striatum showed a significant 
decrease with age (Table 1). Compared to the 6-month-old group, HSP72 expression 
was 42% less in the 18-month-old animals and 49% less in the 30-month-old animals. 
The GP, SN and Ctx did not show significant changes in HSP72 expression in either 
age group.  
HSC70 expression 
HSC70, the constitutively expressed HSP70 family member was examined in 
the 4 regions of the brain using an antibody (SPA-815) that specifically reacts with 
HSC70 and does not cross react with HSP72. HSC70 was abundantly expressed in 
each of the brain regions, but did not vary significantly with age (Table 1).  
Mitochondrial HSP60 expression 
Impaired mitochondrial function is associated with age-related 
neurodegenerative diseases. Because HSP60 is associated with the mitochondrial heat 
shock response, we quantified its expression. HSP60 expression did not change with 
age in any of the brain sections examined (Table 1).  
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FIGURE 13.  
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C.                                                       D.  
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Figure 13. Increased expression of phospho-HSP25 and total HSP25 with age in 
the brain. Expression levels of p-HSP25 and total HSP25 were measured with 
Western blot analysis in the Globus pallidus (A), Substantia nigra (B), Cortex (C) and 
Striatum regions (D) from 6-month-old (6 mos), 18-month-old (18 mos) and 30-
month-old rats (30 mos). All blots were normalized to actin expression as a loading 
control. (***P<0.001, **P<0.01, *P<0.05). Values are means of ± SE for 3 rats per 
group.  
 
 
 
TABLE 1. Age-related changes in expression of HSPs and p38 MAPK in the 
brain.  
 
 
 
 
Globus pallidus Substantia nigra 
 6 mos 18 mos 30 mos 6 mos 18 mos 30 mos 
HSC70 
 
0.588±0.06 0.618±0.08 0.600±0.04 0.459±0.02 0.471±0.02 0.442±0.04 
HSP72 
 
0.365±0.04 0.400±0.05 0.370±0.07 0.287±0.01 0.340±0.05 0.335±0.03 
HSP60 
 
0.417±0.07 0.388±0.08 0.422±0.03 0.511±0.05 0.539±0.08 0.587±0.04 
p-p38 
MAPK 
0.145±0.02 0.150±0.01 0.188±0.03 0.170±0.041 0.268±0.08 0.285±0.03 
p38 
MAPK 
0.272±0.06 0.322±0.03 0.421±0.06 0.258±0.03 0.299±0.04 0.308±0.19 
 
 
 Cortex Striatum 
 6 mos 18 mos 30 mos 6 mos 18 mos 30 mos 
HSC70 
 
0.817±0.05 0.741±0.08 0.755±0.03 0.414±0.06 0.496±0.05 0.435±0.05 
HSP72 
 
0.432±0.04 0.360±0.02 0.382±0.03 0.175±0.11 0.067±0.05* 0.068±0.02*
HSP60 
 
0.656±0.02 0.693±0.14 0.594±0.05 0.665±0.06 0.726±0.06 0.746±0.11 
p-p38 
MAPK 
0.139±0.02 0.131±0.03 0.214±0.04 0.111±0.05 0.139±0.04 0.192±0.03 
p38 
MAPK 
0.323±0.03 0.318±0.04 0.393±0.02 0.411±0.11 0.544±0.03 0.488±0.06 
 
*P<0.05 when compared with 6-mos. Values are means of ± SE for 3 rats per group.  
 122
4.5. Discussion  
 
 Endogenous defense systems such as the heat shock proteins function to protect 
the body against stressors throughout the lifetime of an organism and stressors related 
to the aging process provide the ultimate test of these systems. In this study we 
examined the changes in HSP expression with age, using 3 age time points in 4 
different regions of the brain that are commonly associated with age-related 
neurodegenerative diseases. We found that HSP25 is markedly upregulated in all the 
brain regions examined and this change is most robust in the globus pallidus region. 
On the other hand, HSP72 expression was reduced only in the striatum. 
Understanding the patterns of endogenous HSP protection in the aging brain can help 
in designing therapeutic interventions to prevent neurodegenerative disorders.  
  The most robust age-related changes in our study are seen in HSP25 
expression/phosphorylation. HSP25 has been shown to protect NADH:ubiquinone 
oxidoreductase and NADH dehydrogenase activity (Complex I) in submitochondrial 
vesicles during heat and oxidative stress (Downs et al. 1999). Additional evidence of 
mitochondrial protection by HSP25 includes HSP25 inhibition of 6-
hydroxydopamine-induced cytochrome c release and apoptosis in PC12 cells 
(Gorman et al. 2005). Upregulation of HSP25 has also been reported in the spinal 
cords of a mouse model of familial amyotrophic lateral sclerosis and is accompanied 
by increases in the antioxidant peroxiredoxin 6 (Strey et al. 2004). Thus, increased 
HSP25 could be a possible anti-oxidant defense mechanism that the neuronal cells 
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resort to in a desperate attempt to survive oxidative stress. Further studies will be 
needed to see if removal of age-related oxidative stress can reverse this large increase 
in HSP25 expression.  
We have previously reported that aging is associated with a decrease in HSP 
expression in the skeletal muscle (Gupte et al. 2008) and others have shown decreases 
in cardiac muscles (Colotti et al. 2005). But the pattern of HSP25 expression with 
aging in the brain appears to be just the opposite. This suggests that the response to 
age-related stress is different in different tissues, possibly dependent on multiple 
parameters, including rate of turnover of proteins, rate of regeneration of tissue, 
exposure levels of stressors etc. Studies in the aging model of C.elegans revealed that, 
a progressive deterioration of most tissue occurs with aging, except for the nervous 
system, which remarkably preserves its integrity even in advanced old age (Herndon 
et al. 2002). Thus, it is likely the neurons protect themselves against aging with strong 
defense mechanisms such as the heat shock proteins seen in our study. Failure of 
these mechanisms would make these neurons susceptible to neurodegenerative 
diseases such as PD and AD. In support of this idea, it has been observed that only 
after HSP25 compensation fails, neurodegeneration follows in the ALS-SOD1 mice 
(Maatkamp et al. 2004). 
Different HSPs are induced in response to different stressor such as heat stress 
(induces HSP72) and oxidative stress (induces HSP32) (Goldbaum and Richter-
Landsberg 2001). Thus, it is likely that age-related stress in the brain is associated 
primarily with the induction of HSP25, but not any other HSPs. In our hands, we did 
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not see any changes in HSC70 but saw decreases in the inducible HSP72 with age, 
only in the striatum.  But in the brain regions that we examined in this study, HSP72 
expression is extremely low whereas the constitutive HSC70 expression is abundant. 
Therefore, the relative effect of reduced HSP72 may not be a significant aberration at 
this stage of aging but may serve as a starting point of deterioration of the overall 
defense systems of the brain.  
HSP72 did not change significantly in any other section but the striatum, 
where it reduced with age. The cortex showed trends of HSP72 reduction but did not 
make it to significance. These two regions also showed the smallest increases in 
HSP25 among the regions studied. Thus, it could be speculated that the striatum and 
cortex of the brain lose the HSP protection earlier in the progression of age-related 
deterioration and could be the regions most susceptible to age-related 
neurodegenerative diseases.  
Using immunohistochemical and immunoblot analyses, Murashov et al. 
showed that HSP25 is localized primarily to the facila, trigeminal, ambiguous, 
hypoglossal and vagal motor nuclei of the brain stem (Murashov et al. 1998). 
Astrocytes strongly express HSP25 and astrocytes are known to increase up to 20% in 
the aged cortex and other brain regions (Peinado et al. 1998), and PD and AD are 
both associated with reactive gliosis (Renkawek et al. 1999). Also, the occurrence of 
spheroids with age is seen predominantly in the globus pallidus and substantia nigra 
pars reticulata of aged rhesus monkeys, and the spheroids are associated with 
overexpression of HSPs (Fukuda et al. 2005). In our study, we see the largest 
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induction of HSP25 with age in these two regions. Therefore, future studies will be 
needed to see whether HSP25 expression in the aging brain increases in the neurons 
or is contributed by the increasing number of astrocytes.  
p38 MAPK has been suggested as the primary upstream kinase of HSP25, 
which phosphorylates and activates HSP25 in response to stress (Yuan and Rozengurt 
2008). In this study, although we saw large increases in phosphorylated HSP25, we 
did not see significant changes in p38 MAPK activation. One likely possibility is that 
phosphorylation of HSP25 in the aging brain is mediated by other kinases such as 
PKD, PKD2 and ERK, which have also been indicated as HSP25-kinases (Geum et 
al. 2002; Yuan and Rozengurt 2008).  
In conclusion, our findings suggest that HSP expression is regulated 
differently in different regions of the brain. Maintaining their regulation or 
upregulating their expression may be an important strategy of preventing aging-
associated neurodegenerative diseases.   
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5.1. Abstract  
 
The anti-oxidant alpha-lipoic acid (LA) has been shown to improve insulin 
action in high fat-fed animal models, yet little is known about its underlying 
mechanisms of action. We hypothesize that LA acts by inducing heat shock proteins 
which then inhibit stress kinases known to interfere with insulin signaling 
intermediates. Male Wistar rats were fed a high fat diet (HF diet, 60% calories from 
fat) for six weeks, while controls received a chow diet (10% calories from fat). Half 
of the rats in each group received daily LA injections (30 mg/kg body wt). In rats fed 
a HF diet, LA increased expression of heat shock protein 72 (HSP72) and activation 
of HSP25 in soleus muscle, but had no effect on heat shock proteins in muscle from 
chow-fed rats. LA treatment reduced phosphorylation of c-Jun N-terminal kinase 
(JNK) and Inhibitor of Kappa B Kinase beta (IKKβ) activity (IκBα protein levels) in 
rats fed a HF diet and effectively restored insulin responsiveness, as seen by insulin-
stimulated pAkt/Akt and 2-deoxyglucose uptake in soleus muscle. LA also induced 
activation of p38 MAPK and AMPK, proteins previously implicated in insulin-
independent glucose uptake. In addition, acute LA treatment induced heat shock 
proteins in vitro in L6 muscle cells and prevented the activation of JNK and IKKβ 
with stimulants such as anisomycin and TNF-α, respectively. In conclusion, our 
results suggest chronic LA treatment results in stress kinase inhibition and improved 
insulin signaling through a heat shock protein-mediated mechanism.  
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5.2. Introduction 
 
High fat diet-induced insulin resistance is associated with impaired insulin 
signal transduction and reduced glucose transport in skeletal muscle. Stress kinases 
such as c-Jun N-terminal Kinase (JNK) and the Inhibitor of Kappa B Kinase beta 
(IKKβ) are activated by oxidative stress and activity levels of these kinases are high 
in skeletal muscles from insulin resistant animals (Yuan et al. 2001; Hirosumi et al. 
2002; Ropelle et al. 2006; Gupte et al. 2008). Chronically increased stress kinase 
activation is implicated in dysregulation of the insulin signaling pathway. JNK and 
IKKβ interfere with normal insulin signaling by phosphorylating the insulin receptor 
substrate (IRS-1) on serine-307, reducing its interaction with downstream effector 
phosphatidylinositol 3-kinase (PI3K) (Zick 2005).  
Specific inducible heat shock proteins (HSPs) have the potential to inhibit 
JNK and IKKβ (Park et al. 2001; Park et al. 2003). Heat shock proteins are chaperone 
proteins, extensively studied in their role in mediating protein refolding, tissue 
protection, tissue repair and cellular homeostasis (Bukau et al. 2006). A study by Park 
et al. showed that heat shock protein 72 (HSP72) can also function as a natural 
inhibitor of JNK by direct binding and subsequent prevention of its activation by 
upstream kinases (Park et al. 2001). Similarly, the small heat shock protein HSP25 
binds and inhibits the stress kinase IKKβ (Curry et al. 1999; Park et al. 2003; Alford 
et al. 2007) and can regulate TNF-α-induced NF-κB activation (Park et al. 2003). We 
have recently demonstrated that HSP induction with heat treatment can improve 
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whole body glucose tolerance and muscle specific insulin sensitivity while reducing 
stress kinase activation in rats fed a HF diet (Gupte 2008). Another in vivo study by 
Chung et al. demonstrated that increased HSP72 expression can protect against 
obesity-induced insulin resistance, and this was tightly associated with the prevention 
of JNK phosphorylation (Chung et al. 2008). Based on this evidence, a treatment that 
could induce HSPs in skeletal muscle has the potential to inhibit JNK and IKKβ and 
improve insulin action.  
Alpha lipoic acid (LA) is a short chain fatty acid that acts as a cofactor in the 
pyruvate dehydrogenase complexes and is a potent biological anti-oxidant (Packer et 
al. 1995; Lovell et al. 2003). Administration of LA has demonstrated beneficial 
effects in several disease states associated with oxidative stress such as diabetic 
neuropathy, heavy metal poisoning and liver cirrohosis in humans (Ziegler et al. 
1999). A recent study showed that high fat diet-induced (p)-ser307-IRS-1 in skeletal 
muscle was reduced by treatment with an anti-oxidant mixture containing LA 
(Vinayagamoorthi et al. 2008). In addition, increased skeletal muscle glucose uptake 
following LA treatment in obese zucker rats was associated with an increase in IRS-1 
content and insulin stimulated PI3K activation (Saengsirisuwan et al. 2004). Although 
improvements in IRS-1 function have been shown in previous studies with LA 
treatment, the mechanisms by which LA improves IRS-1 function are unknown. A 
recent study showed that LA treatment can increase production of HSPs in diabetic 
kidney and plasma (Strokov et al. 2000; Oksala et al. 2007) yet its effect on skeletal 
muscle HSPs is unknown. Therefore, the purpose of this study is to determine 
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whether chronic LA treatment increases the expression of HSPs in skeletal muscle, 
and if this induction can effectively inhibit stress kinases and improve insulin action.  
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5.3. Materials and methods  
 
Materials 
(+)-Alpha Lipoic acid was obtained from Sigma (St. Louis, MO) and 
dissolved in Tris-HCl (120 mM, pH 7.4). [14C] Mannitol and 2-Deoxy [1,2-3H] 
glucose were purchased from American Radiolabeled Chemicals (St. Louis, MO).  
Dulbecco’s modified Eagles’s medium (DMEM; 4500 mg/L glucose), fetal bovine 
serum (FBS), penicillin and streptomycin were obtained from Sigma. Antibodies 
against phospho-SAPK/JNK (T183/Y185), total SAPK/JNK, phospho-Akt (S473), 
total Akt, IkBα, and phospho-PKCθ (T538), phospho-p38 MAPK (T180/Y182) , total 
p38 MAPK, phospho-AMPK (T172), total AMPK were purchased from Cell 
Signaling (Beverly, MA). Antibodies against HSP72, phospho-HSP25 (S82) and total 
HSP25 were obtained from Stressgen (Victoria, BC, Canada); an antibody against 
tubulin was obtained from Sigma and the actin antibody was obtained from Abcam 
Inc. (Cambridge, MA). Total PKCθ antibodies and goat-anti-rabbit HRP-conjugated 
secondary antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, 
CA), while goat anti-mouse HRP-conjugated secondary antibodies were obtained 
from Bio-Rad (Hercules, CA). KNK437 was purchased from Calbiochem (San 
Diego, CA). Enhanced chemiluminescence reagents were purchased from Amersham 
(Little Chalfont, Buckinghamshire, UK). All other reagents were obtained from 
Sigma . 
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L6 cell culture and treatment 
L6 myoblasts were obtained from American Type Culture Collection (ATCC, 
Manassas, VA) and cultured (37°C, 5 % CO2) in DMEM supplemented with 10 % 
FBS, 100 units/ml penicillin and 100 µg/ml streptomycin. Cells were differentiated 
into myotubes by changing culture media to DMEM + 2 % FBS 4-6 days after plating 
(at 80 % confluence). Myotubes were used 5-6 days later upon full differentiation. 
Cells were incubated with 300 µM Lipoic acid for 18 hr, washed and stimulated with 
either 10 µg/µl anisomcin (30 min) or 20 ng/ml TNF-α (6 h) before harvesting. For 
the HSP inhibition experiments, an additional set of myotubes was incubated with 
300 µM Lipoic acid and KNK437 (10 µM) for 18 hr. Cells were washed and then 
incubated with either anisomycin or TNF-α as described above. 
Experimental animals and treatment 
 Male Wistar rats (100-120 g) were purchased from Charles River 
Laboratories, Inc. (Wilmington, MA) and were housed in a temperature controlled 
(22 + 2 oC) room with 12 h light and dark cycles. Animals were randomly divided 
into 4 groups (n=8 rats/group): 1) Chow+Tris (Chow), 2) Chow+Lipoic acid 
(Chow+LA), 3) High fat (HF), 4) High fat+Lipoic acid (HF+LA). Chow rats were fed 
ad libitum (Harlan Teklad, Madison, WI, 10% calories from fat), while HF rats 
received a modified- Kraegen diet (Storlien et al. 1986) (60% calories from fat and 
20% calories from carbohydrates (Storlien et al. 1986) for 6 weeks, Table 2.) 
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TABLE 2.  High fat diet recipe  
Ingredient g/kg 
Casein 254 
Sucrose 85 
Cornstarch 169 
Vitamin mix 11.7 
Choline Chloride 1.3 
Mineral mix 67 
Bran 51 
Methionine 3 
Gelatin 19 
Corn oil 121 
Lard 218 
 
Subgroups were injected with Lipoic acid daily, intraperitoneally at a dose of 
30 mg/kg body weight or with vehicle Tris (8.3 ml/kg body weight, pH 7.4). The rats 
were fasted 12 h prior to all experimental procedures to lower and normalize basal 
plasma glucose levels prior to insulin stimulation. The rats were anesthetized with an 
intraperitoneal injection of pentobarbital sodium (5 mg/100 g body weight) for the 
removal of the soleus muscle. All protocols were approved by the Animal Care and 
Use Committee of the University of Kansas Medical Center. 
Intraperitoneal glucose tolerance test (IPGTT) 
Overnight fasted rats were anesthetized and given a glucose load of 2 g/kg 
body weight. Blood glucose was measured at 0, 15, 30, 60, 90 and 120 min post 
injection using a glucometer. To prevent dehydration, 5 ml of 0.9 % saline was 
administered after the GTT.  
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Muscle incubations 
Following dissection, the soleus muscles were carefully trimmed and split 
longitudinally to allow adequate diffusion of substrates as described previously 
(Henriksen and Holloszy 1991; Gupte et al. 2008). Two muscle strips per rat were 
assessed for glucose transport and two strips for Western blot analysis. Muscles strips 
designated for western blot analysis, recovered for 60 min in flasks containing 2 ml of 
Krebs-Henseleit bicarbonate buffer (KHB) with 8 mM glucose, 32 mM mannitol 
(recovery medium), and a gas phase of 95% O2/5% CO2.  The flasks were placed in a 
shaking incubator maintained at 35°C. Following recovery, one muscle strip was 
treated with 1 mU/ml insulin and the other muscle strip was left untreated in recovery 
medium (basal) for exactly 10 min and then clamp frozen in liquid nitrogen.  
Measurement of glucose transport activity 
The muscles recovered after dissection in recovery medium for 1 h at 35°C 
and then rinsed for 30 min at 29°C in 2 ml of oxygenated KHB containing 40 mM 
mannitol, with or without insulin (1 mU/ml). After the rinse step, muscles were 
incubated for 20 min at 29°C in flasks containing 2 ml KHB with 4 mM 2[1,2-3H] 
deoxyglucose (2-DG) (1.5 µCi/ml) and 36 mM [14C] mannitol (0.2 µCi/ml), with or 
without insulin (1 mU/ml), with a gas phase of 95 % O2/ 5 % CO2, in a shaking 
incubator. The muscles were then blotted, clamp-frozen, and processed as described 
previously (Young et al. 1986; Geiger et al. 2006) for determination of intracellular 2-
DG accumulation (3H DPM) and extracellular space (14C DPM) on a scintillation 
counter.  
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Western Blotting 
Clamp frozen soleus muscles were homogenized in a 12:1 (volume to weight) 
ratio of ice cold buffer from Biosource (Invitrogen, Camarillo, CA) containing: 10 
mM Tris-HCL (pH 7.4), 100 mM NaCl, 1 mM each of EDTA, EGTA, NaF, PMSF 
and 2 mM Na3VO4, 20 mM Na4P2O7, 1 % Triton X-100, 10 % glycerol, 0.1 % SDS, 
0.5 % deoxycholate, 250 μl/5ml protease inhibitor cocktail. Homogenized samples 
were rotated for 30 minutes and then centrifuged for 30 minutes at 3,000 rpm at 4°C. 
The protein concentration of the supernatant was determined by the Bradford method 
(Bio-Rad, Hercules, CA).  Samples were prepared in 2 X Laemmli buffer containing 
100 mM dithiothreitol and boiled in a water bath for 5 minutes.  
30-100 μg of protein was separated on a SDS-PAGE (6.25-10% gel) followed 
by a wet transfer to a nitrocellulose membrane for 90 min (200 mA). To verify 
transfer of proteins and equal loading of lanes, the membranes were stained with 
ponceau S (data not shown). Membranes were blocked for 1 hour at room 
temperature in TBST 5 % non-fat dry milk followed by an overnight incubation with 
the appropriate primary antibodies at a concentration of 1:1000. Antibodies were 
diluted in Tris-buffered saline, 0.1% Tween-20 (TBST), 5% BSA. Blots were 
incubated in TBST 1% non-fat dry milk supplemented with an HRP-conjugated goat 
anti-rabbit secondary antibody at a concentration of 1:10,000 for 1 hour at room 
temperature. Bands were visualized by ECL and quantified using Image J 
densitometry.  
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Statistical Analysis 
Two way analysis of variance (ANOVA) was used when differences between 
both diet and lipoic acid treatments were studied. This was followed by a post hoc 
comparison using the Student-Newman-Keuls test when necessary. Statistical 
significance was set at P<0.05.   
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5.4. Results  
 
Animal characteristics.  
Six weeks of the HF diet induced a small increase in body weight with a trend 
for a decrease in body weight with LA treatment, though neither change was 
significant (Chow 369 ± 35.4 g, Chow+LA 360.5 ± 36.8 g, HF 397.25 ± 27.45 g, 
HF+LA 391 ± 30.07 g, P=0.09). An intraperitoneal glucose tolerance test was 
performed to assess whole body glucose utilization in response to a glucose 
challenge. The HF-fed rats showed decreased glucose tolerance compared to both 
chow groups and did not effectively clear the glucose bolus at the end of the 2 h 
period (Figure 14A). LA treatment administered in parallel with the HF diet 
effectively improved glucose tolerance compared to non-treated HF-fed rats in 
agreement with previous work (Saengsirisuwan et al. 2001). This is further reflected 
by a decrease in the glucose area under the curve (Figure 14B). 
Effects of LA treatment on insulin action in the soleus muscle.   
Skeletal muscle accounts for the largest amount of insulin-stimulated glucose 
transport and consequently, insulin resistance in skeletal muscle can reflect whole 
body changes in glucose homeostasis (Bjornholm and Zierath 2005). To investigate 
the effects of a HF diet and LA on skeletal muscle glucose uptake, we performed 2-
deoxyglucose uptake assays on rat soleus muscles. The HF diet resulted in reduced 
insulin-stimulated glucose transport compared to the chow-fed rats (54.7 % reduction 
in HF compared with chow, Figure 15A). LA had no effect on glucose uptake in 
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FIGURE 14. 
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Figure 14. Lipoic acid reverses HF diet-induced whole body insulin resistance. 
IPGTT (A): Overnight fasted rats were injected with a glucose load of 2 g/kg body 
weight, intraperitoneally. Blood glucose was measured at 0, 15, 30, 60, 90 and 120 
min post injection using a glucometer. IPGTT is expressed as glucose area under the 
curve (B). (*P <0.05 HF vs. Chow, #P <0.05 HF+LA vs. HF. Values are means of ± 
SE for 6-8 rats per group). 
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chow-fed rats. However, LA treatment significantly improved 2-deoxyglucose uptake 
in the HF-fed rats (55.7 % increase in HF+LA over HF). Akt is a serine threonine 
kinase in the insulin/IRS-1/PI3K signaling cascade, activation of which is crucial for 
insulin-stimulated glucose transport. Activation of Akt in response to insulin 
stimulation, as measured by phosphorylation of Akt on Serine 473, was reduced in 
the muscles from rats fed a HF diet (47.8 % reduction in HF compared with chow, 
Figure 15B). LA treatment did not induce further Akt activation in chow-fed rats, 
however, it partially restored Akt phosphorylation in the HF diet rats (74 % increase 
in HF+LA over HF). No significant changes were seen between groups for basal 
(non-insulin stimulated) glucose uptake or Akt activation. 
LA induces activation of AMPK and p-38 MAPK  
Apart from improving glucose metabolism through insulin-sensitive 
mechanisms, there is evidence that LA can improve glucose uptake by activating 
insulin-independent mechanisms (Henriksen et al. 1997; Khanna et al. 1999). AMP-
activated protein kinase (AMPK) is an enzyme that is activated in response to a 
decrease in cellular energy (Hardie and Carling 1997) and plays an important role in 
insulin-independent glucose uptake. AMPK activation has been reported in beta cells 
and in muscles with 3 days of LA treatment (Lee et al. 2005; Targonsky et al. 2006) 
and we wanted to assess the effect of long-term LA treatment on AMPK in skeletal 
muscle. Our results indicate chronic LA treatment also induces AMPK activation, 
again only in HF-fed rats (57.6 % increase in HF+LA over HF, Figure 16A).  
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Figure 15. Lipoic acid improves glucose uptake and phosphorylation of Akt in 
soleus muscles from HF-fed rats. Insulin stimulated glucose transport (A): Soleus 
muscles were incubated in presence of insulin (1 mU/ml, filled bars) or in the absence 
of insulin (open bars) along with 2[1,2-3H]-deoxy glucose and [14C] mannitol. Insulin 
stimulated 2-deoxyglucose uptake into the soleus muscles was determined. 
(***P<0.001 Insulin vs Basal, ### P<0.001 HF vs. Chow, #P<0.05 HF+LA vs. HF. 
Values are means of ± SE for 6-8 muscles per group). Insulin stimulated (p)-Ser473-
Akt (B): Soleus muscles were incubated with insulin (1 mU/ml, filled bars) or without 
insulin (open bars) for exactly 10 min. Muscle lysates were separated with SDS-PAGE 
and blots were analyzed for (p)-Akt. Blots were then stripped and probed for total Akt. 
(***P<0.001 Insulin vs. Basal, ## P<0.01 HF vs. Chow, #P<0.05 HF+LA vs. HF. 
Values are means of ± SE for 4-6 muscles per group) 
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FIGURE 16.  
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Figure 16. Lipoic acid leads to activation of p38 MAPK and AMPK in soleus 
muscles from HF-fed rats. Soleus muscles from Chow and HF-fed animals, treated 
with either Tris or LA, were analyzed for (p)-AMPK (A) and then stripped and probed 
for total AMPK; (p)-p38 MAPK (B), then stripped and probed for total p38 MAPK 
with Western blot analysis. (# P <0.05 HF+LA vs. HF. Values are means of ± SE for 4 
samples per group). 
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Studies in L6 cells have shown that acute LA treatment induces mitogen activated 
protein kinase p38 (p38 MAPK) activation which is potentially important in 
activation of GLUT4 (Konrad et al. 2001). In our study we report that even long term 
LA treatment administered in parallel with a HF diet results in activation of p38 
MAPK (26.4 % increase in HF+LA over HF, Figure 16B).  
Induction of HSPs with LA treatment. 
 We examined levels of HSPs in the soleus muscles from chow- and HF-fed 
rats treated with either tris or LA using Western blot analysis. The HF diet showed a 
slight trend for a reduction in HSP72 expression (14 % reduction in HF compared 
with chow, P= 0.1, Figure 17A). LA treatment did not affect HSP72 expression in the 
chow-fed rats, while LA induced HSP72 in rats fed a HF diet (44.9 % increase in 
HF+LA over HF). Phosphorylation or activation of HSP25 also showed a significant 
increase with LA treatment in rats fed a HF diet (44.5 % increase in HF+LA over HF, 
Figure 17B). As shown in Figure 17B, p38 MAPK, a kinase upstream of HSP25 
(Yuan and Rozengurt 2008), is activated by LA and could play a role in its activation. 
The most likely mechanism for HSP induction would be activation of the primary 
HSP transcription factor, heat shock factor 1 (HSF-1). In the current study, activation 
of HSF-1, as examined by its phosphorylation on Serine 230, tended to increase with 
LA treatment (data not shown, P=0.07).  
Effects of LA treatment on stress kinase activation.  
JNK1/2 activity levels were measured with Western blot analysis using a 
phospho-specific antibody. While rats fed a HF diet showed a significant increase in  
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FIGURE 17.  
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Figure 17. Lipoic acid induces expression of heat shock proteins in soleus muscles 
from HF-fed rats. Soleus muscles from Chow and HF-fed animals, treated with either 
Tris or LA, were analyzed for HSP72 (A) and then stripped and probed for tubulin 
(###P<0.001 HF+LA vs. HF. Values are means of ± SE for 8 muscles per group). 
Blots were analyzed for (p)-HSP25 (B) then stripped and probed for total HSP25 with 
Western blot analysis. (#P<0.05 HF+LA vs. HF. Values are means of ± SE for 8 
muscles per group). 
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phosphorylated JNK levels (35 % increase in HF over chow), LA treatment reversed 
this to the levels seen in chow-fed rats (30.4 % decrease in HF+LA compared with 
HF, Figure 18A). No changes were detected in total JNK expression (representative 
blot in Figure 18A, data not shown). IKKβ activation results in degradation of its 
downstream target IκBα and therefore, IκBα degradation is considered a marker of 
increased IKKβ activity (Hacker and Karin 2006). Figure 18B demonstrates that IκBα 
protein levels were reduced in the soleus muscles from rats fed a HF diet (19.44 % 
reduction in HF compared with chow), but increased to levels in the muscles of 
chow-fed rats when treated with LA (44.8 % increase in HF+LA over HF). High 
levels of diacylglycerol (DAG) resulting from HF feeding are known to induce 
Protein Kinase C-θ activity. PKCθ is implicated in causing DAG-induced insulin 
resistance by phosphorylation of the insulin receptor substrate IRS-1 on serine 
residues (Haasch et al. 2006). In our study, a HF diet resulted in increased 
phosphorylation of PKCθ in the soleus muscles (84 % increase in HF over chow, 
Figure 18C). However, LA treatment did not significantly reduce activation of PKCθ. 
This suggests some specificity for LA to decrease JNK and IKKβ activation in 
skeletal muscle.  
LA pretreatment induces HSPs and prevents activation of JNK and IKKβ in L6 
muscle cells 
 To verify the effects of chronic LA on induction of heat shock proteins and 
inhibition of stress kinases seen in HF-fed animals, we examined the effect of acute 
LA treatment on L6 muscle cells. The cytokine TNF- α was used to induce stress  
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FIGURE 18. 
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Figure 18. Lipoic acid prevents HF diet-induced stress kinase activation in soleus 
muscles from HF-fed rats. Soleus muscles from Chow and HF-fed animals, treated 
with either Tris or LA, were analyzed for (p)-JNK (A), then stripped and probed for 
total JNK. (**P=0.01 HF vs. Chow, ##P<0.01 HF+LA vs. HF. Values are means of ± 
SE for 8 muscles per group). IKKβ activation (B): Western blots were analyzed for 
IkBα and then stripped for tubulin as a loading control (*P<0.05 HF vs. Chow, 
#P<0.05 HF+LA vs. HF. Values are means of ± SE for 8 muscles per group). (p)-
PKCθ (C): Soleus muscles were analyzed with western blotting using an antibody 
specific for phospho-T538-PKCθ. Blots were normalized to total PKCθ. (**P<0.01 
HF vs. Chow. Values are means of ± SE for 4-5 muscles per group). 
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FIGURE 19.  
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Figure 19. Lipoic acid induces heat shock proteins and prevents stress kinase 
activation in L6 muscle cells. L6 cells were pre-treated with Lipoic acid (300 µM) or 
Tris for 18 h. Cells were then washed briefly and treated with TNF-α (20 ng/mL) for 6 
hr or with Anisomycin (Aniso, 10 µg/mL) for 30 min. Homogenates of the cells were 
analyzed for HSP72/Actin (A), (p)-HSP25/HSP25 (B), (p)-JNK/JNK (C) and 
IkBα/Actin (D). (***P <0.001 Aniso vs. Ctrl., ### P=0.001 Aniso+LA vs. Aniso, 
**P<0.01 TNF-α vs. Ctrl , #P<0.05, ##P<0.01 TNF-α+LA vs. TNF-α. Values are 
means of ± SE for 6-13 samples per condition). 
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kinase activation in muscle cells. Treatment of L6 myotubes with LA for 18 h, 
followed by TNF-α for 6 h, resulted in an increase in HSP72 expression and 
phosphorylation of HSP25 (Figure 19A and 19B). Consistent with our findings for 
LA treatment in chow-fed animals, LA did not increase HSP expression/activation in 
control cells not exposed to TNF-α. Anisomycin, a potent inducer of JNK (Grollman 
1967; Aguirre et al. 2000), induced a robust activation of JNK in L6 myotubes, 
however, pretreatment with LA for 18 h suppressed this anisomycin induced JNK 
activation (45.2 % decrease from Anisomycin, Figure 19C). Similarly, TNF-α 
induced activation of IKKβ as seen by reduced IκBα levels, but pretreatment with LA 
protected the myotubes from the TNF-α induced IKKβ activation (Figure 19D). 
These data further suggest a role for LA in inducing HSPs as a potential mechanism 
of stress kinase inhibition.  
Inhibition of HSP72 abolishes the protective effective of LA on JNK 
 To examine the specificity of HSPs in the effects of LA, we inhibited HSP72 
and assessed its effects on JNK activity. L6 myotubes were treated with the HSP72 
inhibitor, KNK437, along with LA for 18 hours, followed by incubation with TNF-α 
for 6 hours. KNK437 inhibits the induction of HSP72 at mRNA levels and prevents 
transcription of new HSP72 (Yokota et al. 2000). As seen before (Figure 19A), LA 
treatment induced HSP72 expression, but this was blunted when incubated in the 
presence of 10 µM KNK437 (24% reduction from LA+TNF-α, Figure 20A). Higher 
concentrations of KNK437 caused greater suppression of HSP72 but also resulted in a 
small non-specific decrease in JNK activation. In the presence of KNK437, LA 
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treatment did not prevent anisomycin-induced JNK activation (43% increase over 
LA+Aniso, Figure 20B). This indicates that in the absence of HSP72 induction, LA 
does not effectively suppress JNK activation. 
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FIGURE 20.  
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Figure 20. In the absence of HSP72 induction, LA does not prevent JNK 
activation. L6 cells were treated with either Tris or LA (300 µM) or a combination 
of LA (300 µM) +KNK437 (10 µM) for 18 h. Cells were then washed and treated 
with TNF-α (20 ng/mL) for 6 hr or with Anisomycin (Aniso, 10 µg/mL) for 30 min. 
TNF-α treated groups were examined for HSP72/Actin (A) and Aniso treated groups 
were analyzed for (p)-JNK/JNK (B). (*P <0.05 TNF-α+LA vs. TNF-α and 
Aniso+LA vs. Aniso, #P<0.01 TNF-α+LA+KNK437 vs. TNF-α+LA, #P<0.05 
Aniso+LA+KNK437 vs. Aniso+LA. Values are means of ± SE for 5-6 samples per 
condition for (p)-JNK and 9-10 samples for HSP72). 
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5.5. Discussion 
 
The purpose of this study was to determine whether chronic LA treatment 
increases the expression of HSPs in skeletal muscle, and if this induction can 
effectively inhibit stress kinases and improve insulin action. We demonstrate the 
ability of LA to induce HSPs in skeletal muscle in vivo and in L6 cells in culture with 
a concomitant reduction in the activation of stress kinases JNK and IKKβ. While the 
effects of LA in skeletal muscle are likely multi-factorial, HSP-mediated stress kinase 
inhibition is a previously unexplored mechanism for the improvement in insulin 
action with LA.  
Kurucz et al. were the first to establish that in patients with type 2 diabetes, 
subjects with impaired glucose tolerance, and in nondiabetic identical twins whose 
twin had type 2 diabetes, very little HSPs are expressed in skeletal muscle (Kurucz et 
al. 2002). Low tissue HSP expression could play a critical role in the induction of 
insulin resistance and diabetes. Hooper et al. (Hooper 2007; Hooper and Hooper 
2008) propose that type 2 diabetes is a vicious cycle stemming from low HSP 
expression that results in an impaired stress response, metabolic inflammation, and 
subsequent insulin resistance. Our results suggest that increasing HSPs with LA could 
be one of the important factors that forestall this cycle, thereby improving insulin 
sensitivity and diabetes. A number of in vitro and in vivo studies demonstrate the anti-
inflammatory action of HSPs (Yenari et al. 2005; Kim et al. 2006). Previous studies 
have shown that NFκB activation is suppressed by HSP inhibition of IKKβ and that 
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HSP72 protects against TNF-α induced IL-6 production, shock, apoptosis and death. 
In addition, HSP72 has been shown to inhibit JNK, and low levels of HSP72 result in 
JNK activation (Chung et al. 2008). The recent study by Chung et al. showed that 
overexpression of HSP72 was tightly associated with the prevention of JNK 
activation in models of diet- and obesity- induced insulin resistance (Chung et al. 
2008). The activation of cytokines as a result of low HSP expression in insulin 
resistant tissue is a relatively new theory regarding the development of insulin 
resistance and type 2 diabetes. Given the number of ways in which HSPs can be 
induced via physiological stressors (exercise, heat, calorie restriction), small 
molecules (BGP-15, geranylgeranylacetone, resveretrol), and antioxidants (lipoic 
acid), therapeutic induction of HSPs could be a promising new approach to the 
treatment of insulin resistance.  
To our knowledge, this is the first study to report that LA can induce HSP 
expression in skeletal muscle. Although our findings did not demonstrate a significant 
increase in HSF-1 activation with LA, a strong trend was seen. Thus, an effect of LA 
on HSF-1 cannot be ruled out. LA has been shown to increase HSF-1 mRNA in 
diabetic kidneys (Oksala et al. 2007). Additional time points following LA treatment 
may be necessary to observe activation of HSF-1 in skeletal muscle. Also, HSF-1 
activation is known to vary depending on the muscle fiber type (Najemnikova et al. 
2007) and further studies will be needed to determine if the effect of LA on HSF-1 is 
evident in fast-twitch muscles. Activation of HSF-1 is tightly regulated by the 
inhibitory phosphorylation of HSF-1 by JNK, ERK and GSK3 on Ser 363, 307, 303 
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respectively (Chu et al. 1996; Dai et al. 2000; Xavier et al. 2000). Increased activation 
of these inflammatory kinases with HF feeding, diabetes and aging is known to 
downregulate the HSF-1 machinery and thereby reduce HSP expression. In our 
hands, six weeks of HF feeding was not sufficient to reduce HSP expression 
significantly in soleus muscles. Longer duration HF diet regimes may be needed to 
determine the role of LA on maintaining HSP expression.  
Data in L6 cells demonstrates that acute treatment with LA also results in an 
induction of HSPs and a concomitant inhibition of JNK and IKKβ. These results 
support our observations in the animal model and validate our findings regarding the 
proposed mechanism of LA action. Several mechanisms of HSP-induced stress kinase 
inhibition have been suggested. HSP72 has been shown to bind to JNK and prevent 
its activation by the upstream kinases SEK1 and MKK7 (Park et al. 2001). Further, 
interaction of HSP72 with a co-chaperone CHIP is thought to negatively regulate 
activity of Dual leucine zipper-bearing kinase (DLK), a kinase upstream of JNK 
(Daviau et al. 2006). While other investigators suggest HSP72 prevents stress-
mediated inactivation of a phosphatase that targets JNK (Meriin et al. 1999; Lee et al. 
2005), both proposed mechanisms effectively inhibit JNK activation. Similarly, IKKβ 
could be inhibited by HSP25, either by direct binding or an as yet uncharacterized 
signaling intermediate (Park et al. 2003). Future studies are needed to determine the 
mechanism of HSP inhibition of stress kinases in insulin resistant tissue. 
 It is possible that LA influences insulin signaling via oxidant effects 
independent of HSP induction. However, research indicating LA has no effect on 
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insulin sensitive tissue argues against a direct activation of insulin signaling 
intermediates as the mode of LA action. LA treatment has little or no effect on cells 
that were not subjected to oxidative stress (Maddux et al. 2001) or even on lean 
insulin sensitive animals (Saengsirisuwan et al. 2002; Lee et al. 2005). Consistent 
with these studies, we saw no significant changes with LA treatment of chow-fed rats 
in insulin sensitivity measures, stress kinase activation, AMPK/p38 MAPK activation 
or HSP expression. AMPK plays an important role in insulin-independent glucose 
uptake and is activated with 3 days of LA treatment (Lee et al. 2005). In our study, 
although we did see a robust increase in phosphorylation of AMPK with LA in high 
fat-fed rats, we did not see a statistically significant increase in basal glucose 
transport. It is likely that the observed increase in AMPK activation was not sufficient 
to result in increased basal glucose uptake or that chronic activation of AMPK with 
LA, as in the present study, might have a greater impact on fatty acid oxidation than 
glucose transport. Chronic AMPK activation can result in increased fatty acid 
oxidation and thus reduced accumulation of fatty acids and reactive oxygen species, 
contributing to the overall insulin sensitizing effects of LA. Also, it has been reported 
that intramuscular triglycerides are reduced with LA treatment (Saengsirisuwan et al. 
2004), potentially as a result of AMPK activation. 
 The ability of LA to display both reducing (anti-oxidant) and pro-oxidant 
properties makes its action in skeletal muscle multi-factorial (Konrad 2005). A 
number of previous studies using LA suggest a mechanism of action primarily 
attributed to its antioxidant properties. For example, in vivo studies show that LA 
 161
treatment reduces protein carbonyl levels in skeletal muscle and significantly 
improves insulin sensitivity in insulin resistant animal models such as the Goto-
Kakizaki rats (Bitar et al. 2004; Bitar et al. 2005). Additional anti-oxidant properties 
of LA include the capacity to scavenge ROS and to regenerate anti-oxidants such as 
reduced glutathione, vitamin C and E (Packer et al. 1995). The antioxidant properties 
of LA could certainly improve the overall metabolic state in the muscle and indirectly 
improve insulin action. The pro-oxidant properties of LA include an ability to activate 
insulin signaling; cell culture studies have shown that high concentrations of LA (2.5 
mM) can directly induce glucose uptake by activating insulin signaling intermediates 
in a PI3K dependent manner (Yaworsky et al. 2000; Konrad et al. 2001). The 
induction of HSPs in skeletal muscle can also be added to the list of LA pro-oxidant 
properties. The finding that LA had a slight but insignificant effect on PKC θ levels 
suggests that the action of LA is targeting primarily JNK and IKKβ in soleus muscle, 
likely due to the induced HSP72 and HSP25, respectively. Our observation that 
HSP72 inhibition with KNK437 abolishes LA’s ability to inhibit JNK, further 
supports the idea that HSPs constitute a key mechanism of LA action. Thus, the 
beneficial effects of chronic LA treatment in skeletal muscle could result from both 
an overall reduction in tissue oxidative stress and, as our results suggest, from a 
complementary increase in the content of stress protective HSPs in skeletal muscle.  
Apart from just increasing glucose uptake into the muscle, LA may also 
facilitate the efficient oxidation of glucose, since LA is a co-factor of the pyruvate 
dehydrogenase (PDH complex). Although we did not measure PDH activity in this 
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study, increased LA treatment has been shown to increase PDH activity and improve 
glucose effectiveness in lean and obese patients with type 2 diabetes (Konrad et al. 
1999).In conclusion, the current findings demonstrate, for the first time, that LA 
treatment increases expression of HSP72 and activation of HSP25 in skeletal muscle. 
Our study provides new information regarding the inhibition of JNK and IKKβ with 
chronic LA treatment and suggests HSP-mediated stress kinase inhibition is one 
mechanism by which LA improves insulin signaling in skeletal muscle. Future studies 
are needed to examine the direct mechanisms by which HSPs inhibit stress kinases.   
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6.1. Abstract  
 
Objective: Heat treatment and overexpression of heat shock protein 72 (HSP72) have 
been shown to protect against high fat diet-induced insulin resistance, but little is 
known about the underlying mechanism or the target tissue of HSP action. The 
purpose of this study is to determine if in vivo heat treatment can prevent skeletal 
muscle insulin resistance.  
Research Design and Methods:  Male Wistar rats were fed a high fat diet (60% 
calories from fat) for 12 weeks and received a lower-body heat treatment (41°C for 20 
min) once per week.  
Results:  Our results show that heat treatment shifts the metabolic characteristics of 
rats on a high fat diet toward those on a standard diet. Heat treatment improved 
glucose tolerance, restored insulin-stimulated glucose transport, and increased insulin 
signaling in soleus and extensor digitorum longus (EDL) muscles from rats fed a high 
fat diet. Heat treatment resulted in decreased activation of JNK and IKK-β, stress 
kinases implicated in insulin resistance, and upregulation of HSP72 and HSP25, 
proteins previously shown to inhibit JNK and IKK-β activation, respectively. 
Mitochondrial citrate synthase and cytochrome oxidase activity decreased slightly 
with the high fat diet, but heat treatment restored these activities. Data from L6 cells 
suggest that one bout of heat treatment increases mitochondrial oxygen consumption 
and fatty acid oxidation.   
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Conclusions: Our results indicate heat treatment protects skeletal muscle from high 
fat diet-induced insulin resistance and provide strong evidence that HSP induction in 
skeletal muscle could be a potential therapeutic treatment for obesity-induced insulin 
resistance.  
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6.2. Introduction 
 
Insulin resistance is associated with many related health complications 
including type 2 diabetes and heart disease. A recent study demonstrated induction of 
the body’s natural defense system, heat shock proteins (HSPs), protects against 
obesity-induced insulin resistance (Chung et al. 2008). Earlier studies in patients with 
type 2 diabetes showed hot tub therapy improved glycemic control (Hooper 1999) 
and an inverse correlation between HSP72 mRNA expression and the degree of type 
2 diabetes (Kurucz et al. 2002). Currently, several HSP-inducing drugs are under 
investigation or in clinical trials for diabetic neuropathy and neurodegenerative 
diseases (Kurthy et al. 2002; Westerheide and Morimoto 2005) and could be 
considered for prevention of insulin resistance. However, little is known about the 
mechanism behind this newly discovered role of HSP72, whether other inducible 
HSPs could be protective against insulin resistance, or the primary target tissue of 
HSP action.  
Skeletal muscle is the major tissue responsible for whole body insulin-
mediated glucose uptake (DeFronzo 1981; Song et al. 1999). HSPs are expressed in 
skeletal muscle and are strongly induced with exercise training (Morton et al. 2006; 
Tupling et al. 2007). Overexpression of HSP72 has been shown to reduce skeletal 
muscle atrophy and oxidative stress with age (Broome et al. 2006). Therefore, 
skeletal muscle is a logical choice as the target tissue for the benefits of HSP 
overexpression. Previous studies indicate basal levels of HSPs differ between muscle 
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fiber types with slow-twitch oxidative muscles having higher constitutive expression 
of HSPs than fast-twitch glycolytic muscles (Gupte et al. 2008). In contrast, fast-
twitch muscles possess greater capacity for HSP induction in response to 
physiological stressors and exercise (Oishi et al. 2002; Gupte et al. 2008). It is 
uncertain whether HSPs would be equally effective as mediators of insulin action in 
slow- and fast-twitch muscle.  
 The purpose of the present study was to determine if weekly in vivo heat 
treatment could prevent skeletal muscle insulin resistance in rats fed a high fat diet 
and elucidate mechanisms of HSP function in skeletal muscle. We hypothesized that 
heat treatment allows skeletal muscle to adapt and resist the development of insulin 
resistance as a result of increased HSP expression. Our findings indicate that heat 
treatment prevents skeletal muscle insulin resistance and stress kinase activation, 
while increased oxygen consumption and fatty acid oxidation in L6 cells suggests 
heat treatment can improve mitochondrial function. 
 
 
 
 
 
 
 
 
 169
6.3. Materials and methods  
 
Materials 
[14C] Mannitol and 2-Deoxy [1,2-3H] glucose were purchased from American 
Radiolabeled Chemicals (St. Louis, MO). Antibodies used include: phospho-
Thr183/Tyr185 and total JNK , phospho-Ser473 and total Akt, IkBα (Cell Signaling, 
Beverly, MA); HSP72, phospho-Ser82 and total HSP25, HSP60, cytochrome c 
(Stressgen, Victoria, BC, Canada); tubulin (Sigma, St.Louis, MO); cytochrome 
oxidase IV subunits I and IV (Molecular probes, Eugene, OR); citrate synthase 
(Alpha diagnostic, San Antonio, TX); UCP-3 (Chemicon International, Temecula, 
CA); PGC-1α (Calbiochem, San Diego, CA); phospho-Tyr612-IRS-1 (Biosource, 
Camarillo, CA) and IRS-1 (BD Biosciences, Franklin lakes, NJ). 3H-Palmitate was 
purchased from Perkin Elmer (Waltham, MA), insulin ELISA kits from Alpco 
diagnostics (Salem, NH) and all other reagents from Sigma. 
Experimental animals and treatment 
Male Wistar rats (100-130 g) from Charles River Laboratories, Inc. 
(Wilmington, MA) were housed in a temperature controlled (22 + 2°C) room with a 
12:12 light/dark cycle. Animals were fed ad libitum for 12 weeks with a standard 
chow diet (Harlan Teklad, Madison, WI, 8604) or high fat (HF) diet (60% calories 
from fat comprised of lard and corn oil, and 20% calories from carbohydrates 
(Storlien et al. 1986)). Experiments were conducted 48 hours after the last heat or 
sham treatment and rats were fasted 12 h prior to experimental procedures. All 
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protocols were approved by the Animal Care and Use Committee of the University of 
Kansas Medical Center. 
In vivo heat treatment  
 Once per week, HF-fed animals were anesthetized with pentobarbital sodium 
(5 mg/100 g body weight) and the lower body was immersed in a water bath. Body 
temperature was gradually increased and maintained between 41 - 41.5°C for 20 min 
as monitored with a rectal thermometer. Sham treatment maintained core temperature 
at 36°C. Following treatment, 5 ml of 0.9 % saline was administered to prevent 
dehydration. Preliminary experiments in our laboratory established that one heat 
treatment per week maintains an increase in HSP72 expression and avoids potential 
HSP inhibition by repeated heat treatment (Lee et al. 2005). 
Intraperitoneal glucose tolerance test (IPGTT) 
An IPGTT was performed in week 11, 48 hr after the last heat/sham 
treatment. Overnight fasted rats were anesthetized and given a glucose load of 2 g/kg 
body weight. To prevent dehydration, 5 ml of 0.9 % saline was administered after the 
GTT.  
Immunoblotting, Glucose Tranport and Kinase Assay  
In week 12, rats were anesthetized for the removal of soleus and extensor 
digitorum longus (EDL) muscles. Muscles were split longitudinally to allow adequate 
diffusion of substrates (Henriksen and Holloszy 1991; Gupte et al. 2008). Two 
muscle strips per rat were assessed for glucose transport and two strips were 
incubated with or without 1 mU/ml insulin for 20 min and frozen for Western blot 
 171
analysis as previously described (Gupte et al. 2008). Western blots were first probed 
for phosphorylated proteins and then stripped for total protein expression. Glucose 
transport activity was determined using 2[1,2-3H] deoxyglucose (2-DG) (1.5 µCi/ml) 
and [14C] mannitol (0.2 µCi/ml) (Young et al. 1986; Geiger et al. 2006; Gupte et al. 
2008). Activity levels of IKKβ in whole cell lysates were assayed as previously 
described (Tse et al. 2007). Phosphorylated IκBα levels were detected by Western 
blot analysis.  
KNK437 incubation 
Soleus muscles were isolated from 3 month-old Fischer 344 rats and subjected 
to 42ºC heat or 35ºC sham treatment for 30 min in vitro. Subsets of muscles were 
incubated in 100 µm HSP70 inhibitor KNK437 (Calbiochem, San Diego, CA) and 
stimulated with anisomycin (10 µg/ml, Calbiochem). HSP72 and p-JNK/JNK were 
detected by Western blot analysis.  
Mitochondrial enzyme activity 
Citrate synthase activity was assessed in muscle lysates (prepared in the cell 
extraction buffer used for immunoblotting, Biosource), using a modified protocol 
(Smirnova et al. 2006) by Srere et al. (Srere 1969). The absorbance was recorded at 
405 nm every 20 sec for 3 min at 30°C, using a MRXII microplate reader and kinetic 
software package (Dynex Technologies, Chantilly, VA). The linear portion of the 
reaction curve was used to calculate activity levels of citrate synthase, normalized to 
citrate synthase protein expression levels, in µmol/g/min.  
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For the cytochrome oxidase assay, 140 µg of muscle lysate in potassium 
phosphate buffer (20 mM, pH 7.0) and dodecyl maltoside (0.2 mg) was warmed to 
30°C (Ghosh et al. 2007). The reaction was initiated by addition of 25 µM reduced 
cytochrome c and oxidation of reduced cytochrome c was followed for 2 min at 550 
nm on a DU series spectrophotometer (Beckman Coulter, Fullerton, CA). Maximal 
oxidization of cytochrome c was determined by adding potassium ferricyanide. 
Activity was calculated and normalized to Cox-4 protein expression levels (sec-1 / mg 
protein). 
Measurement of oxygen consumption rates 
L6 myoblasts from American Type Culture Collection (ATCC, Manassas, 
VA) were cultured in DMEM supplemented with 10 % FBS, 100 units/ml penicillin 
and 100 µg/ml streptomycin. 5-6 days after differentiation, L6 cells were treated with 
30 ng/ml TNF-α alone or in combination with heat treatment (43°C for 20 min) and 
experiments were performed 24 h later. O2 consumption rate was determined using an 
Oroboros Oxygraph-2K high resolution respirometer (Innsbruck, Austria). After 
baseline stabilization, respiratory chain inhibitors were sequentially injected: 
oligomycin (1 µg/ml), FCCP (3 µM), rotenone (1 µM) and myxothiazol (2 µM). All 
values were normalized to protein content and non mitochondrial respiration rates 
were subtracted.  
Fatty acid oxidation rates  
Fatty acid oxidation was performed as previously described (Djouadi et al. 
2003). Briefly, L6 myotubes were heat or sham treated and exposed to 200 μM 
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palmitate coupled with 7.5% BSA (wt/v) for 72 hours. A second heat treatment was 
given in the last 24 h of palmitate treatment. Cells were washed with PBS and 
incubated with 200 μl of 125 μM 3H-labelled-Palmitate-BSA solution (1 mCi/ml 
stock), supplemented with 1 mM carnitine for 2 hours at 37°C. Following incubation, 
solution from each well was added to 200 μl of cold 10 % TCA and centrifuged at 
3,300 rpm for 10 min. After neutralizing with 6 N NaOH the mixture was run through 
a DOWEX resin column to separate the fatty acid oxidation intermediates and 3H –
labeled water. Scintillation fluid was added to the flow-through and 3H-CPM was 
counted. Fatty acid oxidation rate was normalized to protein content and expressed as 
nmole/hour/mg.  
Statistical Analysis 
Analysis of variance (ANOVA) and two-way ANOVA were used to study 
differences between groups. This was followed by a post hoc comparison using the 
Student-Newman-Keuls test when necessary. Statistical significance was set at 
P<0.05.   
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6.4. Results  
 
Body composition, serum insulin and glucose tolerance 
 Twelve weeks of HF feeding resulted in an increase in body weight compared 
with chow-fed rats (Figure 21A). Weekly heat treatment in HF-fed animals did not 
significantly reduce body weight and there was no difference in food intake between 
the HF-fed groups (Chow 106.05 ± 2.72 kcal/d; HF 114.75 ± 1.41 kcal/d; HF+HT 
116.93 ± 1.57 kcal/d, P<0.05 Chow vs HF). Epididymal fat pad weight increased with 
HF feeding while this increase was blunted in rats subjected to heat treatment (Figure 
21B). Fasting blood glucose levels did not change significantly with either diet or 
heat treatment (Figure 21C). In contrast, fasting insulin levels increased robustly in 
HF rats and heat treatment significantly blunted this increase (Figure 21D). While 
HF-fed rats showed decreased whole body glucose clearance (Figure 21E), heat 
treatment effectively improved glucose clearance as further indicated by a decrease in 
glucose area under the curve (Figure 21F). 
Insulin-action is improved with heat treatment  
 We examined the effect of heat treatment on glucose uptake, for the first time, 
in representative slow-twitch soleus (84% type I, 7% type IIA, 9% type IIB) and fast-
twitch EDL muscle (20% type IIA, 38% type IIB, 38% type IID, 4% Type I) (Delp 
and Duan 1996). In rats fed a HF diet, insulin-stimulated glucose transport increased 
above basal (non-insulin stimulated) values in both muscle types (Figure 22A,  
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Figure 21. Weekly heat treatment improves characteristics of HF diet-induced 
insulin resistance. Male Wistar rats were given a chow or high fat (HF) diet for 12 
weeks. The HF rats received either a lower body heat treatment (HF+HT, 41oC for 20 
min) or sham treatment (HF+ST, 36oC for 20 min) once per week during the diet 
regimen. At the end of the 12 week study, body weight (A) and epididymal fat pad 
weights (B), fasting glucose (C) and fasting serum insulin (D) were measured. IPGTT 
(E): Overnight fasted rats were injected with a glucose load of 2 g/kg body weight, 
intraperitoneally. Blood glucose was measured at time 0, 15, 30, 60, 90 and 120 min 
post injection using a glucometer. IPGTT is expressed as glucose area under the curve 
in (F). (***P<0.001, **P<0.01 HF+ST vs. Chow and ##P <0.01, #P <0.05 HF+HT vs. 
HF+ST). Values are means of ± SE for 5-7 rats per group.  
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HF+ST). However, the insulin effect was significantly reduced compared to chow-fed 
insulin sensitive muscles. With heat treatment, insulin-stimulated glucose transport 
was significantly increased above sham treated soleus and EDL muscles from HF 
rats. 
 Insulin phosphorylates and activates the insulin receptor substrate (IRS-1) on 
tyrosine residues (reviewed in (Karlsson and Zierath 2007)). Phosphorylation of 
Tyr612 on IRS-1 was reduced with the HF diet (not significantly in soleus muscle), 
but rescued fully with heat treatment in both muscles (Figure 22B). Downstream of 
IRS-1, insulin-stimulated activation of Akt by phosphorylation on Ser473 was 
reduced in soleus and EDL muscles with HF feeding (Figure 22C). Akt activation 
was fully rescued with heat treatment in soleus muscle and showed a non-significant 
improvement in the EDL. HF feeding reduced phosphorylation and activation of 
AS160 in EDL muscles (non-significant decrease in soleus muscle Figure 22D); 
while heat treatment improved AS160 activation in both muscles.  
Induction of HSP72 and inhibition of JNK with heat treatment 
   HSP72 expression was unchanged in soleus and EDL muscles with HF 
feeding. Heat treatment resulted in a much greater increase in HSP72 expression in 
EDL muscle compared to soleus (Figure 23A). Heat treatment also induced an 
increase in HSP72 expression in adipose tissue and liver (adipose: Chow 0.258 ± 
0.06, HF+ST 0.287 ± 0.09, HF+HT 0.760 ± 0.11, P<0.005 HF+HT vs. HF+ST; liver:  
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Figure 22. Heat treatment increases insulin stimulated glucose uptake and 
phosphorylation of IRS-1, Akt, and AS160. Insulin stimulated glucose transport 
(A): Soleus and EDL from Chow, HF+ST and HF+HT rats were incubated in presence 
or absence of 1 mU/ml insulin with 2[1,2-3H]-deoxyglucose and [14C]-mannitol and 2-
deoxyglucose uptake into the muscles was determined. Values are means of ± SE for 
3-5 muscles for the HF and HF+HT groups, 11-12 muscles per group for chow. 
Insulin signaling: Soleus and EDL muscles were incubated in the presence or absence 
of insulin (1 mU/ml) for exactly 20 min. Muscle lysates were separated with SDS-
PAGE and blots were analyzed for (p)-Y612-IRS-1/IRS-1(B), (p)-S473-Akt/Akt (C) 
and (p)-T642-AS160/AS160 (D). Open bars represent basal (non-insulin stimulated) 
measurements and filled bars represent insulin-stimulated measurements. (*P<0.05 
Insulin treated vs. Basal, ### P<0.001, ## P <0.01 and # P<0.05). Values are means of 
± SE for 5-6 muscles per group. 
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Figure 23. Heat treatment induces HSP72 expression and a concomitant JNK 
inactivation. Soleus and EDL muscles were dissected from Chow, HF+ST and 
HF+HT rats and snap frozen in liquid nitrogen. Lysates were subjected to Western 
blot analysis for HSP72/Tubulin (A) and (p)-JNK/JNK (B). (*P<0.05 HF+ST vs. 
Chow, ###P<0.001, #P <0.05 HF+HT vs. HF+ST). Values are means of ± SE for 5-7 
muscles per group. Pharmacological inhibition of HSP72 prior to heat treatment 
eliminates heat stress-mediated inhibition of JNK. Isolated soleus muscles from F344 
rats were incubated in KHB in a water bath at 35°C and then exposed to sham (35°C) 
or heat treatment (HT, 42°C for 30 min). A reversible pharmacological inhibitor of 
HSP72, KNK437 (100 µM), was included in the incubation buffer prior to, during and 
post HT for a subgroup of muscles. Following recovery for 12 h at 35°C, muscles 
were assessed for HSP72 (C). JNK activation in response to Anisomycin (A, 10 µg/µl, 
30 min), a potent inducer of JNK, was tested at the end of the recovery period (D). 
(*P<0.001 A vs. C, #P<0.001 HT vs. C and HT+A vs. A, +P<0.001 HT+KNK vs HT 
and HT+KNK+A vs HT+A). Values are means of ± SE for 7-20 muscles per group. 
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Chow 0.061 ± 0.01, HF+ST 0.058 ± 0.01, HF+HT 1.157 ± 0.21, P<0.001 HF+HT vs. 
HF+ST). JNK activation, as measured by phosphorylation levels, increased in both 
soleus and EDL muscles with a HF diet (Figure 23B), although to a greater extent in 
EDL muscles. With heat treatment there was a significant reversal of JNK activation 
in both muscles. As shown in Figure 23C, the ability of heat treatment to increase 
HSP72 expression in isolated soleus muscle was blunted in the presence of the 
HSP72 inhibitor, KNK437 (Yokota et al. 2000). KNK treatment alone did not inhibit 
HSP72 activation (data not shown). Muscle incubation in anisomycin results in an 
increase in JNK phosphorylation that can be directly inhibited by prior heat treatment 
(Figure 23D). The presence of the HSP72 inhibitor KNK437 in the incubation 
medium eliminated the ability of heat treatment to decrease JNK phosphorylation. 
Activation of HSP25 and inhibition of IKKβ with heat treatment 
 Phophorylation of HSP25 occurs in response to heat stress. (p)-HSP25 was 
unaffected with diet or heat in the soleus, but was significantly increased in EDL 
muscles with heat treatment (Figure 24A). Phosphorylation of HSP25 was not 
increased in adipose tissue (Chow 0.331 ± 0.1, HF+ST 0.359 ± 0.09, HF+HT 0.563 ± 
08), however, there was a dramatic increase in the liver (Chow 0.030 ± 0.00, HF+ST 
0.031 ± 0.00, HF+HT 0.379 ± 0.15, P<0.05 HF+HT vs. HF+ST). Activity of IκKβ 
was assessed by measuring the protein levels of its downstream target IkBα, which 
upon activation of IKKβ gets phosphorylated and targeted for degradation (Hacker 
and Karin 2006). Protein levels of IkBα were reduced with HF in both muscles  
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Figure 24. Heat treatment prevents HF-induced IKKβ activation in skeletal 
muscles in a fiber type specific pattern. Snap frozen soleus and EDL muscles from 
Chow, HF+ST and HF+HT rats were analyzed by Western blot for (p)-
HSP25/HSP25 (A) and IκBα/Tubulin as a measure of IKKβ activity (B). Kinase 
activity of IKKβ was assessed by measuring phosphorylation of exogenous IκBα 
substrate (C). Equal amounts of total IKKβ were immunoprecipitated and subjected 
to a kinase assay in the presence of ATP and IκBα substrate. (*P<0.05 HF+ST vs 
Chow and #P <0.05 HF+HT vs HF+ST). Values are means of ± SE for 5-7 muscles 
per group.  
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indicating increased IKKβ activation (Figure 24B). However, heat treatment reversed 
this activation only in the EDL muscle. Direct assessment of IKKβ kinase activity 
showed the same pattern of IKKβ activation in soleus and EDL muscles (Figure 
24C).  
Effects of heat treatment on mitochondrial protein expression and enzyme activity  
 Proteins involved in mitochondrial metabolism including cytochrome c, 
citrate synthase, cytochrome c oxidase subunit-1 (Cox-1, encoded by the 
mitochondrial genome) and subunit-4 (Cox-4, encoded by the nuclear genome) were 
assessed in the current study. Our results indicate these mitochondrial proteins 
increased with the HF diet exclusively in the EDL muscle (Figure 25A-D). However, 
an increase in mitochondrial proteins did not occur when heat treatment was 
administered in parallel with the HF diet. The mitochondrial HSP, HSP60, was 
slightly reduced with a HF diet and showed a significant increase with heat treatment 
(Chow 0.971 ± 0.047, HT+ST 0.834 ± 0.033, HF+HT 1.117 ± 0.113; P<0.05 for 
HF+ST vs HF+HT). The HSP60 expression pattern differs from other mitochondrial 
proteins, but is consistent with the pattern of other HSPs in the current study. 
Expression of uncoupling protein-3 (UCP-3), regulated by peroxisome proliferator-
activated receptor (PPAR) (Wang et al. 2003), increased with the HF diet in EDL 
muscles and heat treatment further potentiated this increase (Figure 25E). While HF 
feeding resulted in an increase in the master regulator of mitochondrial biogenesis, 
Peroxisome Proliferator-Activated receptor-γ Coactivator 1α (PGC-1α), this effect 
was not observed in HF muscles given heat treatment (Figure 25F). Mitochondrial 
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protein expression was not significantly altered in the soleus muscle with diet or heat 
treatment (data not shown).   
 In spite of the increase in mitochondrial protein expression seen with a HF 
diet, mitochondrial enzyme activity was not maintained in EDL muscle. A 12 week 
HF diet resulted in a slight decrease in citrate synthase and cytochrome oxidase 
activity in EDL muscles (Figure 26A & B). In muscles given weekly heat treatment, 
enzyme activity levels were maintained. Soleus muscle mitochondrial enzyme 
activity was unchanged with diet or heat treatment. 
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Figure 25. HF-feeding results in an increase in mitochondrial protein expression 
but this increase does not occur when HF-fed rats are given heat treatment. 
EDL muscles from Chow, HF+ST and HF+HT rats were analyzed for mitochondrial 
protein expression using Western blot analysis. Cytochrome c (A), citrate synthase 
(B), cytochrome c oxidase subunit-1 (Cox-1) (C) and cytochrome c oxidase subunit-
4 (Cox-4) (D) were increased with HF feeding in EDL muscles but not in rats given 
heat treatment. UCP-3 expression was increased with HF feeding and further 
potentiated by HT (E). The long form of UCP-3 is detected at 33 KDa and short form 
is detected at 27 KDa. Expression of the master regulator of mitochondrial 
biogenesis, PGC-1α (F) was also increased in EDL with HF, but no increase was 
seen with HT. (**P<0.01, *P<0.05 HF+ST vs Chow; #P <0.05 HF+HT vs HF+ST, 
+P<0.05 HF+HT vs Chow). Values are means of ± SE for 5-7 muscles per group. 
 
 189
FIGURE 26. 
Figure 26. Heat treatment maintains citrate synthase and cytochrome oxidase 
activities in the presence of a HF diet. Soleus and EDL muscle homogenates were 
assessed for citrate synthase (A) and cytochrome oxidase (B) activity levels as 
described in the methods section. Citrate synthase activity was normalized to total 
protein levels of citrate synthase and cytochrome oxidase activity was normalized to 
total Cox-4 protein present in EDL and soleus muscles.  (#P <0.05 HF+HT vs 
HF+ST). Values are means of ± SE for 5-7 muscles per group. 
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Acute effects of heat treatment on glucose uptake and mitochondrial function  
 We measured, for the first time, the effects of a single heat treatment on 
skeletal muscle glucose uptake and insulin signaling. As shown in Figure 27, 24 h 
after heat treatment, insulin-stimulated glucose uptake was increased in EDL muscles 
above that seen with insulin alone, with no effect of heat treatment in soleus muscle. 
Phosphorylation levels of the insulin signaling intermediates Akt and AS160 were not 
increased in either muscle 24 h after one heat treatment (data not shown). Additional 
time points may be necessary to determine effects of acute heat treatment on insulin 
signaling.  
 
FIGURE 27.  
  
 
Figure 27. A single bout of heat treatment improves insulin stimulated glucose 
uptake in EDL muscle. Male Wistar rats received one heat bout of 41oC for 20 min 
or a sham treatment of 36oC for 20 min. Twenty-four hours post treatment, insulin-
stimulated glucose uptake was assessed in isolated soleus and EDL muscles. 
(**P<0.001, *P<0.05 Insulin vs. Basal and #P <0.05 Heat treatment vs. Sham). 
Values are means of ± SE for 7-10 muscles per group. 
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To determine the impact acute heat treatment may have on mitochondrial function, 
we measured oxygen consumption in L6 muscle cells (Figure 28A). L6 muscle cells 
treated with TNF-α, a cytokine known to induce mitochondrial dysfunction and 
insulin resistance (Mariappan et al. 2007), show reduced ATP-coupled oxygen 
consumption compared with untreated cells (Figure 28B). In contrast, cells given one 
heat treatment in the presence of TNF-α show preserved ATP-coupled oxygen 
consumption. Maximal respiratory rate and proton leak showed a non-significant 
increase with heat treatment (Figure 28C and 28D). As another assessment of 
mitochondrial function, fatty acid oxidation in response to palmitate and heat 
treatment was measured in L6 cells. Exposing L6 cells to chronic palmitate results in 
decreased fatty acid oxidation and insulin resistance (Pimenta et al. 2008) and 
decreased mitochondrial enzyme activity (Bonnard et al. 2008). In the current study, 
chronic exposure of L6 cells to palmitate reduced the fatty acid oxidation rate, while 
heat treatment resulted in a small but significant increase in fatty acid oxidation 
(Figure 28E). These findings suggest acute heat treatment can positively enhance 
glucose uptake and mitochondrial function.  
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Figure 28. Heat treatment improves oxygen consumption and fatty acid oxidation 
in L6 muscle cells. (A) Representative tracing of O2 consumption rates in L6 
myotubes in a respirometer. Rates were determined by measuring O2 consumption in 
time frames O1 for Baseline, O2 for rates after oligomycin addition (1 µg/ml), O3 for 
rates after FCCP (3 µM) addition, O4 for  rates after rotenone (1 µM)/myxothiol (2 
µM) addition. O2 consumption rates of L6 cells were measured under control 
conditions, after treatment with TNF-α (20 ng/mL, 24 hr) and treatment with both 
TNF-α (20 ng/mL, 24 h) and one bout of HT (43°C, 20 min, recovery 24 h). ATP-
coupled oxygen consumption (B) was calculated as the mitochondrial rate sensitive to 
oligomycin, proton leak (C) as the mitochondrial rate insensitive to oligomycin and 
maximal uncoupled respiration rate (D) as the O2 consumption rate after FCCP 
addition (Amo et al. 2008). Rates were normalized to cellular protein, calculated in 
pmol/s.mg and expressed as percentage of basal (*P< 0.001 TNF- α vs Control, 
#P<0.01 TNF-α+HT vs TNF- α). Values are means of ± SE for 5-6 samples per group. 
(E) L6 cells were treated with 200 μM palmitic acid coupled with BSA for 72 hours 
(PA) while control cells received BSA only (Basal). A subgroup of cells (PA+HT) 
received two heat treatments (43°C, 20 min), one right before the palmitate incubation 
and one after 48 hours. Cells were washed thoroughly and fatty acid oxidation was 
assayed using 3H-palmitate-BSA (125 uM). (*P<0.001 PA vs. Basal and +P=0.05 
PA+HT vs. PA). Values are means of ± SE for 4 wells per group. 
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6.5. Discussion 
 
 New data in the present study demonstrates the ability of heat treatment to 
restore glucose uptake and improve insulin signaling in skeletal muscle from rats fed 
a HF diet. Our results indicate heat treatment can prevent an increase in JNK 
phosphorylation and IKKβ activation, possibly through direct interaction with the 
inducible HSPs, HSP72 and HSP25, respectively. Heat treatment increases 
mitochondrial HSP60 and UCP-3 expression and maintains mitochondrial enzyme 
activity in the presence of a HF diet. Our findings in L6 muscle cells indicate acute 
heat treatment increases mitochondrial oxygen consumption and fatty acid oxidation. 
These results provide strong evidence that HSP induction in skeletal muscle could be 
a potential therapeutic treatment for obesity-induced insulin resistance. 
 Twelve weeks of a HF diet resulted in increased overall body weight and 
epididymal fat pad weight. Epididymal fat pad weight was reduced with heat 
treatment although body weight and food intake remained the same between the HF 
sham and heat treated rats. These changes suggest an increased level of metabolism in 
the animals receiving heat treatment. Whole body hyperthermia has been shown to 
reduce plasma triglycerides and free fatty acids in db/db mice (Kokura et al. 2007), 
suggesting heat treatment improves fatty acid utilization and reduces their 
accumulation. Data from the current study demonstrating increased fatty acid 
oxidation in palmitate treated muscle cells with acute heat treatment support this idea. 
Future studies are needed to measure the effects of chronic heat treatment on fatty 
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acid oxidation in skeletal muscle. Heat treatment, like exercise, could increase the 
cells’ demand for energy such that fatty acid uptake and utilization are matched, 
reducing the accumulation of free fatty acids and adipose tissue in the presence of a 
HF diet.  
 We demonstrate for the first time that heat treatment can restore insulin-
stimulated glucose transport and increase activation of insulin signaling intermediates 
in skeletal muscles from HF-fed rats. Increased oxidative stress has been strongly 
implicated as a cause of diet induced-insulin resistance (Houstis et al. 2006; 
Matsuzawa-Nagata et al. 2008). Activation of stress-induced kinases such as JNK, 
glycogen synthase kinase (GSK3β), IKKβ and protein kinase C (PKC-θ) (Wellen and 
Hotamisligil 2005; Vinayagamoorthi et al. 2008) can cause inhibitory 
phosphorylation of IRS-1 on serine 307. A decrease in muscle oxidative stress with 
heat treatment could result in decreased stress kinase activation and improved insulin 
signaling. Alternatively, HSP72 and HSP25 have been implicated as natural inhibitors 
of JNK and IKKβ, respectively (Park et al. 2001; Park et al. 2003). 
 In soleus and EDL muscles, an increase in HSP72 expression with heat 
treatment was accompanied by a concomitant decrease in JNK activity. Our findings 
combined with Chung et al. (Chung et al. 2008) indicate HSP72 protection is strongly 
associated with prevention of JNK phosphorylation. HSP25 phosphorylation was 
increased in the EDL muscles with heat treatment, and a corresponding reduction in 
IKKβ was observed. However, without an induction of HSP25 in soleus muscle, 
IKKβ was unchanged with heat treatment. This suggests IKKβ may not play a 
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significant role in insulin resistance in the soleus muscle, since insulin signaling and 
glucose uptake were restored despite the lack of effect on IKKβ. Higher constitutive 
levels of HSPs in the soleus muscle may provide protection from stress kinase 
activation, as evidenced by much smaller activation of JNK in soleus compared to 
EDL. Muscle fiber type differences and the potential role of HSP25 were not 
explored in the previous study by Chung et al. (Chung et al. 2008) and demonstrate 
the importance of fiber type and pre-existing HSP levels in determining HSP function 
in skeletal muscle.  
 Changes in mitochondrial number and function with obesity and insulin 
resistance are currently controversial in the literature (Petersen et al. 2004; Morino et 
al. 2006; Turner et al. 2007; Bonnard et al. 2008; Hancock et al. 2008; Koves et al. 
2008). Our findings agree with previous studies demonstrating an increase in 
mitochondrial proteins with a HF diet (Garcia-Roves et al. 2007; Turner et al. 2007; 
Hancock et al. 2008). Proteins involved in mitochondrial metabolism increased with a 
HF diet in EDL muscle, however this increase did not occur in HF-fed rats given heat 
treatment. It is hypothesized that skeletal muscle mitochondrial biogenesis occurs as 
an adaptation to an increased supply of fatty acids with a HF diet. An increased 
muscle energy demand, as a result of heat treatment given in parallel with a HF diet, 
could reduce the accumulation of free fatty acids and preclude the stimulus for 
mitochondrial biogenesis with a HF diet in the EDL muscle. Interestingly, 
mitochondrial biogenesis occurs in response to a HF diet in fast-twitch glycolytic and 
not in slow-twitch oxidative muscle. To our knowledge, this is the first study to make 
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this direct comparison in fast- and slow-twitch muscles and could explain 
contradictory findings in the literature using mixed muscle types. Oxidative muscle 
has greater potential to fully oxidize lipid substrates (Koves et al. 2005) and therefore 
may not undergo adaptive mitochondrial biogenesis in the presence of a HF diet. In 
spite of HF diet-induced mitochondrial biogenesis, citrate synthase and cytochrome 
oxidase activities decreased in EDL muscle. Bonnard et al. (Bonnard et al. 2008) 
suggest a decrease in citrate synthase activity in mice with 4 weeks of HF feeding, 
despite any other indications of mitochondrial dysfunction, could reflect initiation of 
mitochondrial dysfunction subsequently observed with 20 weeks of HF feeding. 
Other studies have demonstrated an increase in mitochondrial function, as measured 
by oxidative capacity, with a HF diet in parallel with increased mitochondrial protein 
expression (Garcia-Roves et al. 2007; Turner et al. 2007; Hancock et al. 2008). It is 
unknown whether muscle oxidative capacity could increase due to enhanced fatty 
acid oxidation even in the presence of decreased citrate cycle and respiratory chain 
enzyme activity. Interestingly, Koves et al. (Koves et al. 2008) found that in spite of 
high rates of fatty acid catabolism with HF feeding, moderate depletion of several 
citrate cycle intermediates occurred in insulin resistant muscle. These authors 
hypothesize that an increase in fatty acid oxidation that is not matched by increased 
flux through downstream mitochondrial pathways results in an accumulation of 
incomplete fatty acid oxidation by-products and reactive oxygen species (ROS) that 
could activate stress kinases (Koves et al. 2008; Muoio and Newgard 2008).  
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 In this context, heat treatment, like exercise training (Koves et al. 2008), could 
result in a coordinated increase between fatty acid oxidation and downstream 
mitochondrial pathways in skeletal muscle. In support of this idea, citrate synthase 
and cytochrome oxidase activity levels were restored in EDL muscles of rats given 
heat treatment in the present study. In addition, data from L6 muscle cells suggest 
heat treatment can increase fatty acid oxidation and mitochondrial oxygen 
consumption. This data is supported by previous studies demonstrating HSPs can 
protect and enhance mitochondrial function (Polla et al. 1996; Sammut et al. 2001). 
Future studies are needed to assess chronic heat treatment on specific steps in fatty 
acid metabolism in conjunction with a HF diet. 
 Mitochondrial proteins HSP60 and UCP-3 were increased in response to heat 
treatment in the current study. HSP60 has been shown to protect complex IV activity 
in mitochondria (Veereshwarayya et al. 2006) while heat treatment enhanced 
mitochondrial complex I-V activity (Sammut et al. 2001). Based on previous findings 
and those of the current study, the mitochondria may be a primary target site for the 
protective effects of heat treatment from oxidative stress (Polla et al. 1996). UCP-3 
expression increased in response to a HF diet and to a greater extent with heat 
treatment in the EDL muscle. Although efforts to define UCP-3 function are ongoing, 
a recent study suggests UCP-3 induction may limit ROS emission in conditions of 
lipid excess (Anderson et al. 2007). Increased UCP-3 with heat treatment could 
reduce ROS and enhance metabolic flux through mitochondrial pathways. Future 
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studies are needed to investigate these potential heat shock-mediated mechanisms in 
the prevention of insulin resistance.  
 In conclusion, our study shows that weekly in vivo heat treatment can mitigate 
HF diet-induced skeletal muscle insulin resistance. Our findings indicate heat 
treatment decreases JNK phosphorylation and IKKβ activation, significantly 
improves insulin signaling and glucose uptake, and preserves oxidative 
phosphorylation capacity. Exercise, resveratrol, the small molecule BGP-15, and 
lipoic acid have all been shown to induce HSP expression. Targeted induction of 
HSPs for the prevention of insulin resistance is a realistic approach for future 
therapeutic applications.  
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SUMMARY OF RESULTS AND DISCUSSION 
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7.1. Summary of results 
 
Our studies examined the role of stress kinases in insulin resistance in aging 
and high fat diet models, and determined the role of heat shock proteins in protecting 
against insulin resistance. The principle findings and future implications of our 
studies are as follows: 
1.) Age-related insulin resistance is associated with stress kinase activation 
and reduced HSP expression. Stress kinase activities are exacerbated in fast-twitch 
muscles compared to slow-twitch muscles, the latter showing greater HSP expression 
and being less affected by insulin resistance.  
? These observations raise an important question as to whether or not high HSP 
expression provides the slow-twitch muscles with a greater ‘reserve capacity’ to 
handle oxidative stress. Our studies highlight the importance of fiber type and 
preexisting HSP levels in determining insulin action.  
2.) We show for the first time that HSP72 overexpression via heat treatment in 
the aging soleus muscle directly inhibits JNK activation.  
? This role of HSP72, as a natural inhibitor of JNK, could be potentially explored to 
design treatments that alleviate JNK-induced insulin resistance. Additional potential 
mechanisms of heat shock protein action and its applications in other tissues also 
need to be investigated. For example, heat-induced HSP72 may have ‘hormetic’ 
effects, protecting the body from various stressors of aging/HF feeding. 
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3.) Normal aging in the brain is associated with oxidative stress, but, in 
contrast to the muscles, the neurons in the brain exhibit high levels of compensatory 
defense mechanisms. We report that HSP25 expression in the brain is robustly 
increased with age.  
? We hypothesize that, in situations where this protection is lost, the brain could 
become more susceptible to neurodegenerative disorders like AD and PD.  
4.) The anti-oxidant lipoic acid alleviates high fat diet-induced insulin 
resistance, and we show that the underlying mechanisms of action include inhibition 
of stress kinases JNK and IKKβ, activation of AMPK, p38 MAPK and importantly, 
induction of HSPs.  
? To our knowledge, this is the first report of HSP protein induction by LA, which 
supports the theory that LA has both pro-oxidant and anti-oxidant properties that 
make it a very versatile therapeutic agent. 
 5.) Our studies show that weekly heat treatment protects against high fat diet-
induced insulin resistance. For the first time, we show that heat treatment protects 
muscle-specific insulin signaling and glucose uptake, and reduces stress kinase 
activities. Heat treatment resulted in systemic improvements of glucose tolerance, 
reductions in fat deposition and hyperinsulinemia. Further, we demonstrate that the 
benefits of heat treatment also come from its protective actions in the mitochondria, 
which are stressed with lipid overload due to high fat feeding.  
? These results provide strong evidence that HSP induction in skeletal muscle could 
be a potential therapeutic treatment for obesity-induced insulin resistance. Our studies 
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also give an insight into the muscle-specific mitochondrial protein changes in insulin 
resistance and propose a potential role for HSPs in enhancing mitochondrial function 
to more effectively cope with lipid overload and its detrimental effects. HSP-inducing 
treatments such as heat, exercise and pharmacological agents need to be investigated 
for therapeutic applications.  
Taken together, our studies show that age-related and obesity-related insulin 
resistance are associated with increased stress kinase activities and that HSP 
upregulation can prevent insulin resistance in both cases. The following discussion 
attempts to explain the rationale behind using HSP-inducing stressors for treatment, 
identifies similarities and differences in the two models of insulin resistance studied 
here, explains the variations in observations in the different muscle fiber types and 
provides possible explanations to some controversies in the field. 
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7.2. Discussion 
 
7.2.1. Heat treatment, a mild stress: the concept of hormesis: 
In our studies, we found that mild heat treatment induces HSP expression and 
decreases insulin resistance. One might wonder how heat stress, a stress in itself, can 
protect against stressors that cause insulin resistance. The prevailing theory is that 
mild heat stress, as well as other stresses discussed below, function in a ‘hormetic’ 
fashion to prepare the body to combat larger stresses. 
  ‘Hormesis’ refers to the beneficial effects of a toxin or stress at low doses, 
which at higher doses would have an opposite and detrimental effect (Mattson 2008). 
Several phytochemicals are believed to reduce the risk for diseases such as cancer, 
CVD, neurodegenerative diseases, and delay the aging process. Their primary 
mechanism of action is believed to be their roles as anti-oxidants, but recent evidence 
suggests that they have a hormetic effect and prepare the body to protect against the 
above risks. In a plant, these phytochemicals function as toxins to protect against 
predators such as insects. However, in the small doses that humans consume them, 
these phytochemicals trigger an adaptive cellular stress response mechanism that 
enables protection from a variety of adverse conditions (Son et al. 2008). Resveratrol 
and curcumin are some examples of phytochemicals shown to improve glucose 
metabolism and increase lifespan (Baur et al. 2006; Lagouge et al. 2006; Weisberg et 
al. 2008). Interestingly, both of these chemicals also induce HSP72 expression 
(Kanitkar and Bhonde 2008; Putics et al. 2008). It has been proposed that 
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phytochemicals mediate their action by stimulating production of antioxidant 
enzymes and protein chaperones as a protective mechanism against even larger 
stressors to come.  
Therefore, although heat treatment is a stress in itself; mild heat treatment has 
hormetic mechanisms of action. We propose that mild heat treatments, like the 
phytochemicals, induce cellular stress response elements (such as the HSPs) and thus 
protect against the insult of high fat feeding and age-related oxidative stress. In 
support of this idea, it has been shown that repeated mild heat stress to human skin 
fibroblasts undergoing aging in vitro has an anti-aging hormetic effect. The effects 
include maintenance of stress protein profiles, reduction of oxidatively damaged 
proteins, enhanced levels of antioxidant enzymes and stimulation of proteasomal 
activities to degrade abnormal proteins (Rattan 2005). We found that lipoic acid, 
commonly studied as an anti-oxidant, also induces HSPs. Therefore, the HSP-
inducing ability of LA might be a hormetic effect that has yet to be formally 
recognized as such. This concept of hormesis is receiving increasing attention in 
elucidating the therapeutic role of phytochemicals in improving disease resistance in 
neurological disorders (Son et al. 2008), and could have future implications in 
designing treatments to protect against insulin resistance.  
7.2.2. Aging versus obesity:  
In our studies, we examined insulin resistance in aging and obesity, but 
whether the underlying causes of insulin resistance are the same in the two cases is 
not clear. We believe that the connecting link between the two models is the common 
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pathology of increased oxidative stress (Berlett and Stadtman 1997; Levine 2002). In 
aging, a lifelong accumulation of ROS through metabolic processes, as well as 
increasing mtDNA mutations (hence mitochondrial dysfunction) are responsible for 
oxidative stress  (Melov et al. 1995; Short et al. 2005; Frisard and Ravussin 2006). In 
the case of obesity, excessively large lipid load and reduced metabolic demand for 
ATP results in incomplete lipid oxidation and ROS production (Furukawa et al. 2004; 
Muoio and Newgard 2008). It is this chronic oxidative stress that is becoming 
increasingly recognized as the underlying trigger for insulin resistance (Houstis et al. 
2006).   
Aging is often associated with adiposity, which raises the question of whether 
age-related insulin resistance is really a consequence of the aging process or of excess 
fat accumulation. To that end, abdominal adiposity has been shown to be a better 
predictor of insulin resistance than fitness levels in the elderly (Racette et al. 2006). 
But the strongest evidence for involvement of muscle-insulin resistance versus 
adiposity induced-insulin resistance in aging came from a study by Petersen et al. 
(Petersen et al. 2003). In this study, young and elderly subjects were matched for lean 
body mass and percent fat mass. The selected subjects in the study were all lean 
(BMI<25 m2/kg), and young (18 to 39 years old) subjects were compared with old 
subjects (61 to 84 years old). Despite removing the adiposity variable, the study 
found that the elderly were more insulin resistant than the fat mass-matched young 
individuals. Petersen et al. concluded that the insulin resistance was associated with 
reduced insulin-stimulated muscle glucose metabolism, which was, in turn, associated 
 208
with increased intramuscular lipid accumulation and a 40% reduction in 
mitochondrial oxidative and phosphorylation activity (Petersen et al. 2003). 
Therefore, when studying age-related insulin resistance, it would be important to use 
the appropriate animal model and take the adiposity into account.  
7.2.3. Choosing the right animal models: 
- Aging models: In our studies, the choice of animal model with respect to 
aging was influenced by the adiposity component, in an effort to determine whether 
the adiposity or pathogenic changes due to aging are responsible for the age-related 
insulin resistance. The Fischer 344XBrown Norway hybrid rat model gains 
significant abdominal fat mass, lives longer and exhibits significant sarcopenia, and is 
thus regarded as a superior model for studying age-related diseases (Larkin et al. 
2001). We used this rat model to study age-related changes in HSP expression in the 
brain. But for studying age-related insulin resistance, we used non-hybrid Fischer 344 
rats, in order to reduce the adiposity variable in our studies. The Fischer 344 rats 
exhibit muscle insulin resistance, but do not exhibit as much adiposity as the Fischer 
344XBrown Norway hybrids. To confirm age-related muscle pathology and 
sarcopenia, we measured the muscle mass of young and old Fischer 344 rats. When 
muscle mass is compared with body weight, Fischer 344 rats also exhibit significant 
sarcopenia (Young soleus 0.530±0.03 g, Aged soleus 0.397±0.02 g, n=3, P=0.01).  
- High fat feeding models of insulin resistance: Several models of obesity-
induced insulin resistance have been reported in the literature, including genetically 
altered models such as the ob/ob mice, db/db mice, zucker fatty rats (White and 
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Martin 1997; Lindstrom 2007), and diet induced obesity models (Buettner et al. 
2007). Although genetically altered (leptin deficient/mutated leptin receptor) mice 
exhibit strong insulin resistance and hyperglycemia, these models do not sufficiently 
represent the majority of obesity cases in humans. Obesity due to leptin deficiency is 
extremely uncommon in humans (Friedman and Halaas 1998). For this reason, we 
removed the variable of genetic susceptibility from our studies and used a high fat 
diet model to mimic the obesity-inducing Western diet. Male Wistar rats were given a 
fat-rich diet, in which 60% of the calories came from fat. This model and diet 
composition (modified from the Kraegen diet (Storlien et al. 1986)), has been 
extensively used in previous studies, and results in whole body and muscle specific 
insulin resistance (Kim et al. 2000). Recent studies report that effects of the high fat 
diet vary with sex, strain and age of the animals at the start of the diet regime 
(Nishikawa et al. 2007). Therefore it would be important to extensively characterize 
the specific model used within each study.  
7.2.4. Muscle fiber type differences: 
The skeletal muscle is highly heterogeneous and differences in the metabolic 
properties of the muscle fiber types are striking. Therefore, it became important in our 
studies to examine the effects of insulin resistance and interventions to alleviate it in 
both the fast- and slow-twitch muscles.  Insulin’s action of glucose uptake and 
metabolism occurs in a muscle fiber type-specific pattern, with a greater response of 
insulin signaling and glucose uptake seen in type I versus type II (Song et al. 1999). 
Sarcopenia in aging is associated with a loss of primarily type II muscle fibers 
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(Grimby 1995), but in contrast, it is the percentage of type I muscle fibers that is 
reduced with extreme obesity (Hickey et al. 1995; Gaster et al. 2001) and inactivity 
(Hjeltnes et al. 1998).  
In our studies, we see that fast-twitch epitrochlearis muscles show reduced 
insulin sensitivity compared with slow-twitch soleus muscles, and further reduction 
occurs with age (Chapter 2). In contrast, high fat feeding showed slightly more 
insulin resistance in slow-twitch soleus muscles than in fast-twitch EDL muscles 
(Chapter 6), a finding also supported by previous observations (Song et al. 1999). But 
upregulation of mitochondrial proteins in response to HF feeding occurred only in the 
EDL muscles. These observations indicate that compensatory mechanisms activated 
to rescue insulin action are different within muscle types and between aging and 
obesity. 
One possible explanation is the source of oxidative stress in the two cases. In 
the case of aging, it is likely that the cumulative mtDNA mutations leading to 
mitochondrial dysfunction cause oxidative stress. The soleus muscles appear to have 
a ‘reserve capacity’ (large number of mitochondria, greater expression of insulin 
signaling intermediates and more GLUT4) that protects them from becoming severely 
insulin resistant. High levels of oxidative stress in the type II muscle fibers with age 
(Anderson and Neufer 2006) cause dysfunction to the smaller number of 
mitochondria in these fibers. Also, greater mitochondrial dysfunction with age is 
evident in muscles with higher type II fiber content in humans (Conley et al. 2007). 
Therefore, in terms of insulin action, the fast twitch muscles do worse with aging. 
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In the case of high fat feeding, a mitochondrial compensation to handle the 
excess lipid load is seen only in the fast-twitch fibers and this compensation could be 
protecting these fibers from insulin resistance. Since fast-twitch fibers have less 
oxidative capacity, lipid overload in high fat feeding forces a fuel switch which, in 
turn, forces a mitochondrial biogenesis response. Previous studies showing robust 
mitochondrial biogenesis in response to HF feeding have also reported this 
observation in fast-twitch epitrochlearis muscle (Hancock et al. 2008) or mixed 
quadriceps (Turner et al. 2007); but neither of these studies examined slow-twitch 
muscle types. We believe that this compensation may eventually fail as the duration 
of the diet increases and the disease becomes more severe. Further studies using 
several different age-points, durations of HF diet and fiber-type specific analyses will 
be needed to see whether insulin resistance occurs before or after mitochondrial 
dysfunction in aging and obesity. 
7.2.5. Mitochondrial controversies: the chicken or the egg? 
 In our studies, we observed mitochondrial dysfunction in the aging skeletal 
muscle (Chapter 2) and increased mitochondrial protein expression with high fat 
feeding (Chapter 6). As illustrated in the introduction (Chapter 1, section 1.4.4.), 
strong evidence suggests that mitochondrial depletion and dysfunction is associated 
with insulin resistance (Petersen et al. 2004; Lowell and Shulman 2005; Morino et al. 
2006), while opposing evidence suggests that insulin resistance can occur in the 
presence of elevated mitochondrial number and activity (Turner et al. 2007; Hancock 
et al. 2008). Clearly, future studies are required to fully elucidate the association of 
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mitochondrial function and insulin resistance. It would be important to investigate 
whether these discrepancies arise from the type of diet regimes, duration of diet, the 
tissue under study, severity of the disease or animal models versus human tissue 
under study. Several of these studies have used mixed muscles such as the quadriceps 
muscle. Because the slow-twitch and fast-twitch muscles have distinctively different 
mitochondrial capacity and metabolic responses, one would expect differential 
responses to a HF diet in the two muscle types. Further, given the vastly different 
HSP levels in the two muscle types, it would be important to understand the muscle 
type-specific responses to both a high fat diet as well as heat-induced mechanisms 
that improve mitochondrial function.  
It has been suggested that mitochondrial dysfunction occurs over time. 
Chanseuame et al. (Chanseaume et al. 2007) showed that a HF diet induces an initial 
increase in mito-OXPHOS activity, followed by a decrease. Respiration rates and 
ATP production increased with HF diet at day 14, and then were significantly reduced 
at day 40, compared with the controls. The authors report that mitochondrial 
dysfunction in the oxidative muscle occurs late and most likely occurs after the onset 
of insulin resistance within the muscle. One could hypothesize that this result might 
be due to the greater ‘reserve oxidative capacity’ of this muscle type. Although there 
is an initial compensation for processing the excess free fatty acids, the mitochondria 
eventually lose the ability to keep up in the face of prolonged excess fat delivery. So, 
before getting ‘victimized,’ the mitochondria attempt to compensate and thus, any 
intervention to increase mitochondrial OXPHOS activity should be advantageous to 
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the prevention of frank diabetes (Chanseaume et al. 2007). We show that heat 
treatment increases the mitochondrial OXPHOS activity, thereby protecting the 
muscle from lipid accumulation and insulin resistance.  
To understand the mitochondrial biogenesis response to prolonged HF 
feeding, we examined PGC-1α expression in 2 different diet regimes and in db/db 
diabetic mice (preliminary data, Figure 29). Our data shows PGC-1α expression 
increased by 60% in rats fed a high fat diet for 6 weeks, but only a mere 25% increase 
was observed in a more severe model of 12 weeks of high fat feeding. Further, db/db 
diabetic mice showed a reduction in PGC-1α expression. Thus, these data support the 
idea that severity or duration of the high fat diet affects mitochondrial compensation, 
which eventually fails in frank diabetes.  
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FIGURE 29. 
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Figure 29. PGC-1α expression changes with longer duration of HF diet and 
obesity. PGC-1α expression increases with HF feeding, potentially to compensate for 
the lipid overload. However, increase in PGC-1α is less with longer duration of the 
HF diet and obesity. Muscles from male Wistar rats fed a high fat diet for 6 weeks or 
12 weeks and from ob/ob obese mice were analyzed for PGC-1α expression with 
Western blot analysis. Within each group, values were compared with the respective 
controls (chow-fed rats for HF diet and wild type mice for db/db) and values were 
expressed as percentage change from controls.  N=5-7 per group. 
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In our studies, we see increased mitochondrial protein expression with high fat 
feeding in EDL muscles only. Heat treatment normalized the protein levels and 
increased mitochondrial function to the levels of the controls, again only in the EDL 
muscles. This muscle-type specific response to high fat diet gives an interesting 
insight into the importance of pre-existing oxidative capacity of the muscle. In 
support of this idea, it has been previously reported that UCP-3 levels are lower in 
oxidative than in glycolytic fibers (Hesselink et al. 2001), and we were not able to 
detect any expression of UCP-3 in slow-twitch soleus muscle (Chapter 6). It has been 
proposed that fibers already equipped with an increased capacity for handling fatty 
acids would not require UCP-3-mediated fatty acid-handling pathways. Anderson et 
al. showed that induction of UCP-3 by exercise suppresses mitochondrial oxidant 
emission during fatty acid-supported respiration (Anderson et al. 2007). Thus, UCP-3 
could control ROS production in heat treated muscles from HF rats, in spite of 
increased fatty acid oxidation. 
Increased capacity for fatty acid oxidation is potentially a compensatory 
response to elevated fatty acid substrate availability. For example, mice with muscle-
specific overexpression of lipoprotein lipase, which increases influx of fatty acid into 
the muscle, show extensive mitochondrial proliferation (Levak-Frank et al. 1995). 
Despite the increases in fatty acid oxidation seen in the studies by Turner et al. and 
Hancock et al. (Turner et al. 2007; Hancock et al. 2008), intramuscular lipid is a 
characteristic feature of these animal models. Increased fatty acid uptake in these 
muscles may cause accumulation of the lipids, but the compensatory increase in fatty 
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acid oxidation is not capable of completely eliminating the fatty acids. These models 
also show increased adipose mass and circulating free fatty acids (Hegarty et al. 
2002).  
Using transcriptomics and targeted metabolic profiling tools based on mass 
spectrometry it was suggested that lipid-induced insulin resistance is a condition in 
which upregulation of PPAR-targeted genes and high rates of beta-oxidation are not 
supported by a commensurate upregulation of the tricarboxylic acid (TCA) cycle 
activity (Koves et al. 2008). The authors suggest that high fat feeding results in a 
persistent burden of high lipid load to the mitochondria, and this lipid load increases 
beta-oxidation. The disconnection between the rates of oxidation and TCA result in 
accumulation of incompletely oxidized acyl-carnitine intermediates. This group 
further found that exercise brings about tighter coupling between beta-oxidation and 
TCA (Reviewed in (Muoio and Koves 2007)). We hypothesize that heat treatment, 
like exercise, increases the coupling between beta-oxidation and TCA, such that flux 
through the mitochondria is increased. Increased mitochondrial flux then reduces 
fatty acid accumulation and deposition, as seen in our heat treated animals. In the 
future, it would be important to study the metabolic rates and oxygen consumption of 
these heat treated/HF-fed animals using metabolic chambers. Lipid accumulation is 
also reflective of the fact that the insulin-resistant muscle has ‘metabolic inflexibility’, 
such that its ability to select substrates for fuel metabolism and to transition between 
carbohydrates and fatty acid oxidation is lost in insulin resistance (Kelley et al. 2002). 
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Heat treatment could also have potential roles in reversing this ‘metabolic 
inflexibility’, a theory that needs experimental validation. 
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8.1. Mechanisms 
Future studies following this project, should focus on the mechanisms of HSP 
action using HSP knock out animals and or siRNA-knockdown techniques. While 
direct stress kinase inhibition is one of the putative mechanisms of action, the 
mechanism of mitochondrial protection by HSPs in insulin resistance is not very clear 
at this point. We see in our studies that heat treatment maintains mitochondrial 
function such that the muscles remain closer to homeostasis, in spite of high fat 
feeding, and exhibit characteristics similar to those of chow fed rats.  However, the 
molecular target(s) of HSPs in the mitochondria are unknown. HSPs are known to 
facilitate protein import into the mitochondria, improve enzyme function and reduce 
mitochondrial oxidative stress (Sammut et al. 2001; Young et al. 2003; Ouyang et al. 
2006). Also, whether the observed mitochondrial effects are due to heat shock 
proteins or the actual heat treatment is not known. One speculation is that heat 
treatment, like exercise, increases the flux of activated fatty acids through beta 
oxidation, TCA and the electron transport chain, and facilitates complete oxidation of 
the fatty acids. This reduces accumulation of fatty acids as adipose depots, as well as 
free fatty acids that impair insulin signaling. Despite high levels of fatty acid 
oxidation flux through the mitochondria, ROS levels might be maintained by UCP-3 
and the HSPs themselves; a theory that needs to be experimentally verified in future 
studies. An important follow-up experiment will be to feed HSP knockout (hspa1a, 
hspa1b-/-) mice a high fat diet and then determine whether or not insulin resistance is 
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worse than that of wild type mice. Such an experiment will determine the specific 
beneficial role of HSP72 on insulin action and mitochondrial function.  
In our studies, we saw that HSP72 showed the most robust effects in 
preventing insulin resistance, but other HSPs such as HSP25 and HSP60 also 
contributed. Studies examining aging effects in the brain show that HSP25 has more 
robust effects in the brain than HSC70, HSP72 and HSP60. Small HSPs like HSP32 
are known to increase with oxidative stress in neurons (Goldbaum and Richter-
Landsberg 2001), and may have potential roles in combating oxidative stress-
associated neuronal damage. In addition, it would be important to determine the 
cellular localization of the HSPs, especially HSP25, in response to age, diet and heat. 
HSP25 activation is accompanied by phosphorylation, oligomerization and nuclear 
localization, and HSP25 is thought to perform different functions in these three states 
(Benndorf et al. 1994). Thus, future studies would be important to characterize the 
functions of each of these major HSPs in insulin resistance and their induction with 
heat in different tissues.  
8.2. HSPs as therapeutic targets against insulin resistance 
Current therapeutic agents administered for controlling insulin resistance 
mainly consist of the thiazolidinediones (TZDs). TZDs function as insulin sensitizing 
drugs, by activating the transcription factor peroxisome proliferator-activate receptor 
γ (PPAR γ) axis and are thought to improve metabolism in both adipose tissue and 
liver (Bhatia and Viswanathan 2006). Although TZDs have so far been the best in 
improving glycemia control, several undesirable side effects have been reported, 
 221
including fluid retention (Berlie et al. 2007), weight gain (Boden and Zhang 2006), 
worsening of coronary artery disease and an increased risk of myocardial infarctions 
(Lincoff et al. 2007). Given the complications associated with the current 
therapeutics, it is highly crucial to discover novel therapeutic targets and therapeutic 
agents to improve glucose homeostasis with minimal side effects.   
HSPs represent a very important treatment target for insulin resistance and 
associated diseases. The importance of this under-appreciated role of HSPs is being 
increasingly recognized in the scientific community (Hooper and Hooper 2005; 
McCarty 2006). We report the role of HSPs in protection against insulin resistance, 
but the scope of this mechanism may not be limited to insulin resistance. HSPs also 
protect against disuse muscle atrophy in senescence (Dodd et al. 2008), as well as 
age-related muscle damage (Broome et al. 2006) and the mechanism involves 
inhibition of NF-κB and Foxo3a transcriptional activities (Senf et al. 2008). HSP70 
overexpression reduces symptoms of peripheral neuropathy in diabetes (Kurthy et al. 
2002) and increases beta-cell survival during chronic hyperglycemia (Laybutt et al. 
2002). Thus, sufficient evidence exists to show that HSPs may serve as a beneficial 
target for the treatment of insulin resistance and several associated complications. 
Current drug trials including that of BGP-15-like compounds should soon validate the 
use of HSPs as a therapeutic target (Kolonics et al. 2006). KU-32, a non-toxic small 
molecule, is an HSP90-inhibitor and therefore, functions as an HSP72-activator (Lu 
et al. 2008). KU-32 inhibits the interaction between HSP90 and HSF-1 such that free 
HSF-1 can then bind the heat shock elements and promote transcription of heat shock 
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genes.  Preliminary data from our lab showed that intraperitoneal administration of 
KU-32 induces HSP72 in the epitrochlearis muscle (Figure 30). Future experiments to 
determine the effects of this drug on insulin sensitivity will be important.  
While novel HSP-inducing drugs such as BGP-15 are being investigated, it 
would also be important to recognize the HSP-inducing properties of naturally 
occurring compounds such as glutamine (Wischmeyer et al. 2001), resveratrol (found 
in grapes (Putics et al. 2008)) and curcumin (found in curry spice turmeric (Kanitkar 
and Bhonde 2008)). These compounds have also shown beneficial effects in 
maintaining glucose homeostasis (Baur et al. 2006; Weisberg et al. 2008), and thus, 
warrant more attention as potential therapeutic agents. Including these compounds as 
dietary supplements may offer protection from insulin resistance. Novel resveratrol-
like compounds that are more efficacious are being investigated in clinical trials to 
treat metabolic disorders and age-related pathologies (Milne et al. 2007).  
 
 
 
 
 
 
 
 
 
 223
FIGURE 30.  
 
 
Young Aged Young Aged
H
SP
72
/T
ub
ul
in
0.0
0.2
0.4
0.6
0.8
1.0 Basal
 Vehicle
 *
*
#
 
 #
 
Soleus EPI
Figure 30. The HSP90-inhibitor, KU-32 induces HSP72 expression in the 
epitroclearis muscle. KU-32 (2 mg/kg body weight) was administered via 
intraperitoneal injection to young (6-month-old) and aged (30-month-old) 
F344XBrown Norway hybrid rats. HSP72 expression in the soleus and epitrochlearis 
muscles was determined 1 week after injection. KU-32 induced HSP72 expression 
only in the epitrochlearis (fast-twitch) muscle but not in the soleus (slow-twitch) 
muscle. KU-32-induced increase in HSP72 expression was dampened in the aged 
rats.  *P <0.05 KU-32 vs. vehicle, #P<0.01 aged vs young for KU-32 and vehicle; 
n=4-5 rats per condition. 
 224
8.3. HSP function in non-muscle tissues 
 Most of the HSP benefits reported here were observed in the skeletal muscle. 
We focused on the skeletal muscle because of its crucial function in glucose disposal 
and its ability to respond to HSP-inducers. However, preliminary data from our 
studies also suggest beneficial effects of HSPs in the liver and adipose tissue (data not 
shown). In response to heat treatment, both adipose tissue and liver were protected 
from HF diet-induced JNK activation, adipose tissue depots were reduced and 
triacylglycerol accumulation was reduced in the liver. Previous studies have 
repeatedly shown the benefits of heat pretreatment in recovery from ischemia-
reperfusion (Ooie et al. 2001). HSP70 overexpression protects mitochondria of the 
heart from hypoxia/reoxygenation injury (Williamson et al. 2008). HSPs are 
protective against nerve damage in neurodegenerative diseases. Gifondorwa et al. 
(Gifondorwa et al. 2007) have shown that exogenous delivery of HSP70 increases the 
lifespan in a mouse model of amyotrophic lateral sclerosis (ALS). HSP72 attenuates 
renal tubular cell apoptosis and interstitial fibrosis in obstructive nephropathy (Mao et 
al. 2008). Taken together, one can say that the benefits of HSPs are not limited to the 
skeletal muscle and could be potentially extrapolated to several other tissues. 
However, caution should be exercised in this approach, since different tissues appear 
to have different thresholds for HSP induction and have varied responses in aging and 
oxidative stress. For example, the fast-twitch muscles induce higher levels of HSPs 
with heat treatment than slow-twitch muscles. Further, our data shows that HSP 
expression decreases with age in the skeletal muscle whereas the brain actually shows 
 225
an age-related increase in HSP expression. We believe that this is because the neurons 
in the brain possess stronger anti-oxidant defense systems related to their essential 
functions in the body, and because they are one of the longest living cells in the body. 
Nevertheless, future translational use of HSPs must consider that some tissues will 
respond to HSP treatments to a greater extent than others.  
8.4. Exercise and heat shock proteins 
 Exercise is a potent inducer of heat shock proteins (Noble et al. 2008), 
although the precise mechanism(s) are currently poorly understood. The general 
consensus is that several factors, activated by exercise, act as stimuli for the HSP 
response. The stimuli include exercise-induced increase in muscle temperature (Oishi 
et al. 2002), reactive oxygen species generated during exercise (Kayani et al. 2008), 
ATP depletion (Chang et al. 2001) and activation of signaling pathways (Noble et al. 
2008). Exercise induces HSP expression in diabetic animals but the HSP response is 
severely blunted (Atalay et al. 2004). But if exercise training is started in the insulin 
resistant state (before diabetes), it can protect the HSP response and potentially 
prevent diabetes. One of the postulated mechanisms of exercise-induced HSPs is that 
exercise activates Akt (Sakamoto et al. 2003) and inhibits GSK3-β activity, which in 
turn regulates HSF-1 activation (Xavier et al. 2000). Therefore, exercise can 
positively regulate HSF-1 activity and prevent reduction of HSP response in diabetes 
and aging. 
 Our studies suggest that heat treatment and exercise have several similar 
effects. Both induce robust HSP expression and improve glucose uptake. But the 
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underlying mechanisms could be different. AMPK activation, mitochondrial 
biogenesis and increased GLUT4 (Holloszy 2005) are major mechanisms implicated 
in the insulin-sensitizing effects of exercise. None of these changes were observed in 
the heat-treated HF-fed animals. Heat treatment has direct effects on activation of the 
insulin signaling cascade, but like exercise, heat also increased mitochondrial 
function and mitochondrial flux. We therefore propose a combination therapy for 
those who cannot derive the benefits of exercise.  A co-therapy of heat, followed by 
exercise, might help in increasing the HSP response. Also, potentially lower heating 
temperatures and less intense exercise protocols could be employed to get the same 
beneficial effects of a single treatment of heat or exercise alone.  
8.5. Potential problems with HSP induction as a therapeutic intervention 
The role of HSPs in protection from neurodegenerative diseases has long been 
recognized, but none of the potential HSP-inducing drugs have had sufficient success. 
Geldanamycin was rejected for its toxicity, while its conjugates that followed are still 
being verified for toxicity (Sharp and Workman 2006). A large part of the concern 
regarding HSP drugs comes from the cancer literature. While we are trying to induce 
HSPs for protection from diabetes, some cancer researchers are trying to inhibit HSPs 
to reduce drug resistance, thermotolerance or increase immunosuppression (Yokota et 
al. 2000). So it would be imperative to use HSP treatment cautiously and design the 
treatment regime in a case-specific manner.  
Mild heat treatment used by our laboratory and others in diabetes research has 
shown significant benefits, but one has to be vigilant about the potential hazards of 
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heat therapy in treatment. In our study model, local heat treatment restricted to the 
lower body showed systemic benefits, suggesting that a treatment targeting just the 
skeletal muscles of the lower limbs can have whole body benefits. However, in 
elderly individuals or in individuals with advanced diabetes, the heat shock response 
ability is diminished (Hooper and Hooper 2005; Najemnikova et al. 2007; Kayani et 
al. 2008). Hence, a heat treatment of sufficient temperature and duration for 
promoting systemic benefits in such individuals may be very stressful and may cause 
other complications. Thus, use of HSP-inducing drugs may be more beneficial.  
 Several drugs belonging to the bimoclomol class of drugs are believed to act 
as co-inducers of HSPs rather than direct inducers of HSPs (Hargitai et al. 2003). 
Preliminary data from our lab suggests that resveratrol may serve to potentiate the 
heat shock response (Figure 31). Future studies examining the mechanism of HSP-
induction by resveratrol, its use as an HSP-co-inducer and its use as an insulin-
sensitizing drug could yield exciting information. Such drugs could be used in 
combination with a very mild heat therapy, where lower temperature or shorter 
duration of heat treatment may achieve an optimal HSP induction required for 
improving insulin sensitivity. Alternatively, such drugs could be used along with mild 
exercise. Therefore, a combination therapy involving a co-inducer and a low dose 
inducer could be a safer strategy of treatment. 
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FIGURE 31. 
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Figure 31. Resveratrol potentiates the effect of heat treatment on HSP72 
expression.  L6 myotubes were pretreated with vehicle (DMSO, Veh) or 100 µM and 
200 µM resveratrol (RSV) for 3 h. All cells except basals were then heat treated for 20 
min at 43 ºC. Cells were recovered for 24 h at 37 ºC with fresh RSV or vehicle. Cells 
were harvested to measure HSP72 expression with Western blot analysis. *P <0.01 
compared with all other groups, n=3-5 samples per condition. 
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8.6. Protecting HSP expression in diabetes and aging: a potential therapeutic 
strategy 
 In our study of heat treatment and high fat diet, we administered the heat 
treatment in parallel with the high fat diet, such that their HSP levels were maintained 
throughout their diet regime (Chapter 6). Since loss of HSP expression is a common 
finding in aging, obesity and frank diabetes, an important strategy of treatment could 
be aimed at maintaining tissue HSP expression. One thought is that insulin action is 
involved in maintaining the HSP response and this is mediated by PI3K-dependent 
Akt activation (Shinohara et al. 2006). Thus, HSP treatment benefits may be limited 
in the case of full blown diabetes. HSP expression is tightly controlled by GSK-3β, 
ERK and JNK via inhibitory phosphorylation of the transcription factor HSF-1 (Chu 
et al. 1996; Dai et al. 2000). Activation of these kinases is increased in insulin 
resistance (Aguirre et al. 2000; Dokken et al. 2005; Henriksen et al. 2008) and thus, 
HSF-1 is maintained in its inactive state. HSPs are, in turn, responsible for inhibiting 
stress kinases which means that regulation of HSPs and kinases is interdependent. 
Inhibition of GSK-3β, ERK and JNK may be especially important in individuals that 
are more susceptible to insulin resistance, such as first degree relatives of T2D 
patients, children in families with hereditary obesity or diabetes and people from high 
T2D-risk ethnic communities such as within the Hispanic, Native American and 
Asian Indian populations. 
While all of these proposed methods of HSP-based treatments may provide 
promising results of protection from insulin resistance, managing a healthy diet will 
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be of prime importance to their success, and such treatments should not be an excuse 
for leading an unhealthy lifestyle.  
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